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 Triploidy is the presence of 69 chromosomes instead of the normal diploid number of 46 and can 
occur in a complete form or in a mixoploid state in which there are populations of diploid and triploid 
cells in the same individual.  The extra haploid set can be of paternal or maternal origin.  Triploidy is one 
of the most common chromosome aberrations seen in 1-2% of all recognized pregnancies and can lead to 
partial mole which can in turn lead to serious complications for the mother and fetus.  Given the high 
incidence of chromosome abnormalities including triploidy and its impact on individuals with 
chromosomally abnormal pregnancies, a greater understanding of their etiology has a potential to 
contribute greatly to public health by enhancing the management and possible future prevention.   Though 
complete triploidy is not compatible with postnatal survival, mixoploid individuals are capable of 
surviving into adulthood.  Both syndromes have a broad phenotypic spectrum though it is generally less 
severe in mixoploids.  Though much has been learned in the nearly half century since the first case report 
of diploid/triploid mixoploidy was published, many questions still remain.  A major issue is a large 
between study difference in the ratio of diandric to digynic triploidy and the prevalence of partial 
hydatidiform mole.  Additionally, there is a clear parent-of-origin effect on fetal and placental 
morphology as well as developmental age that is believed to be related to genomic imprinting.  The goals 
of this paper include summarizing the current body of knowledge on triploidy and diploid/triploid 
mixoploidy, examining the remaining questions, and a side-by-side comparison of the two syndromes.  
An exhaustive literature search was undertaken which produced many case reports of triploidy and 
diploid/triploid mixoploidy as well as studies on the mechanisms leading to triploidy, phenotypic 
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characteristics, and the characteristics of triploid cells.  It appears that the complex pattern surrounding 
parental origin of the extra haploid set of chromosomes may have contributed to between study 
ascertainment bias.  More complex studies with careful attention to detail must be undertaken to fully 
understand the etiology and pathophysiology of triploidy
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1.0 INTRODUCTION 
 
 
 
Triploidy is defined as the presence of an extra haploid set of chromosomes for a total of 69 rather than 
the normal diploid number of 46 chromosomes.  It is believed that 1% of all fertilized eggs are triploid 
and that triploidy is present in 1-3% of all recognized pregnancies (ROSENBUSCH 2008; ZARAGOZA et al. 
2000).  Triploidy is also present in 99% of molar pregnancies than include an embryo or fetus (MALAN et 
al. 2006).  Triploidy is one of the three most common causes of pregnancy loss along with trisomy 16 and 
monosomy X, though its extremely high occurrence rate is often overlooked (EGOZCUE et al. 2002; 
ROSENBUSCH et al. 2002).   
 It is believed that 98-99% of all triploid conceptuses end in spontaneous abortions (PHILIPP et al. 
2004).  Triploidy is estimated to account for anywhere from 4.5% to more than 10% of all spontaneous 
abortions and miscarriages as well as accounting for 5% of those that are karyotyped (DEVRIENDT 2005; 
NIEBUHR et al. 1972; ROYSTON and BANNIGAN 1987; ZARAGOZA et al. 2000).  It is the most common 
chromosomal aberration seen among first trimester abortuses, accounting for 15-30% of such cases 
(BRANCATI et al. 2003; PETTENATI et al. 1986; TUERLINGS et al. 1993).  Among all spontaneous 
abortions, triploidy is thought to account for 10-21% of those found to have cytogenetic abnormalities 
(BETTS et al. 1989). 
 Triploidy is estimated to occur in 1 out of every 50-56,000 term births (GALAN et al. 1991; 
MARASCHIO et al. 1984).  Long intrauterine survival is extremely rare for triploid conceptuses with only 
0.08% of such pregnancies believed to reach term (FORRESTER and MERZ 2003).  Various studies have 
indicated that triploidy may account for 0.6% of all stillbirths and 0.002% of all livebirths, though among 
triploids only 1-2% are either stillborn or liveborn (ZARAGOZA et al. 2000).  It has been estimated that 
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approximately 1 in 10-20,000 triploid conceptuses result in livebirth (NIEBUHR 1974; ROSENBUSCH et al. 
2002). 
 The vast majority of triploid conceptuses likely fail before implantation, with only 10-13% of 
cultured triploid zygotes reaching the blastocyst stage (GOLUBOVSKY 2003; MALAN et al. 2006).  Indeed, 
triploidy is believed to be one of the most common fertilization errors responsible for early embryonic 
failure at the cleavage or implantation stage.  The early development of triploids often tends to fall behind 
that of normal diploid embryos, with developmental arrest being quite common and occurring around 5.1 
weeks gestation on average (NIEBUHR 1974).  Genotype as well as the presence or absence of a 
discernable embryo also appears to play a role in the developmental potential of triploid conceptuses.  In 
the absence of an embryo, 69,XXX and 69,XXY conceptuses usually arrest at 3-4 weeks as opposed to 
nine weeks when an embryo is present.  On the other hand, 69,XYY conceptuses almost never proceed 
beyond four weeks of development.  Development beyond 10 weeks of gestation is considered unusual in 
non-mosaic fetuses with most pure triploid conceptuses thought to die between three and six weeks of 
gestation  (BLACKBURN et al. 1982; GIURGEA et al. 2006).  A recent study found eight triploid 
conceptuses among 12,322 patients undergoing routine first trimester screening from 10-14 weeks 
gestations suggesting that the prevalence of triploidy may be as high as one in 1540 during this period 
(YARON et al. 2004) 
 It is very rare for triploid conceptuses to reach the fetal period.  The prevalence of triploidy is 
thought to be 1 in 3,500 at 12 weeks of gestation but declines to 1 in 300,000 by 16 weeks (DALMIA et al. 
2005).  It is thought to account for 0.03% of 10-14 week fetuses and 0.002% of 16-20 week fetuses 
(BARKEN et al. 2008).  The vast majority of triploid conceptuses spontaneously abort at 10-20 weeks with 
most of these being diandric in origin (ZARAGOZA et al. 2000).  Those rare triploid fetuses that survive 
beyond 20 weeks of gestation usually result in stillbirths (GIURGEA et al. 2006). 
 The majority of human triploids are thought to be diandric in origin since dispermy is relatively 
common with digynic triploidy arising from errors in oogenesis being much rarer (MIGEON et al. 2008).  
It is estimated that 73-85% of triploids are diandric, with the remaining 15-27% being digynic in origin 
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(DOSHI et al. 1983; TUERLINGS et al. 1993).  Assuming that all male and female gametes have an equal 
chance at contributing to the formation of a triploid conceptus, one would expect to observe an 
XXX(33%) : XXY(50%) : XYY(17%) genotype distribution (PIETERS et al. 1992).  However, the actual 
observed frequencies for all triploids at all gestational ages are more along the lines of XXX(37%) : 
XXY(60%) : XYY(3%) (FORRESTER and MERZ 2003).  Based on an assumption that the 69,XYY 
genotype has no more of an adverse effect on viability than 69,XXX or 69,XXY and that most triploids 
are of diandric origin, the observed genotype distributions do not appear to fit well with expected values 
(MCFADDEN and LANGLOIS 2000).  That is, one would expect values to be somewhat closer to the 1:2:1 
ratio predicted for all diandric triploids.  However, assuming that 80% of triploids are of digynic origin 
yields a ratio of XXX(4) : XXY(5) : XYY(1), a value much closer to the actual observed values.  Of 
course, this does not take into account that 69,XYY triploids do in fact appear to be at a severe 
disadvantage in terms of viability. 
 A number of studies have noted the genotype distributions in populations of triploid conceptuses.  
As shown in table 1,  the XXX : XXY : XYY distribution in nearly 1400 cases of triploidy covering 
several studies appears to approximate the 4:5:1 distribution suggested by McFadden and Langlois (2000) 
which assumes 80% of triploids are of digynic origin.  It should however be noted that the total number of 
triploids from these studies does not represent any particular gestational age, but more closely reflects the 
population of triploid gestations as a whole.  It is also worthwhile to note that of the 48 XYY triploids, 36 
were in a group of triploids ascertained through preimplantation genetic diagnosis in a study by 
McWeeney et al. (2009).  The ratio among this group of triploids was XXX(189) : XXY(188) : XYY(36).  
This group is also unique in having an equal proportion of XXX and XXY triploids.  This phenomenon 
could potentially be explained by a high proportion of XXX digynic triploids in this group that would 
have aborted very early thus avoiding detection in other studies which only ascertained triploids through 
spontaneous abortion or prenatal cytogenetic testing in later stages of gestation.  The remaining XYY 
triploid from this study was a first trimester spontaneous abortion. 
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Table 1. Genotype distribution of triploidy in selected studies 
 
Study Major study population XXX XXY XYY 
Szulman et al., 1981 SA, 7-27 weeks 15 39 1 
Jacobs et al., 1982 SA, 5-29 weeks 33 70 1 
Proctor et al., 1984 SA, 7-21 weeks 4 7 0 
Uchida & Freeman, 1985 Early SA, SB, LB 44 57 2 
McFadden & Kalousek, 1991 Fetal 3n, ≥ 10 weeks 9 5 0 
Warburton et al., 1991 SA, 7-17 weeks 84 99 2 
Miny et al., 1995 GA 9-33 weeks 7 10 0 
Staessen & Van Steirteghem, 1997* IVF/ICSI fertilized zygotes 43 48 5 
Baumer et al., 2000 SA, LB, 8-37 weeks 20 11 0 
McFadden & Langlois, 2000 <10-34 weeks 36 42 1 
Zaragoza et al., 2000 SA 5-19 weeks 36 53 3 
Forrester & Merz, 2003 All karyotyped births 15 22 1 
McFadden & Robinson, 2006 SA 8-18 weeks 12 15 0 
McWeeney et al., 2009 PGD through 3rd trimester 264 235 37 
Totals 622 713 53 
Percentage of 1388 Total Cases 44.81% 51.37% 3.82% 
* = Also includes triploid mosaics, ICSI = Intracytoplasmic sperm injection, IVF = in vitro fertilization, LB = Live 
Birth, PGD = Preimplantation Genetic Diagnosis, SA = Spontaneous Abortion 
 
 
 
Since X and Y bearing sperm have an equal likelihood of fertilizing an oocyte, the expected 
genotype frequencies for digynic triploidy are a straightforward XXX(1) : XXY(1).  The expected 
genotype ratios for diandric triploidy are XXX(1) : XXY(2) : XYY(1) (MIGEON et al. 2008).  However, 
the predicted large number of 69,XYY triploids is not observed.  Rather, the actual observed genotype 
frequencies for diandric triploidy are approximately 69,XXX(27%) : 69,XXY(70%) : 69,XYY(3%) 
(GENEST et al. 2002).  Table 2  summarizes the genotype distributions of triploids according to parental 
origin from a number of studies conducted over the past 30 years.  An additional note regarding the study 
of Jacobs et al. (1982) is that these authors reported a single case of 69,XYY triploidy however were not 
able to definitively determine the parental origin in this case.  For this reason, the authors did not include 
this case of 69,XYY triploidy among their results.  However, since it can be fairly safely assumed that all 
69,XYY triploids are of diandric origin, this case was included as a diandric triploid for the purpose of 
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this paper.  As can be seen in table 2, the ratio of XXX to XXY digynic triploids is fairly close to the 
expected 1:1 ratio.  Among diandric triploids, the ratio of XXX to XXY is also fairly close to the 
expected 1:2 ratio for these two genotypes, however the number of XYY diandric triploids is far less than 
the number of XXX diandric triploids. 
 
Table 2. Genotype distributions of triploidy according to parental origin in selected studies 
 
Study Major Study 
Population 
Total 
Cases* 
Diandric Digynic 
XXX XXY XYY Total XXX XXY Total 
Jacobs et al., 1982 SA 5-29 weeks 79 15 42 1 58 9 12 21 
Procter et al., 1984 SA, 7-21 weeks 6 2 4 0 6 0 0 0 
Uchida et al., 1985 Early SA, SB, LB 68 15 27 2 44 14 10 24 
Miny et al., 1995 GA 9-33 weeks 17 1 4 0 5 6 6 12 
Baumer et al., 2000 SA, LB, 8-37 
weeks 
25 1 4 0 5 13 7 20 
McFadden & Langlois, 
2000 
GA <10-34 weeks 38 5 8 1 14 14 10 24 
Zaragoza et al., 2000 SA 5-19 weeks 87 21 36 3 60 12 15 27 
McFadden & Robinson, 
2006 
SA 8-18 weeks 27 3 5 0 8 9 10 19 
Totals 347 63 130 7 200 77 70 147 
Percentage of Total XXX = 31.50%  
XXY = 65.00% 
XYY = 3.50% 
XXX = 52.38%
XXY = 47.62% 
* = Reflects only cases where parental origin was successfully determined, GA = gestational age, LB = live 
births, SA = spontaneous abortion 
 
 
 
It has been suggested that a large number of 69,XYY conceptuses may be created but that they 
don’t survive past implantation.  Some support for this hypothesis comes from a study by Staessen and 
Van Steirteghem (1997) in which they examined the genotypes of tripronuclear zygotes following in vitro 
fertilization.  These authors obtained a ratio of XXX(9) : XXY(10) : XYY(5).   Though they suggested 
these values were not significantly different from the expected 1:2:1 ratio, there appears to be a 
significant difference.  Another survey found 8.7% of triploids ascertained by preimplantation genetic 
diagnosis had a 69,XYY karyotype, but this value fell to 0.7% of triploid pregnancies ascertained during 
the first trimester (MCWEENEY et al. 2009).  This survey did not identify any 69,XYY triploids beyond 
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the first trimester.  These authors suggested that an imbalance between maternally and paternally derived 
chromosomes or between X chromosomes and autosomes may be responsible for this reduced viability.  
Also, in vitro studies have supported the theory that 69,XYY cells have a reduced viability when 
compared to 69,XXY or 69,XXX cells (NIEBUHR 1974). 
 The predicted proportions of diandric versus digynic triploidy have changed over the past few 
decades. Up through the 1980’s it was largely accepted that the majority of triploids were diandric in 
origin and that the majority of these also exhibited a partial hydatidiform molar phenotype  (ZARAGOZA et 
al. 2000).  However, later reports indicated that only 15% of triploids were partial moles, a drastic change 
from earlier figures based on cytogenetic analysis.  Ascertainment bias may have played a role in possibly 
overestimating the proportion of triploids complicated by partial mole.  It has been noted that earlier 
studies of placental pathology in triploidy often analyzed cases culled from larger studies of only molar 
gestation thereby increasing the detection of PHM in conjunction with triploidy (MCFADDEN and 
PANTZAR 1996).  It is now accepted that even though partial mole is almost always associated with 
diandric triploidy, triploidy is not necessarily associated with partial mole.  These findings of a much 
lower than previously thought frequency of PHM in conjunction with triploidy also seem to lend support 
to more recent molecular evidence that digyny rather than diandry is the more prevalent mechanism 
leading to the creation of triploid conceptuses (MCFADDEN and PANTZAR 1996). 
 Early cytogenetic studies seemed to indicate a clear preponderance of diandry as the origin of 
most triploid conceptuses.  In a study using Q- and C-banding techniques to identify cytogenetic 
polymorphisms in triploid conceptuses and their parents, Jacobs et al. (1978) determined that 66.4% of all 
triploids resulted from dispermy with an additional 23.6% from diplospermy and only 10% of digynic 
origin.  The first indication that this may not be the case came from a 1993 DNA polymorphism study 
which determined that 6/8 triploids where the parental origin was determined were of digynic origin 
(MCFADDEN et al. 1993).  This result was later supported by several additional molecular polymorphism 
studies.  A 1994 study using random highly polymorphic loci determined  that 6/6 triploid fetuses 
progressing into the third trimester were of digynic origin (DIETZSCH et al. 1995).  Another study using 
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variable number of tandem repeat (VNTR) analysis determined digynic origin in 7/12 cases with the 
remainder being diandric (MINY et al. 1995). 
This paper has several goals and objectives.  It will begin with a more detailed examination of 
historical studies that attempted to elucidate the parental origins of triploidy as well as the prevalence of 
the partial hydatidiform mole (PHM).  This section will also include an examination of the sources of bias 
and error and how this may explain the vastly different results obtained in more recent molecular studies 
compared to those obtained in older cytogenetic studies.  Next is a discussion of the pronuclear stage of 
the fertilized zygote and the first cleavage division and what role these events may play in the creation of 
triploid embryos.  This will be followed by a more detailed discussion of the mechanisms, both 
theoretical and observed, that may lead to complete triploidy or diploid/triploid mixoploidy.  Next is a 
discussion of the overall characteristics of triploid cells and how they behave in vivo and in vitro.  This 
section includes a discussion on X-inactivation patterns as well as tissue specificity in diploid/triploid 
mixoploid individuals.  The general phenotypic trends of complete triploidy will then be examined 
followed by a comparison with the phenotype of diploid triploid mixoploidy.  Finally, this paper aims to 
look at the complex relationships surrounding the parental origin of the extra haploid set of chromosomes 
in triploidy.  The final section of this paper is devoted to a literature review of all published cases of 
diploid/triploid mixoploidy as well as a sampling of cases of complete triploidy.  This review will first 
examine the genotype and parent-of-origin distributions.  An examination of the different methods used to 
ascertain the parental origin will follow this section.  Finally, a comparison of the phenotypic traits by 
parental origin as well as between complete triploidy and 2n/3n mixoploidy will be undertaken. 
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2.0 THE PREVALENCE OF DIGYNY, DIANDRY, AND PARTIAL HYDATIDIFORM 
MOLE 
 
 
2.1 EARLY CYTOGENETIC STUDIES: DIANDRY AND PHM PREDOMINATE 
 
 
The first major cytogenetic study to investigate the parental origins of triploidy was published in 1978 
and later expanded upon in 1982 (JACOBS et al. 1978; JACOBS et al. 1982b).  These authors were able to 
successfully determine the parental origin of 78 triploid spontaneous abortions (SA) by analyzing Q- and 
C-band heteromorphisms on fetal and parental bloods.  Their results indicated that 57 triploids were of 
diandric origin while 21 were digynic accounting for 73% and 27% respectively.  Furthermore, through 
the use of statistical methods, the authors were able to determine the probable meiotic error that lead to 
the creation of a triploid conceptus.  Among the diandric triploids, 41 were believed to have resulted from 
dispermy while the remainder was believed to have been the result of diplospermy I or dispermy.  Among 
the digynic triploids, eight were felt likely to have arisen from a maternal meiosis I error while the 
remaining 13 were felt likely the result of a maternal meiosis II error (JACOBS et al. 1982b). 
A later study using cytogenetics to determine the parental origin of a large number of triploid 
early SA found fairly similar results with 52 cases being diandric and 29 being digynic (UCHIDA and 
FREEMAN 1985).  These authors also determined that 33 of the diandric cases resulted from dispermy 
with the remaining 19 resulting from diplospermy while 20 of the 29 digynic cases were the result of a 
maternal meiosis II error.  These two studies were the only large scale cytogenetic surveys of triploidy 
and were fairly similar except that while Uchida and Freeman (1985) surveyed only early abortions, 
Jacobs et al. (1982) surveyed all spontaneous abortions in their study.  Additionally, Uchida and Freeman 
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also included twelve stillbirths and livebirths in their study populations, though gestational ages were not 
provided for any specimens. 
Additionally, at least two smaller scale cytogenetic studies have been published.  Proctor et al. 
(1984)  found twelve cases of triploidy among 164 spontaneous abortions examined over a 2 ½ year 
period.  Among these 12 cases, the parental origin was able to be determined in six.  All were found to 
have arisen through dispermy (PROCTER et al. 1984).  One of the last cytogenetic studies was also 
arguably one of the most pivotal as it was the first such study to describe the phenotypic differences 
between diandric and digynic triploids (MCFADDEN and KALOUSEK 1991).  Their description of diandric 
triploids being characterized by a well-grown, proportionate fetus with a large cystic placenta and of 
digynic triploids being characterized by severe asymmetric intrauterine growth retardation, relative 
macrocephaly and a small non-cystic placenta has since become the gold standard for ascertaining 
parental origin based on phenotype alone.  Based on these findings, the authors divided triploidy into two 
syndromes.  The diandric triploidy phenotype was termed type I triploidy while the digynic triploidy 
phenotype was termed type II triploidy.  The authors also performed cytogenetic analysis on one type I 
fetus and two type II fetuses to determine parental origin and determined that the type I fetus was diandric 
and that one of the type II fetuses was digynic with the remaining type II fetus being uninformative. 
Szulman et al. (1981) carried out a histological survey of 92 cytogenetically confirmed cases of 
triploidy in an attempt to determine the frequency of partial hydatidiform mole.  They determined that 79 
specimens were partial moles and that these moles virtually always aborted in the second trimester with a 
mean gestational age of 16.9 weeks.  Among the 13 nonmolar triploids, virtually all aborted during the 
first trimester with six aborting before 10 weeks (SZULMAN et al. 1981).  However, this study did not 
attempt to identify the parental origins of these triploid moles.  A second study that cytogenetically 
examined all cases of histologically confirmed molar pregnancy found that 75/80 cases were triploid, but 
again did not examine the parental origin of these molar pregnancies (JACOBS et al. 1982a).  However, 
these two studies cemented the assumption that greater than 80% of triploids were partial moles. 
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Further support for this theory came from a second study by the same group which showed that 
all diandric triploids with sufficient tissue to establish a histological diagnosis were partial moles (JACOBS 
et al. 1982b).  In their examination of 12 cytogenetically confirmed cases of triploidy, Procter et al. 
(1984) determined that 8/10 triploid placentas with sufficient material for histological examination were 
partial moles.  However, this included only two of the six cases confirmed to have been diandric in origin.  
Uchida and Freeman (1985) reported that only 19/52 diandric triploids were partial moles, however these 
authors did not specify what proportion of these 52 cases had sufficient placental material to establish the 
diagnosis.  It can be said that the prevalence of partial mole in these earlier studies was based more on 
ascertainment than technology.  That is, these cases were identified mainly through the use of gross 
and/or microscopic examination in the absence of more modern methods in use today. 
 
2.2 LATER MOLECULAR STUDIES: DIGYNY IS MORE COMMON, PHM IS LESS 
COMMON 
 
As molecular genetics techniques began to emerge in the early 1990’s, the results of early cytogenetic 
studies began to come into question.  Even the study by McFadden and Kalousek (1991), though still a 
cytogenetic study, found that the type II digynic triploid phenotype was far more common among their 
sample.  A 1995 molecular polymorphism study found 12 digynic triploids but only five diandric cases 
(MINY et al. 1995).  A later microsatellite polymorphism study also found only five diandric triploids, all 
arising from dispermy, while finding 20 digynic triploids (BAUMER et al. 2000).  These authors also 
reported an equal frequency of maternal meiosis I and meiosis II errors as the origin for digyny, but noted 
that a high rate of pericentromeric crossovers during oogenesis may have lead to some misinterpretation 
of results. 
 The first molecular study to show digynic triploidy to be more common was published in 1993 
though these results were expanded upon in a later publication (MCFADDEN et al. 1993; MCFADDEN and 
LANGLOIS 2000).  This study used molecular polymorphisms to determine that 11/14 cases with fetal 
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development and ranging from 11 to 34 weeks gestational age were of digynic origin.  Among the non-
fetal group which included conceptuses of less than 10 weeks gestational age as well as those of greater 
than 10 weeks but lacking a discernable embryo or fetus, the authors found 11 diandric and 13 digynic 
triploids.  Among the digynic triploids, they found that 18 arose from maternal meiosis II error while only 
six arose from maternal meiosis I error.  A later study by the same group reported eight diandric triploids 
and 19 digynic triploids, with 10 in the latter group arising from maternal meiosis II error, among their 
study population of triploid embryos with gestational ages ranging from 8-18 weeks (MCFADDEN and 
ROBINSON 2006). 
 Most published molecular studies on the origins of triploidy have been based on fairly small 
samples.  The largest molecular study on the origins of triploidy was also the only such study that agreed 
with the earlier cytogenetic studies with respect to the prevalence of diandric versus digynic triploidy.  
This study reported that 60 triploids were of diandric origin and 27 were of digynic origin (ZARAGOZA et 
al. 2000).  Of the diandric cases, 27 were thought to have arisen from dispermy, four from diplospermy I 
and two from diplospermy II.  Meiosis II error was the most common mechanism leading to digynic 
triploidy accounting for 14 of the 20 cases where it could be determined. 
 For the most part, these molecular studies found that partial mole was not as common a feature of 
triploidy as previously reported.  Miny et al. (2000) reported that five of their 17 triploids were partial 
moles and that four of the five diandric triploids were PHM.  Interestingly, they also reported one digynic 
triploid as exhibiting a partial molar phenotype.  At least two other studies have reported the occurrence 
of digynic triploid partial moles (JACOBS et al. 1982b; UCHIDA and FREEMAN 1985).  However, most 
recent studies have come to the conclusion that digynic triploid PHM do not actually exist (REDLINE et al. 
1998; ZARAGOZA et al. 2000).  A 1996 report indicated that of 53 cases of triploidy with some fetal 
development, only 15% were partial moles  (MCFADDEN and PANTZAR 1996).  Finally, Zaragoza et al. 
(2000) reported that only 33 of 58 diandric triploids with sufficient material were partial moles and 
further noted that the frequency of PHM increased with gestational age. 
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 Tables 3 and 4 clearly show the discrepancies in results.  The majority of diandric triploids were 
identified through cytogenetic studies while the majority of digynic triploids were identified through 
molecular studies.  If not for the predominance of diandric triploidy in the molecular study published by 
Zaragoza et al. (2000), there would be far more digynic triploids ascertained through molecular studies 
than diandric triploids.  The differences are also apparent when looking at the proportions of partial mole 
in earlier versus later studies.  The earliest three studies suggest that partial mole is associated with 
approximately 70-97% of triploids while later studies suggest that no more than 39% of triploids are 
partial moles.  There appears to be somewhat less consistency with determining the proportion of diandric 
triploids that are partial moles with values ranging from 33% to 100%.  Digynic triploid partial moles 
were actually reported in three studies, however more recent evidence has cast serious doubt on these 
classifications as digynic partial moles are now believed not to exist. 
Table 3. Prevalence of diandric versus digynic triploidy 
Mode Diandric Digynic 
Jacobs et al., 1982 Cytogenetics 58 21 
Procter et al., 1984 Cytogenetics 6 0 
Uchida et al., 1985 Cytogenetics 52 29 
Miny et al., 1995 Molecular 5 12 
Baumer et al., 2000 Molecular 5 20 
McFadden & Langlois, 2000 Molecular 14 24 
Zaragoza et al., 2000 Molecular 60 27 
McFadden & Robinson, 2006 Molecular 8 19 
Overall Totals 208 152 
Cytogenetics Study Totals 116 50 
Molecular Study Totals 92 102 
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Table 4. Prevalence of the partial hydatidiform mole among triploid conceptuses 
 All Triploids Diandric Triploids Digynic Triploids 
Study Total PHM % PHM Total PHM % PHM Total PHM % PHM 
Szulman et al., 1981 82 79 96.34% N/A N/A N/A N/A N/A N/A 
Jacobs et al., 1982 106 74 69.81% 54 54 100.00% 15 3 20.00% 
Procter et al., 1984 10 8 80.00% 6 2 33.33% N/A N/A N/A 
Uchida et al., 1985 81 19 23.46% 52 19 36.54% 29 1 3.45% 
Miny et al., 1995 17 5 29.41% 5 4 80.00% 12 1 8.33% 
McFadden & Pantzar, 1996 53 8 15.09% N/A N/A N/A N/A N/A N/A 
Zaragoza et al., 2000 88 33 38.82% 58 33 56.90% 27 0 0 
Totals 434 226 52.07% 164 106 64.63% 88 5 5.68% 
 
 
 
2.3 EXPLAINING THE DISCORDANT RESULTS 
 
A number of possible explanations have been put forth to explain the differences in results obtained from 
early cytogenetic studies and those obtained from more recent molecular studies.  It has been suggested 
that at least some of the difference can be attributed to the greater accuracy and reliability of molecular 
techniques over conventional cytogenetic techniques  (MCFADDEN et al. 1993).  Several early cytogenetic 
studies even made note of the limitations of determining parental origin based on cytogenetic methods 
alone (JACOBS et al. 1978; JACOBS et al. 1982a).  This bias is mainly a result of interpretation bias in the 
sense that different investigators may judge the presence or absence of informative heteromorphisms 
differently (ZARAGOZA et al. 2000).  When comparing band width or intensity, different investigators 
may use different criteria for determining if these markers on homologous chromosomes are alike or 
different.  As a result, some investigators may interpret a set of markers as being informative while a 
different investigator may interpret the same set of markers as being uninformative.  Because cytogenetic 
techniques rely on examining C- or Q-banded chromosomes, the banding technique also plays a major 
role.  The intensity and clarity of the bands will vary from slide to slide and consequently, so will the 
appearance of informative heteromorphisms.  Finally, these techniques are limited by the low number of 
heteromorphisms present in the population.  These heteromorphisms are often limited to the size and 
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intensity of bands containing non-coding stretches of heterochromatin as well as the secondary 
constrictions and satellites of the acrocentric chromosomes. 
It may also be possible that the inaccuracy of cytogenetic techniques for determining the parental 
origin of triploidy is being overestimated.  When using cytogenetic heteromorphisms to determine the 
parental origin of a single chromosome trisomy, these techniques may be less accurate since the 
investigators have only a single chromosome to examine for markers. However, when attempting to 
determine the parental origin of triploidy, the investigators have an entire extra set of chromosomes on 
which to compare markers.  The observation that the single large molecular study reported by Zaragoza et 
al. (2000) found proportions of diandric and digynic triploidy that were similar to those reported in the 
two largest cytogenetics studies may lend support to this theory. 
 Molecular genetics techniques can virtually eliminate all of the inherent difficulties of cytogenetic 
techniques.  Since these techniques are automated and the results computer generated, the possibility of 
interpretation bias is effectively eliminated.  Unlike cytogenetics techniques, molecular techniques 
examine the DNA sequence itself so that the identification of informative polymorphisms is much more 
straightforward.  An additional advantage of molecular techniques is the ability to establish the dosage of 
different alleles so that even if only two distinct alleles are present in a triploid cell line, it may still be 
possible to determine the parental origin in some cases by observing which allele has a double dose.  
Finally, since molecular techniques examine sequence polymorphisms, there are many more loci that can 
be examined and thus a greater chance of finding informative loci as well as having more informative loci 
per case. 
 Another concern that may contribute to error in molecular studies as well as cytogenetic studies is 
meiotic crossing over since such events can change the makeup of the chromosome by creating new 
patterns of heteromorphisms.  Most cytogenetic studies attempted to use polymorphisms located very 
close to the centromeres and assume that crossing over hasn’t occurred between the centromere and 
heteromorphism (JACOBS et al. 1978).  McFadden and Langlois (2000) used markers located less than 
five centimorgans from the centromeres feeling that this would virtually eliminate this source of error.  
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This sort of error primarily comes into play when attempting to ascertain the meiotic stage at which the 
error leading to triploidy occurred and has even been cited as a likely explanation for the results obtained 
in at least one study (BAUMER et al. 2000). 
 Probably the most often cited source of bias is the method by which specimens are ascertained.  
Small sample size has been cited on a number of occasions, though McFadden et al. (1993) claimed this 
wasn’t a significant source of error due to the high degree of prevalence of the type II digynic triploidy 
phenotype in their study.  In light of the complex relationship between the parental origin of the extra 
haploid set of chromosomes and gestational age, it has been strongly suggested that the gestational age of 
specimens in different studies may strongly bias the results.  It has been noted that most early cytogenetic 
studies examined spontaneous abortions from a wide range of gestational ages and that these studies did 
not attempt to correlate gestational age with parent-of-origin (MCFADDEN et al. 1993; MCFADDEN and 
LANGLOIS 2000; MINY et al. 1995).  Conversely, the study reported by Miny et al. (1995) included only 
fetuses surviving to the point at which they were ascertained through routine cytogenetic diagnosis or 
after abnormal ultrasound findings.  Gestational age of specimens is of particular importance since 
diandric triploids are more likely to spontaneously abort while digynic triploids are more likely to survive 
into the fetal period (MCFADDEN et al. 1993).  At least one study has reported an apparent spike in the 
number of triploid fetuses being ascertained at 18-22 weeks gestations (BAUMER et al. 2000).  The 
authors attributed this spike to elective abortions following routine prenatal screening and diagnosis.  It is 
possible that with the increased availability and prevalence of routine prenatal screening, the gestational 
age effects on triploidy may become more difficult to see, at least later in gestation.  This is because the 
majority of such cases surviving until the time of prenatal screening will be therapeutically aborted such 
that there will appear to be a spike in all triploid gestations during that period when such screenings take 
place. 
 The between study differences in the rate of partial mole, diandric triploidy and digynic triploidy 
can probably be largely attributed to biased selection of the study population.  It has been suggested that 
placentas showing partial molar degeneration or other abnormal morphology are more likely to be 
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examined than those with normal morphology thus leading to an overestimate of the prevalence of PHM 
and diandric triploidy (MCFADDEN et al. 1993).  Redline et al. (1998) also suggested that some studies 
may suffer from referral bias in which the participants were referred due to some specific risk for partial 
mole or otherwise abnormal gestation.  It has also been noted that cytogenetic studies predominantly 
examined spontaneous abortions of 8-20 weeks gestational age regardless of phenotype and with some 
specimens containing only extrafetal material (ZARAGOZA et al. 2000).  Conversely, molecular studies are 
often restricted to cases with a well formed fetus or embryo or those with gestational ages less than 10 
weeks. These latter points becomes important when considering the prevalence of diandric triploidy and 
PHM since both groups separately and as a whole are less likely to contain fetuses than digynic triploids.  
It is also known that diandric triploids with a partial molar placenta in which the fetus has died are more 
likely to be retained in utero for a longer period of time due to sustained elevated levels of hCG produced 
by the hypertrophic trophoblast. 
 It has also been suggested that selection criteria in some studies may preferentially enrich for 
digynic triploidy or diandric triploidy (ZARAGOZA et al. 2000).  Those studies examining very early 
spontaneous abortions or pregnancies surviving well into the second trimester may show a predominance 
of digyny while those studies examining late first trimester or early second trimester gestations with 
abnormal placentas may show a predominance of diandry.  The observation of a complex relationship 
between gestational age and parent-of-origin lends support to this hypothesis (ZARAGOZA et al. 2000).  It 
is also possible that improved technology and better ascertainment may partially explain the differences 
(MCFADDEN and LANGLOIS 2000).  Pregnancy can be detected earlier now than it could 20 or 30 years 
ago and there is a greater understanding of the need to examine all spontaneous abortions and otherwise 
abnormal pregnancies. 
 There are a number of factors that could potentially explain the differences in the prevalence of 
partial mole between earlier and more recent studies.  One important factor is the strictness of criteria for 
establishing the diagnosis for partial mole. Molar pregnancies weren’t well described before the 1980’s 
and so different investigators may have used different criteria for establishing the diagnosis.  Similarly, 
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the mode of ascertaining the diagnosis of PHM may have played a significant role.  Some studies may 
have relied on gross appearance alone to establish the diagnosis, though this could have biased results in 
both directions.  Grossly hydropic placentas that were assigned a diagnosis of PHM without being 
examined under the microscope may have turned out to be nonmolar had such microscopic examination 
been undertaken.  This scenario could potentially explain the observation of digynic triploid partial moles 
in some studies.  Conversely, macroscopically normal placentas diagnosed as nonmolar may have in fact 
shown some molar changes had they been examined under the microscope, especially at earlier 
gestational ages.  The effect of gestational age may be of even greater importance when comparing earlier 
and later surveys.  Earlier studies such as that reported by Szulman et al. (1981) identified their partial 
moles from populations of spontaneous abortions when the characteristic features were well developed.  
However, with increased used of prenatal screening allowing for earlier termination of pregnancy, it is 
now possible to examine placental morphologies at earlier gestational ages where the characteristic 
features of PHM may not have yet developed. 
Also of note is that most studies before 1980 did not distinguish between partial mole and 
complete mole (JACOBS et al. 1982a).  Furthermore, these earlier studies tended to only examine triploid 
conceptuses with signs of molar change or culled triploid specimens only from larger samples of 
placentas with molar change (MCFADDEN et al. 1993; MCFADDEN and PANTZAR 1996).  These sampling 
methods may have largely contributed to earlier results suggesting that most triploids were diandric and 
partial moles.  Finally, missed diagnosis may have played a role.  Early partial moles could potentially be 
missed if the characteristic features haven’t become apparent or late partial moles may be missed because 
tissue degeneration and fibrosis may mask some of the characteristic features (REDLINE et al. 1998). 
 A number of additional sources of error may exist.  One possibility is false paternity in which the 
legal father is not the biological father (JACOBS et al. 1978).  This could lead to misinterpretation of 
results.  It has also been suggested that some studies may be biased towards advanced maternal age since 
cytogenetic screening is more frequent and routine in this group (MCFADDEN and PANTZAR 1996).  
Though there doesn’t appear to be a maternal age effect for the occurrence of triploidy alone, at least one 
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study reported a distinct maternal age effect for triploidy with concurrent aneuploidy (UCHIDA and 
FREEMAN 1985). 
 Finally, a potentially important source of error that doesn’t seem to receive much attention is the 
way in which the age of specimens is determined.  Some studies use developmental age while others use 
gestational age and still others use menstrual age.  When comparing specimen ages between studies, it is 
of great importance to be sure that the same method of determining age is used otherwise the results may 
be skewed.  An additional problem when determining gestational age is recall bias which can be 
introduced by inaccurate recollection of the timing of the last menstrual period (REDLINE et al. 1998).  
Using developmental age provides its own set of difficulties since it is well established that triploid 
gestations are often growth retarded and that growth of different parts is often discordant.  This is also a 
problem when considering the retention time of aborted specimens since those missed abortion specimens 
retained in utero for a longer period of time will show a higher degree of growth discordance than those 
with recent fetal demise or therapeutic termination of an abnormal living fetus.  A final point to consider 
is the use of crown-rump length (CRL) as a means of establishing gestational age.  Warburton et al. 
(1991) noted that the tables correlating CRL with gestational age were revised sometime after 1976 and 
so there may be some discordance between studies conducted before and after this revision took place. 
 Overall, it appears that the studies of Jacobs et al. (1982) and Uchida and Freeman (1985) are the 
most reliable of the cytogenetics studies in determining the true ratio of diandric to digynic triploidy.  
This is because these studies ascertained their specimens from a series of consecutive spontaneous 
abortions and were able to determine the parental origin in a large number of samples.  These studies are 
limited primarily by the accuracy of cytogenetic results in determining parental origin and by the methods 
and criteria used to establish the diagnosis of partial hydatidiform mole.  The study by Zaragoza et al. 
(2000) is probably the single best molecular study of parental origin since it includes the largest sample 
size.  However, this study also has its limitations.  This study included two different populations of 
specimens from two different institutions located in Cleveland and Pittsburgh (ZARAGOZA et al. 2000).  
Though the cases ascertained in Cleveland were part of a consecutive series of karyotyped spontaneous 
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abortions, the Pittsburgh cases were not.  Rather, the Pittsburgh cases were ascertained for a variety of 
reasons including advanced maternal age and abnormal placental morphology, factors which may enrich 
for partial mole and thus diandric triploidy.  Indeed, when looking at the Cleveland and Pittsburgh results 
separately, clear differences can be seen.  Though diandric triploidy predominated in both populations, 
the ratio was 39:23 in Cleveland but 21:4 in Pittsburgh.  The authors of this study also noted a slightly 
higher incidence of PHM among the Pittsburgh group, though they stated that this difference was not 
statistically significant. 
It should also be noted that the results from the Cleveland population in the Zaragoza et al. study 
had been published previously (REDLINE et al. 1998).  It is possible that this subset of the population from 
the study by Zaragoza et al. (2000) may provide the best estimates yet of the population frequencies of 
digynic triploidy, diandric triploidy, and partial hydatidiform mole.  This is possible since this population 
was obtained from  a consecutive series of spontaneous abortions unlike the Pittsburgh population.  The 
only possible drawback is that this study examined only SA of less than 20 weeks developmental age thus 
excluding later fetal deaths which may have yielded a higher proportion of digynic triploids. 
The remaining studies, both cytogenetic and molecular, are largely hampered by small sample 
sizes and the mode and timing of ascertainment of specimens.  Though the study by Proctor et al. (1984) 
culled cases of triploidy from a series of consecutive abortions, this sample included only 12 triploids of 
which parental origin was determined in only six.  Though the study by McFadden and Kalousek (1993) 
was pivotal in establishing the phenotypic differences between diandric and digynic triploids, the fact that 
they were selecting cases with fetal development automatically enriches for digyny since digynic triploids 
are more likely to have a recognizable fetus than diandric triploids.  Similarly, studies by Miny et al. 
(1995) and Baumer et al. (2000) examined specimens that were obtained primarily through abnormal 
routine prenatal cytogenetics results and/or abnormal sonography results.  Since this population is largely 
centered on the mid-second trimester of gestation, these studies will again enrich for digynic triploidy. 
McFadden and Langlois (2000) attempted to avoid some of these problems by examining both 
embryonic and fetal triploids, however this study also presents several methodological problems.  Firstly, 
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because this study population included cases that were therapeutically aborted after abnormal prenatal 
screening, this would automatically enrich from specimens surviving to the age at which such screening 
typically take place.  Of perhaps greater concern is manner in which the authors defined their groups.  
Fetuses were defined as being greater than 10 weeks gestational age while embryos were defined as 
having a gestational age of less than 10 weeks.  However, the embryo group also included an “other” 
subgroup which was defined as specimens of greater than 10 weeks gestational age but lacking a 
discernable embryo or fetus (MCFADDEN and LANGLOIS 2000).  It should also be noted that all four 
specimens that fell into this “other” category were found to be of diandric origin.  Even if this group had 
been included in the fetal group, digyny would have still predominated though the results would have 
been less striking.  It would seem more logical to have included all specimen of greater than 10 weeks 
gestational age in the fetal group regardless of the presence or absence of fetal development. 
Though many studies have been undertaken in an effort to determine if most triploids are diandric 
or digynic and how often triploidy is associated with partial mole, they all suffer from some degree of 
bias.  In order to truly understand the complex nature of triploidy and partial mole, a study would have to 
take into account the entire body of knowledge that is currently available regarding triploidy.  Such a 
study would best be carried out using a large series of consecutive abortions as a source for triploid 
specimens.  Such a study should entirely exclude therapeutic abortions of live fetuses since inclusion of 
such a group would bias towards fetuses of a gestational age where prenatal diagnosis may precede such 
abortions.  Additionally, therapeutic abortions would also bias towards abnormal fetal or placental 
morphology.  Such a series should ideally include more than 50 triploid specimens in which the parental 
origin can be determined.  In light of the complex relationship between parental origin of the extra 
haploid set of chromosomes and gestational age, the gestational age of all specimens should be carefully 
noted.  It would also be prudent to divide these cases into several groups based on gestational age such as 
early embryonic, late embryonic, early fetal, et cetera.  Additionally, placental morphology should be 
examined both grossly and microscopically in all cases with particular note again being paid to 
gestational age and parental origin.  Finally, though molecular studies are currently the norm, it may be 
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prudent to examine both cytogenetic and DNA polymorphisms in such a study.  Doing so could help to 
establish just how accurate or inaccurate early cytogenetics results were as well as potentially shedding 
some light on the differences between cytogenetic and molecular results.  In short, such a study would 
require extreme attention to detail in order to eliminate as many sources of bias and error as possible. 
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3.0 MECHANISMS GIVING RISE TO TRIPLOIDY 
 
 
3.1 PRONUCLEAR STAGES AND EARLY MITOTIC ERROR 
 
The mitotic machinery of the zygote plays a major role in the proper incorporation and segregation of the 
parental pronuclei during the first few cell divisions.  Of particular importance are the zygotic centrioles 
and centrosomes which are paternally derived (GOLUBOVSKY 2003).  These structures play a critical role 
in the proper segregation of chromosomes during the first zygotic division.  Whereas digynic triploid 
zygotes contain a single pair of active centrioles and can engage in relatively normal mitosis, dispermic 
triploid zygotes inherit two pairs of active centrioles and are thus more prone to gross mitotic error 
(GOLUBOVSKY 2003; MALAN et al. 2006).  Tripolar spindles arise following dispermy and are capable of 
producing diploid or triploid blastomeres (GIURGEA et al. 2006).  The bipolar spindles of digynic triploid 
zygotes results in a lower incidence of mosaicism, at least in the very early cleavage stage. 
 The majority of information on tripronuclear zygotes and tripolar spindles comes from the study 
of embryos following in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) (MALAN et 
al. 2006).  Tripronuclear zygotes arise when two gametes from one parent fuse with one gamete from the 
other parent.  This phenomenon has been reported in 5-7% of all IVF or ICSI fertilized zygotes, with the 
majority of them being found to have a triploid chromosome constitution (ROSENBUSCH et al. 1997).  A 
study by Staessen and Van Steirteghem (1997) indicated that tripronuclear zygotes can cleave at a rate 
comparable to that of normal dipronuclear zygotes.  The majority of 3PN zygotes observed following IVF 
have been shown to progress to the cleavage stage and often result in complete triploidy (ROBINSON et al. 
2007).  Most remaining cases are either fully diploid or diploid/haploid mosaics resulting from exclusion 
of a pronucleus or irregular cleavage. 
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Dispermic tripronuclear zygotes will generally proceed down one of three possible developmental 
paths (GOLUBOVSKY 2003).  Approximately 25% of cases will result in a bipolar spindle leading to 
mitosis and the formation of two triploid blastomeres with stabilization of the triploid state.  (MALAN et 
al. 2006).    Alternatively, the exclusion of a single haploid set from the metaphase plate at the first 
cleavage division can result in the formation of 2n, 2n/3n, or n/2n clones of cells (GOLUBOVSKY 2003).  
This scenario is thought to occur in 14-32% of cases.  Androgenetic complete mole can arise if the 
excluded haploid set is paternal in origin and subsequently undergoes endoreduplication to become 
diploid. 
 Finally, the formation of a tripolar spindle at the first cleavage division can result in highly 
aberrant segregation in 50-60% of cases (GOLUBOVSKY 2003).  This occurs because the three haploid sets 
of chromosomes will remain relatively separate within the oocyte (GOLUBOVSKY 2003).  This zygote will 
first divide into three cells and then into six as opposed to dividing into two and then four cells in normal 
2PN zygotes.  This chaotic segregation can result in mosaicism and gross aneuploidy in daughter 
blastomeres.  It has also been proposed that triploidy may arise from tripolar division of a tetrapronuclear 
zygote (NIEBUHR 1974).  This scenario would agree with aberrant segregation of tripronuclear cells, 
however, there is little experimental evidence supporting this theory.  This latter scenario could 
potentially help to explain the origins of several unusual cases.  Gropp et al. (1964) described a case of a 
patient with non-syndromic cleft palate and an approximately triploid cell line that was apparently 
restricted to the epithelium overlying the palatal defect.  Also, Sellyei et al. (1971) reported detecting a 
few 69,XYY cells in the peripheral lymphocytes of a normal adult undergoing genetic screening due to an 
apparent chromosomal defect in his son.  It is possible that both of these cases originated from the 
isolated occurrence of tetraploid cells in the affected tissues which then underwent abnormal tripolar 
cleavage to produce the triploid line.  This may be especially pertinent in the latter case considering the 
apparent extremely low viability of 69,XYY cells. 
 Triploidy arising through mitotic error has been proposed, but currently remains unproven in 
humans (ZARAGOZA et al. 2000).  One hypothesis involves an error occurring at the pronuclear stage such 
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as premature duplication of a pronucleus.  A similar hypothesis involves aberrant reduplication of a sperm 
or ovum nucleus.  Both of these mechanisms would result in triploid zygotes where two of the three 
haploid sets will show complete homozygosity.  It has been suggested that mitotic error may play a role in 
diploidization of tripronuclear digynic zygotes after intracytoplasmic sperm injection (GOLUBOVSKY 
2003).  Finally, mitotic errors in germ cell precursors could lead to the formation and subsequent 
reduction of a tetraploid oogonium or spermatogonium resulting in diploid gametes (NIEBUHR 1974). 
 Another mechanism that is thought to be highly unlikely involves the defective segregation of a 
haploid set of chromosomes from the metaphase plate during the first zygotic division (DANIEL et al. 
2003; NIEBUHR 1974).  Due to the random alignment of chromosomes along the metaphase plate, one 
would expect a random distribution of maternally and paternally derived chromosomes to comprise the 
additional or lost haploid set.  Consequently, different parental origins would be expected for disomy or 
trisomy of each individual chromosome; a phenomenon which has not yet been observed.  The rule thus 
far has been a consistent parental origin for each chromosome in the triploid line and biparental disomy 
for the diploid line (DANIEL et al. 2003) 
 
 
3.2 DISPERMY 
 
Diandric triploidy produced from normozoospermic males are usually by way of dispermy, whereas those 
from oligozoospermic males are usually by way of diplospermy (GOLUBOVSKY 2003).  Dispermy is the 
most common cause of diandric triploidy and is believed to account for approximately 66% of all triploids 
(ROSENBUSCH et al. 2002; ZARAGOZA et al. 2000).  A study by Zaragoza et al. (2000) found that 37/43 
diandric triploids in which the meiotic origin could be determined were the result of dispermy.  A second 
study that specifically examined the origins of diandric triploidy found dispermy to be the origin in 14/14  
cases (MCFADDEN et al. 2002b).  It may also account for up to 86% of triploid embryos obtained 
following conventional IVF (STAESSEN and VAN STEIRTEGHEM 1997). 
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Dispermy is believed to play a more important role in the origin of triploidy than incorporation of 
the second polar body (TUERLINGS et al. 1993).  Dispermic fertilization results in the formation of a tri-
pronuclear zygote with two paternal pronuclei which has three possible developmental outcomes 
(GOLUBOVSKY 2003; ROSENBUSCH 2008).  The zygote could divide into diploid and triploid blastomeres 
ultimately giving rise to a 2n/3n mixoploid embryo.  Alternatively, the zygote could spontaneously 
eliminate an odd haploid set to produce a normal diploid zygote or an assortment of different aneuploid 
clones.  Finally, the formation of a tripolar spindle could lead to chaotic segregation of chromosomes 
leading to gross aneuploidy and cell death with the occasional survival of some trisomic cells. 
  Diandric diploid/triploid mixoploidy may require a unique set of circumstances for its formation 
(DANIEL et al. 2003).  This mechanism is thought to involve simultaneous fertilization of a normal ovum 
by two separate haploid sperm with only one male pronucleus immediately fusing with the female 
pronucleus.  The second male pronucleus would then remain in the cytoplasm until after the first zygotic 
division at which time it would fuse with one of the resultant blastomeres.  Wegner et al. (2009) described 
this process as “post-zygotic triploidization”.  The ability for pronuclei to remain separated from the 
nuclear genome for some period of time has previously been demonstrated (DANIEL et al. 2003).  The 
concept of delayed incorporation of a paternal pronucleus into a blastomere following simultaneous 
fertilization is believed more probable than true delayed dispermy which would involve sperm penetration 
of a blastomere (WEGNER et al. 2009).  However, simultaneous fertilization by 2 sperm would likely 
result in complete diandric triploidy in most cases. 
 The concept of dispermy presents some logistical problems mainly in the form of mechanisms 
built into oocytes designed to prevent such an occurrence.  The initial penetration of a sperm head into the 
ovum causes an instantaneous depolarization of the ovum plasma membrane blocking penetration by 
additional sperm (DANIEL et al. 2003).  This is theoretically not a problem for non-mixoploid triploids 
arising from the simultaneous penetration of two sperm into the ovum and such a mechanism has been 
observed in the laboratory.  It has been proposed that a number of factors related to the functional 
capacity of both gametes may be involved in polyspermy (ROSENBUSCH et al. 1997).  Defective oocytes 
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may have an impaired zona reaction and block to dispermy by way of absent, delayed, or incomplete 
release of cortical granules from the oocyte.  Defective block to polyspermy could also be affected by 
cracks in the zona pellucida caused by different assisted reproduction technologies or other means 
(PIETERS et al. 1992; ROSENBUSCH et al. 1997). 
 
 
3.3 DIPLOSPERMY 
 
Diplospermy is the rare occurrence of a sperm that contains a diploid rather than haploid number of 
chromosomes.  An early study by Jacobs et al. (1978) suggested that up to 23.6% of all triploids were the 
result of diplospermy.  However, later reports revised this figure to 8.3% of all diandric triploids 
(EGOZCUE et al. 2002; HSU et al. 2008).  It is currently estimated that ~0.06% or six in 10,000 of all 
clinically recognized triploid pregnancies result from paternal meiotic error (ZARAGOZA et al. 2000).  
Diplospermy is seen at a rate of 0.2-0.3% in normozoospermic males, but may be as high as 2% among 
oligozoospermic males (ROSENBUSCH 2008).  A study by Macas et al. (2001) showed that 2.45% (4/163) 
of the abnormal male pronuclei obtained following ICSI were diploid among a population of males with 
cryptozoospermia, oligoasthenoteratozoospermia, or azoospermia.  This figure also constituted 1/3 of the 
12 total abnormal male pronuclei obtained in this study.  It should however be noted that this study only 
used fluorescent markers for chromosomes 18, X, and Y, to identify abnormal pronuclei.  Thus it is 
possible that some observed X-,18,18 sperm may have actually been rare double aneuploids.  Also, 
aneuploid sperm with chromosome anomalies involving chromosomes other than X, Y, or 18 would have 
been missed in this study.  Diplospermy is also the most common chromosome abnormality seen in males 
with meiotic disorders preventing normal spermatogenesis as well as those with other chromosome 
abnormalities such as balanced translocations (EGOZCUE et al. 2002).  Rates of diplospermy may 
approach 9.6% in these groups. 
Diplospermy can arise from failure of either the first or second meiotic division though meiosis I 
errors are more common (ZARAGOZA et al. 2000).  A third possibility is the reduction of a tetraploid 
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spermatogonium (ROSENBUSCH 2008).  Failure of the first meiotic division yields a diploid 46,XY sperm 
in which all loci which are heterozygous in the father will have both alleles transmitted to the sperm 
(NIEBUHR 1974; ROBINSON et al. 2007).  Failure of the second meiotic division will result in 46,XX or 
46,YY sperm that are homozygous at all pericentromeric loci.  Any heterozygosity seen distal to the 
centromeres in this latter case will be a result of meiotic crossing over.  It is believed that a significant 
proportion, if not the majority, of diploid sperm are capable of fertilization (ZARAGOZA et al. 2000).  
Male pronuclei resulting from diplospermy will be able to engage in relatively normal synergy and 
segregation as opposed to the chaotic mitoses seen in dispermy because only one paternal centrosome is 
delivered into the ooplasm (HSU et al. 2008).  Diplospermic fertilization results in the formation of a 
diploid male pronucleus and a seemingly normal dipronuclear zygote following extrusion of the second 
polar body (ROSENBUSCH 2008).  This fact makes it difficult to identify triploidy based on the number 
and size of pronuclei since diploid male pronuclei may not appear larger than normal haploid pronuclei. 
 Diplospermy has several important repercussions when dealing with assisted reproductive 
technology, especially intracytoplasmic sperm injection.  Infertile males, a group known to have an 
increased rate of diplospermy, may undergo ICSI and have an increased risk of forming zygotes with a 
diploid male pronucleus (ROSENBUSCH 2008).  This is especially true among patients with severe 
oligoasthenoteratozoospermia (ULUG et al. 2004).  Triploid conceptuses resulting from diplospermy are 
not usually apparent at the pronuclear stage as there will be a single diploid male pronucleus and the 
zygote will appear to be normal and dipronuclear. 
 
3.4 INCORPORATION OF POLAR BODIES 
 
Errors in the formation of the oocyte polar bodies are thought to be a major contributor to digynic 
triploidy.  Incorporation of the second polar body into one of the blastomeres following the first mitotic 
division is thought to contribute to  diploid/triploid mixoploidy of digynic origin (QUIGLEY et al. 2005).  
This mechanism can be proven by examining a large set of pericentromeric markers in the triploid cell 
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line (VAN DE LAAR et al. 2003).  Two haploid sets derived in this manner would be expected to show 
complete homozygosity at these markers since the second polar body chromatids are the sister chromatids 
of those found in the maternal pronucleus.  Any heterozygosity seen at more distal markers will be the 
result of meiotic crossing over.  This mechanism is thought more credible than true delayed dispermy 
since the second polar body is already within the oocyte and may fail to be extruded (DANIEL et al. 2003).  
It has been theorized that intracytoplasmic sperm injection may cause retention of the second polar body 
(ROSENBUSCH 2008).  Sperm injection may lead to deterioration of the meiotic spindle resulting in the 23 
polar body chromatids remaining within the ooplasm and becoming incorporated into the maternal 
pronucleus.  Alternatively, the damaged spindle microtubules could result in the formation of an extra 
nucleus within the ooplasm which could later lead to segregation errors in early cleavage divisions or 
mosaicism (STAESSEN and VAN STEIRTEGHEM 1997). 
 Involvement of the first polar body seems unlikely because of its diploid state, but can’t be ruled 
out as a possible exceptional circumstance (VAN DE LAAR et al. 2003).  For instance, the first polar body 
may divide into two haploid cells with one of these fusing with the diploid zygote.  Bieber et al. (1981) 
reported a case of twins with a normal 46,XY male coexisting with a holoacardiac 69,XXX fetus and 
suggested first polar body fertilization as a mechanism leading to the formation of the triploid twin.  The 
authors suggested that this may occur due to the proximity of the first polar body to the ovum within the 
perivitelline space of the zona pellucida.  Analysis of leukocyte histocompatibility haplotypes of the 
normal and holoacardiac twin revealed inheritance of different paternal haplotypes suggestive of separate 
fertilization events.  Studies using electron microscopy have yielded observations that show sperm 
penetrating polar bodies suggesting this mechanism is possible (BIEBER et al. 1981).  
 Several mechanisms involving abnormal division of the primary oocyte may lead to 
diploid/triploid chimerism (NIEBUHR 1974; VAN DEN BERGHE and VERRESEN 1970).  Abnormal division 
of the primary oocyte could result in the formation of two equally sized secondary oocytes or, in essence, 
a very large first polar body.  Both of these could then be fertilized by separate sperm with one failing to 
extrude a second polar body.  In theory, chimeras resulting from this mechanism would have three distinct 
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maternal and two distinct paternal haploid sets.  Alternatively, van den Berghe and Verressen (1970) 
proposed a mechanism that would result in a chimera with four maternal and one paternal haploid set.  
This mechanism would involve fertilization of a large first polar body or oocyte by a single haploid sperm 
with both failing to extrude a second polar body.  The result would be a chimera with a population of 
digynic triploid cells and a population of diploid parthenogenetic cells that would be homozygous at all 
markers.  A similar scenario would involve formation of the second polar body in both cells with one of 
them subsequently being incorporated in a blastomere.   
Another proposed mechanism for the formation of 2n/3n mixoploid zygotes involves the 
complete failure of polar body formation in the maturing oocyte (ZHANG et al. 2000).  This would lead to 
the formation of a tetraploid ovum which, when fertilized, would result in a pentaploid zygote.  This 
zygote would then divide into diploid and triploid components.  However, this mechanism seems unlikely 
since one component would be parthenogenetic.  Complete failure of polar body formation has been 
reported in at least one instance (RUDAK et al. 1990).  Oocytes obtained from this patient appeared to 
have two maternal pronuclei, but turned out to be tetraploid with both pronuclei being diploid.  At least 
one of these aberrant oocytes was fertilized during IVF and resulted in a pentaploid zygote. 
 An unusual mechanism that could potentially lead to digynic triploidy involves the fertilization of 
two fused ova or two separate ova by a single haploid sperm (DANIEL et al. 2003; ZARAGOZA et al. 
2000).  This mechanism has been suggested as the origin in at least one case of human triploidy (JACOBS 
et al. 1978).  This mechanism suggests the rare occurrence of two separate maternal genomes contributing 
to a single conceptus (ZARAGOZA et al. 2000).  The meiotic outcomes for this mechanism of “dieggy” 
would be the same as what would be expected from digynic triploids resulting from reduction of an 
initially tetraploid oogonium (ZARAGOZA et al. 2000).  A digynic triploid showing reduction to 
homozygosity at some pericentromeric markers but non-reduction at others may be suggestive of this 
mechanism (MCFADDEN and ROBINSON 2006). 
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3.5 MEIOTIC ERROR AND GIANT OOCYTES 
 
Abnormal oogenesis can also contribute to the formation of a diploid ovum and lead to digynic triploidy 
if fertilized.  It is believed that up to 0.2% of ova may have a meiotic failure of some sort (ROSENBUSCH 
et al. 2002).  The majority of diploid ova are believed to result from errors in the second meiotic division 
with a minority resulting from meiosis I errors (ZARAGOZA et al. 2000).  Maternal meiosis II errors are 
believed to be the second most frequent cause of all triploids behind dispermy.  McFadden and Langlois 
(2000) found that 18/24 digynic triploid embryos and fetuses were the result of meiosis II errors with the 
remainder being meiosis I errors.  However, a second study found equal proportion of meiosis I and 
meiosis II errors among digynic triploids (BAUMER et al. 2000).  However, these authors noted a high 
number of pericentromeric crossovers among their cases making some assignments difficult and possibly 
leading to incorrect assignments.  Failure of the first meiotic division with subsequent failed formation of 
the first polar body would be indicated by a diploid ovum that is heterozygous at all centromeric markers 
for which the mother is heterozygous (MCFADDEN and ROBINSON 2006).  Similarly, failure of the second 
meiotic division with subsequent failed formation of the second polar body would result in a diploid 
ovum that is homozygous at all centromeric markers.  Either type of error is thought to occur in 0.2% of 
all female meioses (ROSENBUSCH et al. 2002). 
 The contribution of giant oocytes has also been considered, though the formation of digynic 
triploidy through fertilization of a diploid giant oocyte in considered improbable (ROSENBUSCH et al. 
2002).  These giant gametes are two times the size of normal female gametes, are tetraploid, and result 
either from nuclear but not cytoplasmic division of an oogonium or fusion of two oogonia (ROSENBUSCH 
2008; ROSENBUSCH et al. 2002).  A study by Rosenbusch et al. (2002) found that giant oocytes may 
occur at a frequency of 0.26%.  These giant primary oocytes can mature to the second meiotic division by 
either maintaining their binucleate state or undergoing fusion of the two separate nuclei.  Binucleate 
oocytes are thought to account for approximately 96% of all abnormal ova in humans (ROSENBUSCH et 
al. 2002).  Maintenance of the binucleate state will result in the formation of a 3PN zygote with two 
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maternal pronuclei when fertilized.  However, if the two nuclei underwent fusion, this would result in an 
apparently normal 2PN zygote when fertilized, however the maternal pronucleus would be diploid. 
 Immature giant binucleate oocytes existing at the germinal vesicle stage have two possible routes 
of maturation (ROSENBUSCH 2008).  The union of both haploid set can give rise to a 2n metaphase II 
oocyte after having extruded a single first polar body.  Monospermic fertilization will then result in the 
formation of a haploid male pronucleus and a diploid female pronucleus after extrusion of a diploid 
second polar body.  Alternatively, if the binucleate state is maintained then the mature oocyte would have 
two haploid chromosome complements and two haploid first polar bodies.  Monospermic fertilization will 
then result in one male pronucleus and two haploid female pronuclei after extrusion of two haploid 
second polar bodies. 
 
3.6 POSTZYGOTIC DIPLOIDIZATION OF TRIPLOIDS 
 
The observation of dispermic triploid zygotes has led to the concept of postzygotic diploidization of 
triploid zygotes (PDT) (MALAN et al. 2006).  This concept has allowed for investigation of PDT through 
the loss of entire haploid sets and has provided new insights into the mechanisms leading to mixoploidy, 
chimerism, hydatidiform mole, and twinning.  This mechanism is thought to only play an important role 
in dispermic triploidy where there are two sets of paternally derived active centrioles whereas it is quite 
rare in digynic triploids where there is a single set of active centrioles. 
 It has been suggested that postzygotic diploidization may play a role in the origins of uniparental 
disomy (GOLUBOVSKY 2003).  This is based on the notion of each genome semi-independently 
segregating from the other two along the metaphase plate during tripolar cleavage.  This deviation from 
the segregation of entire haploid sets as a whole could thus result in a diploid cell line where two 
homologues of at least one chromosome are inherited from the same parent.  Following tripolar cleavage, 
it is predicted that 1/3 of mitoses may result in a uniparental state for one pair of homologues while 1/9 of 
mitoses may result in a uniparental state for two pairs of homologues.  Currently there is no evidence 
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supporting the independent segregation of chromosomes according to parental origin once pronuclear 
fusion has occurred (GIURGEA et al. 2006).  Any abnormalities are thus presumed to occur between the 
time of fertilization and fusion of the pronuclei. 
 It has also been suggested that an additional non-disjunction event during diploidization may lead 
to aneuploidy within the resultant diploid cell line, though the occurrence of 2n/3n mixoploidy in 
conjunction with aneuploidy of the diploid line is extremely rare (QUIGLEY et al. 2005).  Postzygotic 
diploidization may also provide an explanation for cases involving the coexistence of a hydatidiform mole 
with a twin fetus whether it be a triploid partial mole and diploid fetus or a diploid complete mole and 
triploid fetus, though this latter case has never been seen (GOLUBOVSKY 2003).  It may also provide an 
alternative to the empty egg scenario when explaining the co-existence of a diploid fetus with a diploid 
androgenetic complete mole.  In this scenario, tripolar division leads to formation of an n/2n clone of cells 
where either paternal haploid set can be included in the 2n clone and give rise to a diploid fetus of either 
sex.  The 1n clone containing the other paternal haploid set then undergoes endoreduplication and forms 
into a homozygous complete mole with a 46,XX karyotype. 
 Rosenbusch and Schneider (2009) described an interesting case that may indicate another 
possible mechanism leading to the diploidization of triploid zygotes.  The authors describe an oocyte 
being prepped for ICSI that appeared to have two polar bodies, but subsequently underwent a premature 
cytokinesis.  This event involved the incorporation of one pronucleus into a cytoplasmic fragment and 
extrusion of a third polar body-like structure.  This seemed to result in the zygote being 2PN with both 
pronuclei in the larger half, however, further examination revealed a third pronucleus in the smaller 
fragment.  Karyotyping of this 3PN zygote revealed triploidy with one haploid set appearing to include an 
acentric fragment (ROSENBUSCH and SCHNEIDER 2009). 
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3.7 OTHER FACTORS CONTRIBUTING TO THE OCCURRENCE OF TRIPLOIDY 
 
Several other mechanisms may contribute to the formation of digynic triploidy though to a lesser extent.  
It is thought that fertilization of immature oocytes may lead to triploidy as a result of them not being 
ready to complete meiosis (ZARAGOZA et al. 2000).  It is also thought that this immaturity may also result 
in an inability to complete imprinting and that this in turn may underlie the phenomenon of digynic 
triploids either aborting early or surviving late into gestation.  Comparison of allele-specific expression of 
imprinted loci between both groups of digynic triploids has been proposed as a means of testing this 
hypothesis (ZARAGOZA et al. 2000).  The block to polyspermy reaction may also be hindered by 
immaturity of the zona pellucida, cytoplasmic granules, and vitelline membrane (PAL et al. 1996). 
 Similarly, aging oocytes may also play a key role in the formation of triploid conceptuses 
(NIEBUHR 1974).  Older ova have been shown to have an increased likelihood of having a defective block 
to polyspermy mechanism or failing to extrude the second polar body.  A failure of the block to 
polyspermy may also be secondary to an acquired defect in the zona pellucida in aged oocytes (PAL et al. 
1996).  Some evidence has suggested that the interval between the first day of the last menstrual period 
and the probable ovulation date is longer in triploid cases as opposed to controls (NIEBUHR 1974). 
Another possibility is endoreduplication within the maternal pronucleus (ROSENBUSCH 2008).  
This would result in the formation of diplochromosomes with four instead of the usual two chromatids 
with these then separating into two sets of normal maternal chromosomes.  This mechanism could be 
detected by aberrant maternal pronuclear formation or by karyotyping of abnormal zygotes.  On 
karyotyping, diplochromosomes would initially appear as undivided metaphase chromosomes which 
would then separate to form a diploid but completely homozygous pronucleus.  Similarly, it is 
theoretically  possible to get diandric triploidy through abnormal endoreduplication of the paternal 
pronucleus, though this mechanisms has not yet been observed (ROSENBUSCH 2008) . 
A number of extrinsic factors have been hypothesized to increase the risk of triploid conceptuses, 
not the least of which is assisted reproduction technology.  The incidence of triploidy following in vitro 
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fertilization may range from 2-9% and has been hypothesized to be linked with some chemical agents 
used to suppress formation of the second polar body (NIEBUHR 1974; PIETERS et al. 1992).  A 
tripronuclear state has been observed in approximately 5% of zygotes following IVF and can lead to 
triploidy (ROBINSON et al. 2007).  Most of these cases result in the formation of 2n or 2n/n mixoploid 
embryos while only a small proportion displayed pure triploidy when advancing to the cleavage stage.  
Frequently, 2n/3n or 2n/n chimeras have been observed in the 2-8 cell stage following assisted 
reproduction.  It has also been suggested that the freezing and thawing of embryos could lead to 
blastomere fusion which could then result in mosaic polyploidy (BALAKIER et al. 2000).  Though most 
embryos exhibiting this phenomenon are not transferred, those that are usually fail to implant or end in an 
early abortion.  It has been suggested that the use of propanediol as a cryoprotectant may play a role in 
blastomere fusion.  Another possible indication of a link between IVF and triploidy is an observed excess 
of 69,XYY zygotes following conventional IVF which may be indicative of an increased rate of dispermy 
(ULUG et al. 2004). 
 Early studies suggested that becoming pregnant within six months of discontinuing the use of oral 
contraceptives may increase the risk of triploidy (FULTON et al. 1977; NIEBUHR 1974).  These studies 
showed that among spontaneous abortions obtained from women becoming pregnant within six months of 
discontinuing oral contraceptive use, 24-28% were triploid and that 23% of the triploids were mosaic.  
However, later studies have not been able to affirm such a link, possibly due to a change in the 
formulation of contraceptive drugs (JACOBS et al. 1978).  It had been suggested that this phenomenon was 
related to a temporary rise in the concentration of luteinizing hormone following discontinuation of 
synthetic progesterone (NIEBUHR 1974).   
Unlike trisomies, there does not appear to be a link between advanced maternal age and the 
occurrence of triploidy (FORRESTER and MERZ 2003).  However, a study by McFadden and Langlois 
(2000) found that the average maternal age for non-fetal digynic triploids (34.5 y/o) was significantly 
higher than that for non-fetal diandric triploids (30.8 y/o).  These authors noted that this may have been a 
result of different modes of ascertainment for these two groups since seven digynic cases were 
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ascertained due to cytogenetic screening for advanced maternal age while the majority of diandric cases 
were ascertained following abnormal placental findings on ultrasound.  Maternal diabetes also does not 
appear to be a risk factor (FORRESTER and MERZ 2003). 
 
3.8 MOSAIC OR CHIMERA? 
 
One interesting question that arises when discussing cases involving the presence of both diploid and 
triploid cells is whether this should be considered mosaicism or chimerism.  Generally, mosaicism is 
derived from a single fertilized zygote whereas chimerism is derived from separate zygotes.  
Diploid/triploid chimerism may result from the fusion of separate diploid and triploid conceptuses (VAN 
DE LAAR et al. 2003).  A similar mechanism would involve a slightly later fusion of a diploid and triploid 
conceptus with resorption of adjoining chorion.  This latter mechanism was proposed to explain the 
occurrence of apparent monozygotic twins with one being diploid and the other triploid and having 
discordant sexes (BIEBER et al. 1981).  Finally, it has been suggested that the vanishing twin phenomenon 
may explain some of these cases (ENGLISH et al. 2000; TUERLINGS et al. 1993).  Callen et al. (1991) 
reported a case of a normal 46,XX infant with a 46,XX/69,XXY placenta where a large portion of the 
placenta was determined to have originated from a vanished twin indicated by the presence of an empty 
small second gestational sac. 
 Wegner et al. (2009) suggested that neither mosaicism nor chimerism were appropriate terms 
based on two arguments.  The first argument is that chimerism requires the contribution of two 
independent zygotes.  The second argument is that mosaicism requires that the secondary cell line be 
derived from a preexisting primary cell line.  It has also previously been suggested that mosaicism should 
be restricted to differing populations of cells derived from errors involving the segregation of a single 
gene or chromosome (ROBINSON et al. 2007).  It has been suggested that the term “mixoploidy” should be 
used to describe all such cases involving the coexistence of multiple cell lines with different ploidy levels 
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(WEGNER et al. 2009).  This works on the assumption that all such cases are originally diploid with the 
triploid line arising from a secondary incorporation of an additional haploid set. 
 Though some cases can be definitively classified as chimerism, a definitive classification of 
mosaicism would be much more difficult based on the above definitions.  This is because though it is 
possible to determine the parental origin of the extra haploid set, it is generally not possible to determine 
the timing of its incorporation.  If the zygote is initially triploid but then loses a haploid set in the first 
zygotic division, then this would appear to be mosaicism since the diploid cell line was derived from an 
initially triploid zygote.  However, if the zygote is initially diploid but an additional haploid set is 
incorporated into one of the blastomeres following the first zygotic division, this scenario seemingly 
doesn’t fit either definition.  Both cell lines are derived from the same initial zygote so this is not a 
chimera, but the derived cell line originated from the addition of an entire haploid set rather than an error 
involving the original diploid set, so this is not a mosaic.  It would seem that most cases exist in a sort of 
gray area between mosaicism and chimerism and that mixoploidy is indeed the single best description of 
such cases. 
 
3.9 RECURRENT TRIPLOIDY 
 
There have been several reports of women with recurrent triploid pregnancy, the majority of which have 
been of maternal origin (BRANCATI et al. 2003; HUANG et al. 2004).  Overall, the recurrence rate for 
triploidy is not believed to be significantly higher than the general population rate (BAR-AMI et al. 2003).  
Though no definitive mechanism has yet been identified, a genetic error during oogenesis appears to be a 
likely cause.  Abnormal regulation of polar body and pronucleus formation has been implicated as the 
cause of multiple molar pregnancies in one couple (REUBINOFF et al. 1997).  Brancati et al. (2003) 
reported a case of a woman with three consecutive triploid pregnancies in which molecular analysis of the 
latter two revealed digynic origin.  Subsequently, Huang et al. (2004) reported a woman who also had 
three consecutive triploid pregnancies with microsatellite analysis on the most recent demonstrating 
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maternal origin.  Bar-Ami et al. (2003) reported on a couple who had two consecutive early spontaneous 
abortions that were not karyotyped, followed by two mid-trimester abortions for triploidy.  Though the 
parental origin of the extra haploid set was not investigated in this case, the two triploid conceptuses had 
apparently normal placentas, suggesting digynic origin.  The observation of several oocyte abnormalities 
following induced superovulation also points to a digynic origin in this case (BAR-AMI et al. 2003). 
 Pergament et al. (2000) reported a case of multiple apparent digynic triploid embryos in a woman 
seeking assisted reproduction treatment following two previous triploid gestations.  This conclusion was 
based on the observation of two triploid embryos following ICSI, a technique which should largely 
exclude dispermic triploidy though not necessarily diplospermy.  Because sperm injection occurred after 
the formation of the first polar body, the authors speculated that a defect in maternal meiosis II was 
present.  The authors also proposed several alternative mechanisms (PERGAMENT et al. 2000).  These 
include endoreduplication of the maternal pronucleus, the formation of an additional maternal pronucleus 
due to irregularities in the second meiotic division, or formation of an empty first polar body following 
complete meiosis I nondisjunction.  Additionally, Pal et al. (1996) described a case of a woman 
undergoing multiple cycles of IVF which produced an unusually high frequency of triploid embryos.  The 
authors proposed a primary oocyte defect leading to an increased rate of polyspermy.  Though technically 
a case of recurrent diandric triploidy, the underlying mechanism is a defect in the oocyte that increases the 
risk for polyspermy.  The authors also suggested a meiotic defect with polar body retention leading to 
digynic triploidy (PAL et al. 1996). 
A few cases of familial recurrent diandric mole have been linked to global imprinting failure due 
to a recessive mutation of a gene located at 19q13.3-13.4 (BRANCATI et al. 2003; HUANG et al. 2004).  
More recent evidence points to a mutation in the NLRP7 gene possibly being linked to recurrent triploid 
partial moles as well as other types of mole (DEVEAULT et al. 2009).  It remains unknown how this 
mutation may lead to recurrent partial mole, but it is theorized that it may lead to defective oogenesis or 
create a hostile environment for embryogenesis within the fallopian tubes or uterus.  Some evidence 
indicates it may cause early cleavage abnormalities in vitro and in vivo (DEVEAULT et al. 2009).
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4.0 CHARATERISTICS OF TRIPLOID CELLS 
 
 
 
4.1 MITOSIS AND PROLIFERATION 
 
Triploid cells differ in many ways from normal diploid cells.  Some studies have indicated that triploid 
cells take longer to replicate their DNA and thus longer to complete mitosis along with having a 
decreased rate of proliferation (FULTON et al. 1977; NIEBUHR 1974).  Some evidence for this 
phenomenon has been observed in humans.  If this is indeed the case, then one would expect the 
proportion of triploid cells in mixoploid individuals to decline over time, a phenomenon which has been 
observed in several cases.  One patient was described as having a 1:1 ratio of diploid to triploid cells in 
skin fibroblasts at the age of five, but this ratio had decreased to 4:1 by the time the patient was eleven 
years old (FULTON et al. 1977).  Graham et al. (1981) described a patient with 2n/3n mixoploidy in whom 
the proportion of triploid cells in skin biopsies taken from the calf decreased between the ages of one day 
and nine months.  However, another study found that diploid and triploid cells had similar generation 
times in vitro (GRAHAM JR. et al. 1981).  A study of the mitotic behavior of triploid fibroblast cells by 
Book et al. (1962) identified grossly abnormal behavior.  These anomalies involved highly disturbed 
spindle formation and function leading to anaphase lag and ultimately gross aneuploidy and apoptosis in 
daughter cells.  However, other labs have not reported similar findings. 
 Very limited work has been done to examine the meiotic behavior to triploid cells.  Separate 
studies done on the oocytes of two triploid fetuses both reported similar findings (GOSDEN et al. 1976; 
LUCIANI et al. 1978).  The principal observation was the presence of multiple chromosome configurations 
observed during leptotene and pachytene.  These configurations were thought to represent univalents, 
bivalents, and trivalents.  It was also observed that chromosomes could repeatedly change pairing partners 
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even along the same chromosome arm.  It was also noted that synapsis cannot occur between three 
chromosomes and that only two chromosomes could be paired at any one time (GOSDEN et al. 1976). 
 
4.2 X CHROMOSOME INACTIVATION 
 
Triploid cells have also provided a unique opportunity to study the phenomenon of X chromosome 
inactivation (XCI).  An early study of X inactivation in triploid cells found that 69,XXX triploids occur in 
one of two types (JACOBS et al. 1979).  They can either exist with virtually all cells having one inactive X 
or they may have different populations of cells with one or two inactive X’s.  The authors did not identify 
any cases in which the majority of cells had two inactive X’s.  They also noted that there did not appear to 
be any correlation with the parental origin of the extra haploid set of chromosomes and the pattern of X 
inactivation.  One of the more interesting findings of this study was that the number of late replicating X’s 
in cells grown from fetal tissues was significantly lower than in cells grown from extrafetal tissues.  The 
authors proposed two reasons for this phenomenon (JACOBS et al. 1979).  First they suggested the 
possibility of tissue specific XCI in triploidy with fetal tissues tending to have a greater number of active 
X’s.  Alternatively, they suggested that fetal development may be more likely when two active X’s are 
present as opposed to one. 
 This study also observed a significant effect with respect to gestational age.  Extrafetal tissues 
taken from gestations with longer in utero survival tended to have an increased number of late replicating 
X’s relative to gestations that were aborted earlier (JACOBS et al. 1979).  Though apparent in all genotype 
classes, this phenomenon appeared most pronounced in the 69,XXY group.  It is suggested that the 
presence of two active X’s in fetal tissues may be advantageous at least during the early part of gestation 
while the presence of one active X may favor development of extraembryonic tissues.  The authors 
proposed three possible explanations for this phenomenon, all of which suggest a certain degree of non-
uniformity in the process of X inactivation in triploid cells.  In essence, X inactivation in XXY or XXX 
triploid cells operates in such a way as to potentially create clones of cells with anywhere from zero 
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inactive X’s in XXY cells to two inactive X’s in XXX cells.  This process also appears to be completely 
random.  These observations seem to suggest the existence of autosomal factors that may be involved in 
the process of X inactivation. 
The study of XCI in triploid cells has produced evidence of a putative autosomal transfactor that 
may be involved in the process (MIGEON et al. 2008).  The observation that XXX and XXY triploids have 
two active X’s in the majority of their cells has led to the hypothesis that three copies of this putative 
transfactor allows for two X’s to remain active in at least a portion of cells..  However, 69,XXX cells with 
two Barr bodies have been demonstrated (NIEBUHR et al. 1972).  Other studies of X inactivation in XXX 
and XXY triploid cells have shown that the rates of XCI can be quite variable though 69,XXX females 
tend to have one inactive X in the majority of their cells while 69,XXY males tend to have zero inactive 
X’s (MARASCHIO et al. 1984).  One interesting case of 48,XXYY/72,XXXYY mixoploidy was found to 
have no cells with two inactive X’s in the triploid cell line while all diploid cell had one of their two X 
chromosomes inactivated (SCHMID and VISCHER 1967). 
A study by Migeon et al. (2008) showed that 17/30 cases had mixed populations of cells with 
either one or two active X’s.  This observation could possibly reflect a certain level of instability in the X 
inactivation process.  This study also confirmed earlier reports indicating that the presence of two active 
X’s in skin fibroblasts is highly stable.  The authors conclude that most triploid specimens have two 
active X’s regardless of the parental origin of the extra X and that mixed populations of cells with one or 
two active X’s originate at the time of X inactivation.  They also noted that their observations are 
consistent with what would be expected if there is indeed an autosomal transfactor that plays a role in X 
inactivation.  First, if two copies of this transfactor are sufficient for one inactive X, three copies may not 
be sufficient for two inactive X’s.  Second, variable tissue concentrations of this transfactor may lead to 
populations of cells with different numbers of inactive X’s.  Finally, there may be tissue-specific selection 
for or against cells with differing numbers of inactive X’s (MIGEON et al. 2008). 
 
40 
 
4.3 DIPLOID/TRIPLOID MIXOPLOIDY AND TISSUE SPECIFICITY 
 
In the context of 2n/3n mixoploidy, triploid cells often appear to demonstrate some degree of tissue 
specificity.  The most striking feature is that lymphocytes are, in the vast majority of cases, entirely 
diploid with the triploid line only first being detected in skin fibroblasts (SHAFI et al. 2007).  Triploid 
cells are detected solely in fibroblasts in roughly 70% of cases though the ratio of diploid to triploid cells 
is extremely variable (GOLUBOVSKY 2003; QUIGLEY et al. 2005).  On the rare occasion that triploid cells 
are detected in lymphocytes, they are usually present in less than 5% of cells (WULFSBERG et al. 1991).  
There have been several notable exceptions to this rule.  Ginnsberg et al. (1981) reported a 
46,XY(1)/69,XXY(102) lymphocyte karyotype in an infant who died three hours after birth.  A later 
report described a 4 ½ year old child with a 46,XX(57%)/69,XXX(43%) lymphocyte karyotype 
(CARAKUSHANSKY et al. 1994).  There are a number of hypotheses to explain this phenomenon including 
selective elimination of triploid cells during the early differentiation of the hematopoietic system and a 
growth disadvantage of triploid lymphocytes in vivo and in vitro (FLORI et al. 2003).  An additional 
theory suggests that this observation may be an artifact resulting from either an in vitro growth 
disadvantage of triploid cells or an inability of triploid lymphocytes to respond to phytohemagglutinin 
stimulation.  Two cases may provide support for this hypothesis.  The first is a report on a 2n/3n child 
whose bone marrow showed 57% triploid cells, but lymphocyte analysis only revealed 4% triploid cells 
(PETTENATI et al. 1986).  An additional report describes a 46,XX/92,XXXX mixoploid child where 4n 
cells were found in 5/100 bone marrow cells but were entirely absent from peripheral lymphocytes 
(AUGHTON et al. 1988).  These latter authors noted that bone marrow chromosome studies can be done 
without the need for additional culturing thus virtually eliminating the occurrence of in vitro artifacts. 
 It has been proposed that diploid cells have a selective advantage over triploid cells in certain 
tissues during early development and will ultimately replace them with this phenomenon being 
particularly prominent in the development of the hematopoietic system (GOLUBOVSKY 2003; SCHMID and 
VISCHER 1967).  This phenomenon also appears to be prevalent in amniocytes where triploid cells appear 
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to be less able to proceed through mitosis and are apparently lost during metaphase evaluation (FLORI et 
al. 2003).  The varying level of triploid cells in differing tissues is thought most likely due to a tissue 
specific degree of growth disadvantage in comparison with diploid cells (DANIEL et al. 2003).  It has been 
proposed that the survival of 2n/3n fetuses may be dependent on the degree to which triploid cells are 
excluded from the fetus proper.  Thus, 2n/3n fetuses exhibiting confined placental mosaicism for the 
triploid line have the best chance of survival with viability decreasing as the proportion of triploid cells 
within the fetus increases.  The existence of a selective process during early embryogenesis in which 
triploid cells are actively assigned an extraembryonic fate has been proposed (DANIEL et al. 2003).  This 
active sequestration of triploid cells to extraembryonic tissues has been proposed as a reason why 
mixoploidy is less often detected than pure triploidy as opposed to mixoploidy simply being a rarer 
phenomenon.  Niebuhr (1974) proposed that this segregation may begin as early as the two-cell stage in 
which one blastomere is diploid and the other triploid.  In this scenario, the diploid blastomere ultimately 
gives rise to the embryo proper while the triploid blastomere gives rise to extraembryonic tissues. 
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5.0 PHENOTYPIC CHARACTERISTICS OF COMPLETE TRIPLOIDY 
 
 
5.1 PRENATAL DEVELOPMENT AND POSTNATAL SURVIVAL 
 
Phenotypically, triploid conceptuses can exhibit an extremely wide range of characteristics ranging from 
grossly malformed to rarely almost normal in cases of 2n/3n mixoploidy (DOSHI et al. 1983).  It has been 
suggested that the traits associated with triploidy can be viewed as a collection of those seen in individual 
autosomal trisomies, particularly those for chromosomes 13, 18, and 21 (GINSBERG et al. 1981).  The 
spectrum of anomalies seen in triploidy, and even tetraploidy, has been noted to not necessarily be more 
severe than those seen in individual trisomies.  This observation has led to the suggestion that the ratios 
between different chromosomes or parts of chromosomes is more important than the absolute number of 
chromosomes (GINSBERG et al. 1981).  However, no direct relationship between gene dosage and 
metabolic activity has been found.  Triploidy has been noted to most closely resemble trisomy 18, though 
it may also mimic trisomy 13 (BUTLER et al. 1969; GINSBERG et al. 1981).  A large number of triploid 
spontaneous abortions contain severely malformed embryos if one is present at all, a phenomenon that 
mimics that seen in 45,X Turner syndrome (BUTLER et al. 1969). 
 A number of abnormalities within the intrauterine environment have been noted in triploid 
gestations.  These include polyhydramnios as well as a large placenta exhibiting signs of molar 
degeneration (GALAN et al. 1991; THARAPEL et al. 1983).  Polyhydramnios has been noted in 64% of 
cases in which amniotic fluid volume was monitored (BLACKBURN et al. 1982).  Placental anomalies are 
believed to occur in roughly 22% of triploid gestations (MCWEENEY et al. 2009).  An earlier survey of 
triploid spontaneous abortions indicated that 38% of placentas showed grossly cystic villi  while 51% 
showed normal or clubbed villi and 11% showed hypoplastic villi (WARBURTON et al. 1991).  These 
authors also noted that cystic villi were more likely to be identified in specimens retained in utero for a 
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longer period of time.  Additionally, XXY placentas appeared more likely to show cystic changes than 
XXX placentas, an observation consistent with the fact that XXY will be diandric more often than XXX.  
Additional potential complications include maternal toxemia, preeclampsia, and premature labor and 
delivery (BLACKBURN et al. 1982; FULTON et al. 1977).  Such complications were observed in 41/44 
cases in a survey conducted by Blackburn et al. (1982). 
One of the most common features is intrauterine growth retardation (IUGR) which has been noted 
in up to 66% of cases and is thought to result from a generalized deficiency in the proliferative ability of 
triploid cells or aberrant placental maturation and function (BETTS et al. 1989; SCHWAIBOLD et al. 1990).  
Placental dysfunction is thought to be a major cause of hypoplasia, IUGR, and ultimately intrauterine 
demise of triploid fetuses.  Those triploid gestations that survive until birth are typically premature and 
growth retarded with a low to very low birth weight (DOSHI et al. 1983; NIEBUHR 1974; NIEBUHR et al. 
1972).  Crown-heel length generally corresponds to weight (NIEBUHR 1974).  It is thought that low birth 
weight may be a result of decreased mitotic potential of triploid cells as evidenced by an observed 
generalized immaturity of the internal organs relative to the gestational age of triploid fetuses (GINSBERG 
et al. 1981).  Some cases show severe hypoplasia of the internal organs (SCHWAIBOLD et al. 1990). 
 Liveborn triploid infants do not usually survive longer than a few hours to days with average 
postnatal survival being around 20 hours (DOSHI et al. 1983; SCHWAIBOLD et al. 1990).  Longer postnatal 
survival is often correlated with a more normal appearing placenta rather than an absence of severe 
anomalies, though only about 30% of examined triploid placentas show normal histology (GALAN et al. 
1991; SCHWAIBOLD et al. 1990).  The longest reported postnatal survival was 10 ½ months in a 69,XXY 
male infant in which human leukocyte antigen (HLA) typing suggested a digynic origin of the extra 
haploid set (SHERARD et al. 1986).  This child showed limited weight gain and development.  Though no 
diploid cells were found in bone marrow, blood, or skin fibroblasts; the authors could not rule out the 
presence of a cryptic diploid line.  Such a cryptic cell line may have been present in the placenta which 
was not studied in this case.  Pneumonia, respiratory disease, and other respiratory problems are 
frequently noted as the cause of death in triploid liveborns  (SHERARD et al. 1986; TAKABACHI et al. 
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2008).  Alternatively, it has been suggested that death may result from biochemical dosage imbalances 
(DOSHI et al. 1983). 
 
5.2 GENERAL MALFORMATION PATTERNS 
 
A wide variety of malformations have been noted in triploid fetuses and liveborns.  Common cranial 
defects include dysplastic skull bones, particularly of the calvarium, and an unusually large posterior 
fontanelle (RAMSEY et al. 1998; THARAPEL et al. 1983).  Macrocephaly was noted in 16% of cases in a 
survey by Blackburn et al. (1982).  Other common facial features include a broad nasal bridge, epicanthic 
folds, hypertelorism, and low set malformed ears (NIEBUHR et al. 1972; VAN DE LAAR et al. 2003).  
Hypertelorism and ear anomalies have been reported in 15-20% and 27% of cases respectively 
(BLACKBURN et al. 1982; GINSBERG et al. 1981).  Triploidy often presents with some degree of ocular 
anomalies including coloboma, microcornea, ovoid cornea, and microophthalmia (DOSHI et al. 1983; 
GINSBERG et al. 1981; VAN DE LAAR et al. 2003).  Blackburn et al. (1982) reported ocular anomalies in 
39% of cases.  The specific types of ocular anomalies suggest a defect very early in embryogenesis 
(GINSBERG et al. 1981).  Oral anomalies are also common and can include cleft lip and/or palate, seen in 
15% of cases; macroglossia; and micrognathia (CHANG et al. 2001; DOSHI et al. 1983; GALAN et al. 
1991; VAN DE LAAR et al. 2003). 
 Limb and skeletal anomalies are also very common in triploidy.  A high frequency of skeletal 
muscle abnormalities has been noted, particularly increased bulk of the thigh muscles (SCHWAIBOLD et 
al. 1990).  Gosden et al. (1976) examined thigh muscle tissue from a 69,XXX triploid fetus showing 
increased muscle bulk and noted an unusually increased number of myotubes.  This phenomenon is 
thought to result from an increased differentiation of cells which may be responsible for the well 
developed appearance of the thigh muscles.  The authors suggested that this increased differentiation was 
secondary to abnormal intercellular communication and that this phenomenon may also explain the 
myocardial hypertrophy seen in some cases of triploidy (GOSDEN et al. 1976).  Syndactyly of fingers 3-4 
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is one of the hallmark features of triploidy occurring in up to 72% of cases (BETTS et al. 1989).  Another 
report cited that 3-4 syndactyly of the fingers and 2-3 syndactyly of the toes occur in approximately 47% 
of cases (BLACKBURN et al. 1982).  Clinodactyly and/or camptodactyly of the fifth finger, single 
transverse palmar crease, flexion deformities of the upper limbs, and various talipes deformities of the 
feet are also common (BLACKBURN et al. 1982; NIEBUHR 1974). 
 A large number of internal anomalies involving every organ system have been noted in cases of 
triploidy.  Some cases have been noted to show a generalized and severe hypoplasia of all internal organs, 
a feature thought to be related to a diminished proliferative capacity of triploid cells (ROYSTON and 
BANNIGAN 1987).  Central nervous system anomalies are present in up to 57% of cases and include 
various malformations of the brain, hydrocephalus, and spina bifida (NIEBUHR 1974; PETTENATI et al. 
1986).  Holoprosencephaly also appears to be a somewhat common feature of complete triploidy.  A 
literature review carried out by Bekdache et al. (2009) turned up 15 cases of holoprosencephaly 
associated with triploidy of which eight of nine cases where the type was defined were of the alobar type.  
Including the case reported by Bekdache et al. as well as another recently reported case, there have been 
17 reports of holoprosencephaly associated with triploidy of which 10 were of the alobar type 
(BEKDACHE et al. 2009; SOLOMON et al. 2009).  Abnormalities of the limbic system, hypothalamus, and 
pituitary as well as complete or partial agenesis of the corpus callosum have also been reported 
(PETTENATI et al. 1986).  It has also been suggested that abnormalities of the forebrain may be closely 
associated with ophthalmologic abnormalities (BLACKBURN et al. 1982). 
Congenital heart defects have been noted in 47-50% of cases with most involving septal or 
valvular defects (BETTS et al. 1989; DOSHI et al. 1983; NIEBUHR 1974).  A study by Blackburn et al. 
(1982) indicated the rate of heart defects may be as high as 86%.  Pulmonary hypoplasia and abnormal 
lobation of the lungs are also common with the latter being reported in up to 33% of cases (CHANG et al. 
2001; DOSHI et al. 1983).  Deformities of the gastrointestinal tract are seen in around 42% of cases with 
hypoplasia or agenesis of the gallbladder being the most common finding (NIEBUHR 1974; PETTENATI et 
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al. 1986).  Renal anomalies including hypoplasia,  hydronephrosis, polycystic kidneys, and horseshoe 
kidney have been noted in 44% of cases (BETTS et al. 1989; DOSHI et al. 1983; NIEBUHR 1974). 
 One of the more common internal findings in triploidy is adrenal hypoplasia which is seen in 40-
44% of cases (BETTS et al. 1989; PETTENATI et al. 1986).  This feature is thought to be related to the 
production of maternal estrogens by way of the feto-placental unit and may be related to low maternal 
estriol late in pregnancy (MARASCHIO et al. 1984; NIEBUHR 1974).   
 Additionally, triploid infants often show hematopoietic anomalies.  This most frequently 
manifests as extramedullary hematopoiesis, most commonly in the liver but occasionally involving the 
spleen, kidneys, and other tissues (DOSHI et al. 1983; ROYSTON and BANNIGAN 1987).  This 
extramedullary hematopoiesis may be related to delayed maturation of the bone marrow (HOHLFIELD et 
al. 1997).  It has been suggested that this phenomenon may be linked to fetal hypoxia resulting from 
inadequate function of a partially molar placenta.  This phenomenon may also be linked to a biochemical 
abnormality directly associated with the triploid state and may point to an increased tendency towards 
hemolytic destruction of erythrocytes (DOSHI et al. 1983).  Other commonly seen hematopoietic 
anomalies include macrocytosis, abnormally large platelets, and an increased number of nucleated red 
blood cells (DEAN et al. 1997; SMETS et al. 1995; WRIGHT and WALES 2004).  Macrocytosis may be 
linked to the increased DNA content of erythroblasts and/or increased production of fetal hemoglobin 
(SMETS et al. 1995).  In addition to increased hematopoiesis in the liver and spleen, Blackburn et al 
(1982) reported an increased concentration of iron pigment in the hepatic Kupffer cells.  The authors 
suggested that these features may be related to increased hemolysis in triploid infants as the result of an 
increased concentration of red blood cell antigen.  Hohlfield et al. (1997) carried out hematological 
examinations of 11 triploid fetuses and found that all fetuses were anemic and had micromegakaryocytes 
as well as a number of other findings. 
Omphalocele, umbilical hernia, or other abdominal wall defects are thought to account for more 
than half of all anomalies affecting the trunk in triploidy (BLACKBURN et al. 1982; DOSHI et al. 1983).  
Omphalocele is thought to occur due to failure of the midgut loop to return to the abdominal cavity from 
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the extraembryonic coelum around 6-10 weeks of gestation due to defective embryonic folds (LIN et al. 
1998).  This could be interpreted as another indicator of disturbed morphogenesis in the presence of an 
extra haploid set of chromosomes.  Several other anomalies also appear to be somewhat common in 
triploidy including hypoplasia of the thymus, abnormal dermatoglyphics, and postnatal growth deficiency 
in those rare cases of longer postnatal survival (DOSHI et al. 1983; NIEBUHR 1974) 
 
5.3 GENITAL ABNORMALITIES 
 
Abnormalities of both the external and internal genitalia are quite common in triploidy and the severity of 
these defects may be influenced by both genotype and presence of Barr bodies.  The most severe genital 
abnormalities have been observed in liveborns with no Barr bodies (NIEBUHR 1974).  It has been 
proposed that the severity of genital malformations is inversely correlated with the presence of Barr 
bodies (GRAHAM JR. et al. 1981).  Cases where at least a proportion of cells contain Barr bodies may have 
less severe genital abnormalities, however this may not hold true in cases of 46,XY/69,XXY mixoploidy 
in which the triploid line has two active X chromosomes.  Recently, it has been suggested that the Dax1 
gene on chromosome Xp21.3-p21.2 may play a role in the genital anomalies seen in triploidy 
(MCFADDEN et al. 2000).  The gene product is thought to antagonize SRY and is responsible for the 
dosage-dependent sex-reversal seen in 46,XY,dup(Xp) individuals.  Because individuals with 47,XXY 
Klinefelter syndrome develop as males, it is assumed that the extra copy of Dax1 is silenced by X 
inactivation in these cases.  However, the highly irregular X inactivation seen in triploid cells can result in 
populations of cells with 2 active X’s and thus overexpression of Dax1.  In this respect, the authors 
suggest that those 69,XXY cases without gonadal dysgenesis or other severe genital abnormalities may 
have predominantly cells with a single active X chromosome. 
 Genital abnormalities are seen in roughly 15% of 69,XXX triploids (MCFADDEN et al. 2000).  
When present, hypoplastic ovaries are often the only genital abnormalities seen in such cases (NIEBUHR 
1974).  .  There have been two reports of 69,XXX fetuses with hypoplastic external genitalia, unicornuate 
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uterus, and ovarian dysgenesis with few or no oocytes present (CUNNIFF et al. 1991).  Ovarian dysgenesis 
and the associated absence of primordial follicles are thought to be the result of early death of oocytes 
during embryonic development due to meiotic pairing abnormalities  introduced by the extra set of 
chromosomes (CUNNIFF et al. 1991).  Often there is a severely reduced number of primordial follicles 
(DOSHI et al. 1983; SCHWAIBOLD et al. 1990).  Hyperplasia of the ovarian hilum cells has also been noted 
and said to be analogous to testicular Leydig cell hyperplasia (SCHWAIBOLD et al. 1990).  This 
phenomenon is thought to be related to excess stimulation by β-hCG.  There has also been one case of a 
68,XX liveborn with a prominent clitoris not covered by the labia minora and absence of the fourchette 
(MERLOB et al. 1991).  A survey by McFadden et al. (2000) also reported several cases with abnormal 
prominence or persistence of the primitive sex cords. 
 An estimated 97% of 69,XXY triploids have some degree of genital ambiguity (BETTS et al. 
1989).  Among the more commonly reported anomalies are slight to severe genital malformation, small 
penis, hypospadias, bifid scrotum, undescended testes, Leydig cell hyperplasia, and tubular hyperplasia 
with the presence of normal appearing germ cells (DOSHI et al. 1983; NIEBUHR 1974; THARAPEL et al. 
1983).  Blackburn et al. (1982) reported that the most common abnormalities were cryptorchidism (85%), 
micropenis (75%), and scrotal anomalies (61%).  Occasionally the testes may be surrounded by a 
peripheral rim of immature ovarian tissue (KOS et al. 2005).  There has been one report of a 69,XXY 
infant with an abnormal uterus and fallopian tubes (LEISTI et al. 1974).  A second case has been reported 
as having severely dysgenetic undescended testes and rudimentary female internal genitalia (MCFADDEN 
et al. 2000).  The intersex characteristics seen in 69,XXY triploidy are similar to those seen in 
46,XX/46,XY or 45,X/46,XY mosaics (BUTLER et al. 1969).  Considering that 47,XXY Klinefelter males 
are phenotypically male with no intersex characteristics, it has been suggested that the genital 
abnormalities are a result of abnormal interactions between the three haploid sets rather than an imbalance 
between autosomes and sex chromosomes (BUTLER et al. 1969; NIEBUHR 1974).  It has been proposed 
that insufficient levels of luteinizing hormone may be responsible for the observed genital anomalies 
(JARVELA et al. 1993).  Considering that digynic triploids have abnormally small placentas with markedly 
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decreased hCG and estriol, it has been suggested that these low hCG levels may compromise testosterone 
production by the Leydig cells and lead to incomplete virilization (MCFADDEN et al. 2000).  It has been 
suggested that this may account for the findings of genital abnormalities in the presence of normal gonads 
in digynic triploids.  There has only been a single report of liveborn 69,XYY triploidy reported in the 
literature (DELIGDISCH et al. 1978).  This infant was born alive at 22 weeks but died immediately.  
Undescended testes with poorly developed Leydig cells, extreme micropenis, and agenesis of the scrotum 
were present along with numerous other severe anomalies incompatible with life including alobar 
holoprosencephaly. 
 
5.4 ASSOCIATION WITH PARTIAL HYDATIDIFORM MOLE 
 
Partial hydatidiform mole is the most common feature associated with triploid gestation with the majority 
of diandric triploid placentas believed to undergo partial molar degeneration (ZARAGOZA et al. 2000).  It 
is estimated that 80-85% of diandric triploid pregnancies and abortuses have a partial molar placenta 
(DOSHI et al. 1983; MONTGOMERY et al. 1993).  Partial mole has a strong association with diandric 
triploidy but is not associated with digynic triploidy, however it is not clear if all diandric triploids are 
destined to become partial moles (ZARAGOZA et al. 2000).  Indeed, a study by Zaragoza et al. (2000) 
found that only ½ of diandric triploids also received a diagnosis of partial mole.  The authors suggested 
that the diagnosis of PHM in diandric triploids may be related to the gestational age of the fetus since the 
characteristic features of partial mole may not appear until relatively late in gestation. 
 It has been hypothesized that the presence of a partial molar placenta may be related to Leydig 
cell hyperplasia seen in male fetuses (DOSHI et al. 1983).  It is thought that this phenomenon may be 
related to increased production of hCG by the hypertrophic trophoblast.  The observation of similar 
testicular findings in infants with choriocarcinoma lends support to this hypothesis.  The synthesis of 
testosterone in the fetal testis is stimulated by hCG which can bind receptors within testicular Leydig cells 
and tubular epithelium (DOSHI et al. 1983). 
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 Primary identifying characteristics for partial hydatidiform mole include circumferential 
trophoblast hyperplasia, hydropic villi, irregular villous contours, and dysmorphic villi (ZARAGOZA et al. 
2000).  Morphologically, villi can range from normal to cystic and include trophoblastic inclusion and 
occasional villous cistern formation (HOFFNER et al. 2008).  Unlike complete moles, the placental vessels 
of partial moles often contain nucleated fetal erythrocytes indicative of more advanced fetal development 
(SURTI et al. 2005).  Histologically, triploid partial moles can be difficult to distinguish from diploid 
hydropic abortuses (LEGALLO et al. 2008).  Another source of misdiagnosis is the occasional presence of 
some features of partial mole in non-triploid conceptuses.  It has been noted that the occurrence of 
trophoblast inclusions is rather common in trisomy 16 placentas and that these placentas may occasionally 
be mistakenly diagnosed as partial moles (JACOBS et al. 1982a). 
 Though less frequent and less severe than in complete mole, partial hydatidiform mole has the 
potential to lead to a variety of complications.  The most serious of these is persistent gestational 
trophoblastic disease which may follow 0.5-5.0% of partial molar pregnancies (LEGALLO et al. 2008).  
Choriocarcinoma has also been reported following PHM, though the occurrence is rare (MEDEIROS et al. 
2008).  Another infrequent complication is the occurrence of theca lutein cysts which are observed in the 
maternal ovaries in up to 10% of triploid pregnancies. (FRATES and FEINBERG 2000).  These cysts are a 
form of ovarian hyperstimulation resulting from excessive β-hCG secretion by the hyperplastic 
trophoblast.  There has been one report of full blown ovarian hyperstimulation syndrome following a 
spontaneously conceived triploid gestation (LUDWIG et al. 1998).  Early onset preeclampsia developing 
before 20 weeks of gestation is also a common finding with a few reported cases of triploidy complicated 
by severe HELLP syndrome (CRAIG et al. 2000; FALKERT et al. 2009; RAMSEY et al. 1998; STEFOS et al. 
2002).  This phenomenon is thought to result from poor trophoblastic proliferation of the deep maternal 
spiral arteries (PIETRANTONI et al. 1995).  In the context of a diploid fetus coexisting with a triploid 
partial molar placenta, fetal mortality is often the result of anemia due to hemorrhaging from the 
abnormal placental vasculature (HSIEH et al. 1999). 
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 Though rare, there are reports of normal diploid fetuses coexisting with triploid partial molar 
placentas (NIEMANN et al. 2008).  It is estimated that roughly 1 in 22,000-100,000 partial moles occur in 
association with a twin fetus (GOLUBOVSKY 2003).  Some studies have suggested that molar placentas are 
more common when the associated fetal karyotype is 69,XXY as opposed to 69,XXX (RAMSEY et al. 
1998).  A number of factors contribute to fetal survival including fetal karyotype, size and rate of 
degeneration of the molar placenta, and the occurrence of fetal anemia or other obstetric complications 
(HSIEH et al. 1999). 
 
5.5 MOLAR GESTATION FROM TRIPLOID ZYGOTES 
 
Cytological evidence suggests that diploidization of an initially triploid zygote can result in a diploid fetus 
with a triploid partial mole or a triploid fetus with a diploid complete mole (GOLUBOVSKY 2003).  It is 
hypothesized that these sorts of associations may occur frequently but are not diagnosed due to very early 
fetal demise.  It may also be possible to have a diploid biparental fetus coexisting with a diploid 
androgenetic complete mole with both deriving from a single dispermic triploid zygote.  In this scenario, 
one of the male pronuclei will join with the female pronucleus while the second male pronucleus would 
undergo endoreduplication which would temporarily create a tetraploid state in the zygote (NIEMANN et 
al. 2008).  The first zygotic division would then result in the biparental genome going to one blastomere 
and the diploid androgenetic genome going to the other.  A similar result can be obtained following 
trispermic fertilization. 
 Yet another model involves the formation of a tripolar spindle following replication of all three 
pronuclei (HSU et al. 2008).  The zygote would then divide into three blastomeres with one being 
heterozygous and diandric while the other two are biparental with different paternal and like maternal 
genomes.  It may also be possible to get a virtually identical result following diplospermic fertilization 
(HSU et al. 2008).  In this scenario, the diploid male pronucleus replicates prematurely with one of the 
daughter nuclei being separated in a cytoplasmic fragment and developing into an androgenetic complete 
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mole.  The remaining diploid male pronucleus is then separated into two haploid sets by a bipolar spindle 
with each set fusing with one of the replicated maternal pronuclei.  These can then go on to form separate 
biparental blastomeres with different paternal but identical maternal complements. 
  
53 
 
 
 
 
6.0 PHENOTYPIC CHARACTERISTICS OF DIPLOID/TRIPLOID MIXOPLOIDY 
 
 
6.1 COMPARISON WITH COMPLETE TRIPLOIDY 
 
Diploid/triploid mixoploidy has been a recognized syndrome for at least twenty-five years but is believed 
to be rare or underdiagnosed in adults with mental retardation and congenital abnormalities due to the 
infrequency of fibroblast karyotyping (GOLUBOVSKY 2003; VAN DE LAAR et al. 2003).  .  Both 
syndromes likely have similar phenotypes though the mixoploidy phenotype is often less severe and 
associated with longer survival (QUIGLEY et al. 2005; VAN DE LAAR et al. 2003).  It has been suggested 
that the complete triploid phenotype may be blurred by the presence of a high proportion of diploid cells 
(NIEBUHR 1974).  Overall, mixoploids tend to have a less severe phenotype than complete polyploids 
(EDWARDS et al. 1994).  It is possible that some diploid/triploid mixoploids may show only 
placentamegaly and hemihypertrophy (NIEBUHR 1974).  Viability is likely related to the tissue 
distribution of triploid cells, though there does not appear to be a strong correlation between percentage of 
diploid cells in examined tissues and survival (DEVRIENDT 2005; KARTESZI et al. 2006).  It has been 
noted that the highly variable phenotypic spectrum of diploid/triploid mixoploidy mirrors the variability 
seen in other types of chromosomal mosaicism (RITTINGER et al. 2008).  This seems especially true when 
considering the degree of mental retardation which can range from mild to severe.  The internal findings 
in 2n/3n mixoploidy are less consistent and less severe than in complete triploidy (DOSHI et al. 1983; 
PETTENATI et al. 1986).  Specifically, severe brain, cardiac, and renal anomalies are much less common 
in mixoploidy and their absence may contribute to longer survival. 
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6.2 GENERAL PHENOTYPIC TRAITS 
 
The craniofacial anomalies seen in triploid mixoploidy are essentially the same as those seen in complete 
triploidy though they are often less severe.  Among the more commonly seen anomalies are malformed 
and/or low set ears and microstomia which are seen in greater than 50% and 42% of cases respectively 
(VAN DE LAAR et al. 2003).  Other commonly seen anomalies include a broad forehead, downslanting 
palpebral fissures, hypertelorism, micrognathia, a short upturned nose with a depressed bridge, and a 
triangular face (MULLER et al. 1993; QUIGLEY et al. 2005; WULFSBERG et al. 1991).  Eye defects such as 
coloboma and microophthalmia are less common than in complete triploidy, but are still sometimes seen 
(VAN DE LAAR et al. 2003).  Oral defects such as cleft lip and/or palate are also less common than in 
complete triploidy (FULTON et al. 1977). 
 Limb defects are seen in close to 100% of cases of diploid/triploid mixoploidy with 3-4 
syndactyly of the fingers and/or 2-3 syndactyly of the toes being most common (PETTENATI et al. 1986; 
VAN DE LAAR et al. 2003).  Syndactyly can also occur between other digits.  Syndactyly and clinodactyly 
are seen in greater than 50% of cases.  Clinodactyly of the fifth finger is also common as is 
camptodactyly.  The camptodactyly has been described as “unusual and cup-like” and is considered a 
hallmark of the syndrome (RITTINGER et al. 2008).  The presence of a single transverse palmar crease is 
also a common finding (WULFSBERG et al. 1991).  The presence of a sandal gap between the first and 
second toes as well as short halluces are also a common finding having each been reported in 
approximately 45% of cases (VAN DE LAAR et al. 2003). 
 Muscular atrophy confined to the extremities has been documented in approximately 35% of the 
cases of diploid/triploid mixoploidy (SHAFI et al. 2007; VAN DE LAAR et al. 2003).  Shafi et al. (2007) 
described a case of late onset myopathy in a 25 year old woman with 2n/3n mixoploidy and obtained the 
first histological evidence of myopathy.  This case was considered to be a mild form of autosomal 
dominant central core disease and its co-occurrence with diploid/triploid mixoploidy in this patient was 
possibly a random event. 
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 Internal anomalies in 2n/3n mixoploidy are both less common and less severe than in complete 
triploidy.  A study by Doshi et al. (1983) reported no consistent internal findings.  Cerebral anomalies, 
when present, most commonly involve partial or complete agenesis of the corpus callosum (VAN DE LAAR 
et al. 2003).  It has been hypothesized that central nervous system anomalies may lead to anomalies in the 
limbic system, hypothalamus, or pituitary which in turn could lead to abnormalities of the adrenal glands 
or gonads (JARVELA et al. 1993).  Heart defects are also less common than in complete triploidy (VAN DE 
LAAR et al. 2003).  Other occasionally reported findings include congenital hypothyroidism secondary to 
thyroid agenesis and horseshoe kidney (VAN DE LAAR et al. 2003). 
 The longer survival of 2n/3n mixoploids has allowed for the observation of a number of 
anomalies involving growth and development.  Early feeding difficulties have been reported in 38% of 
cases (VAN DE LAAR et al. 2003).  Asymmetric growth with or without minor skeletal anomalies are also 
a common finding seen in up to 57% of cases (DONNAI et al. 1986; PETTENATI et al. 1986).  It has been 
hypothesized that later growth asymmetry arises from early asymmetric distribution of triploid versus 
diploid cells in the blastodermic vesicle (FERRIER et al. 1964).  It is thought that this imbalance may 
adversely affect the growth of embryonic tissues on one side of the body axis and that the child may never 
be able to recover from this early imbalance.  This asymmetry may be restricted to only involving the face 
or only involving one or both limbs on one side of the body (GOLUBOVSKY 2003; MULLER et al. 1993).  
Postnatal growth retardation with or without delayed bone age has been noted in 70-74% of cases with 
70% of these being noted prenatally (PETTENATI et al. 1986; VAN DE LAAR et al. 2003). 
 Mental and psychomotor retardation are a nearly universal feature of 2n/3n mixoploidy (MULLER 
et al. 1993; SHAFI et al. 2007).  It is seen in greater than 50% of patients though with highly variable 
severity that appears to be independent of the proportion of triploid cells present (VAN DE LAAR et al. 
2003).  Mental retardation is often the initial presenting symptom leading to a diagnosis.  Abnormal EEG 
activity with or without an associated seizure disorder is also seen in 44% of cases (MULLER et al. 1993; 
VAN DE LAAR et al. 2003). 
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 Pigmentary dysplasia is an additional finding seen in 38% of patients (GOLUBOVSKY 2003; VAN 
DE LAAR et al. 2003).  This feature often develops later in life and most closely resembles hypomelanosis 
of Ito.  The hyper or hypopigmented streaks often follow Blaschko’s lines and are a feature indicative of 
mosaicism (DEVRIENDT 2005).  It has been hypothesized that this phenomenon may result from genetic 
differences between melanocytes migrating from the neural crest and the surrounding tissues of their 
destination (WULFSBERG et al. 1991).  In other words, the melanocytes may be triploid and the dermal 
cells diploid or vice versa.  Blaschko’s lines are themselves thought to indicate the route of melanocyte 
migration during early embryogenesis. 
 A number of other miscellaneous anomalies are also seen with varying degrees of frequency in 
diploid/triploid mixoploidy.  Neonatal respiratory distress has been reported in up to 44% of cases (VAN 
DE LAAR et al. 2003).  Hypotonia is also common and occurs in greater than 50% of cases.  
Hematological anomalies such as dyserythropoietic anemia have also been reported (WRIGHT and WALES 
2004).  Hearing loss has also been reported (MULLER et al. 1993).  Truncal obesity is also common and 
may develop later in childhood following a somewhat dystrophic appearance during infancy (SHAFI et al. 
2007). 
 
6.3 SEX AND GENOTYPE SPECIFIC TRAITS 
 
Due to the different possible combination of sex chromosomes seen in diploid/triploid mixoploidy, there 
are a wide variety of genital anomalies associated with the syndrome.  Males tend to have small to 
ambiguous genitalia depending on the sex chromosome complement of the two cell lines (QUIGLEY et al. 
2005).  Insufficient luteinizing hormone has been proposed as a possible cause of these anomalies and 
may be tied to hypothalamic problems (GRAHAM JR. et al. 1981; JARVELA et al. 1993).  Cryptorchidism 
is also common and greater than 50% of males have a small phallus (VAN DE LAAR et al. 2003).
 Females tend to have few if any abnormalities.  There have been some reports of precocious 
puberty and ovarian agenesis, though the latter is much less common than in complete triploidy (VAN DE 
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LAAR et al. 2003).  46,XX/69,XXX mixoploids always have apparently normal female external genitalia 
(OKTEM et al. 2007). 
 Individuals with 46,XX/69,XXY mixoploidy can range from normal males to hermaphroditism 
with ovotestis disorder (OKTEM et al. 2007).  This conforms to the rule that the presence of a Y 
chromosome induces testicular differentiation of the primitive gonad, however there has been a reported 
case of normal female phenotype in an individual with a 46,XX/69,XXY karyotype and ovarian 
expression of SRY (OKTEM et al. 2007).  Molecular analysis found no mutations in SRY or its promoter 
sequences, however the patient was not tested for possible mutations in downstream targets of SRY.  The 
authors proposed a mechanism by which double dose of the dosage-sensitive sex-reversal (DAX1) gene 
located on chromosome Xp21 may have caused sex-reversal by overriding SRY.  This phenomenon has 
previously been shown in 69,XXY triploidy presenting with ambiguous genitalia or sex reversal (OKTEM 
et al. 2007).  There is also an increased risk of gonadoblastoma in 46,XX/69,XXY mixoploidy (OKTEM et 
al. 2007). 
The phenotypic spectrum of 46,XY/69,XXY mixoploids may be just as wide as that in 
46,XX/69,XXY.  One report describes a 46,XY/69,XXY fetus with completely ambiguous external 
genitalia, testes surrounded by a rim of immature ovarian tissue, and an absent prostate with an unusually 
large utricle in its place (BENDON et al. 1988).  There has been a single case of very low grade 
46,XY/69,XYY mixoploidy reported in the literature (SELLYEI et al. 1971).  This was found in the blood 
of a phenotypically normal adult male undergoing genetic testing due to a putative genetic disorder in his 
son.  The authors postulated that this may have had a somatic origin by way of tripolar division of a rare 
92,XXYY tetraploid cell. 
 
6.4 DIFFERENTIAL DIAGNOSIS 
 
The large degree of phenotypic variability seen in diploid/triploid mixoploidy allows for a nearly equally 
wide range of potential differential diagnoses.  The syndrome is most often said to mimic different 
58 
 
genomic imprinting disorders and present with different features being more prominent at different times 
of development (RITTINGER et al. 2008).  Features reminiscent of Russel-Silver syndrome, of which 10% 
of cases are associated with UPD(7), may be evident at an early age (LAMBERT et al. 2001; ROBINSON et 
al. 1997).  These features may include asymmetry, a triangular face, and a broad forehead.  The onset of 
truncal obesity may be reminiscent of Prader-Willi syndrome (RITTINGER et al. 2008).  Features 
resembling congenital hyperinsulinism and Beckwith-Wiedeman syndrome, both linked to defects in an 
imprinted gene cluster on chromosome 11p15, have also been seen (GIURGEA et al. 2006; RITTINGER et 
al. 2008).  Finally, the precocious puberty seen in some cases is reminiscent of that seen in maternal 
UPD(14) (DEVRIENDT 2005).  Imbalances in dosage sensitive or imprinted genes have been proposed as a 
possible explanation for this phenomenon (RITTINGER et al. 2008).  The similarity between 2n/3n 
mixoploidy and various imprinting disorders such as BWS and SRS may be explained by imprinted genes 
being expressed on one haploid set and silenced on the other two or vice versa. 
 This syndrome may also mimic several other disorders that are not associated with imprinting 
defects.  There appears to be considerable phenotypic overlap with Camera-Marugo-Cohen syndrome 
(LAMBERT et al. 2001).  Pigmentary anomalies resemble those seen in hypomelanosis of Ito, a disorder 
that is often indicative of mosaicism (RITTINGER et al. 2008).  Finally, there is considerable overlap with 
the even rarer syndrome of diploid/tetraploid mixoploidy (RITTINGER et al. 2008). 
 
6.5 TRIPLOIDY AND TRISOMY 
 
Approximately 7% of triploids occur in conjunction with numerical trisomies (GOLUBOVSKY 2003).  This 
figure appears to be higher than average when considering that 50% of karyotypically abnormal 
pregnancies contain fetal trisomies and that 15-20% of pregnancies end in miscarriages which suggests 
5% of recognized pregnancies contain trisomies.  This co-occurrence is thought to be related to the 
generalized chromosome instability of triploid cells, at least during the pronuclear and early cleavage 
stages of development.  A recent survey of embryos from women undergoing preimplantation genetic 
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screening, but without any known risk factors, has provided some support for this hypothesis (VANNESTE 
et al. 2009).  The authors noted an unusually high rate of chromosome instability in cleavage stage 
embryos including whole chromosome imbalances.  Considering that such instability was found in 
otherwise normal diploid embryos, it seems reasonable to infer that such instability would only be 
increased in triploid embryos due to the presence of an entire extra haploid set of chromosomes.  These 
anomalies can occur as either additional aneuploidies in a single triploid line or as mixoploidy/aneuploidy 
in which there may be two or three different cell lines.  As an example of the former, there have been 
multiple reported cases of fetuses exhibiting a 68,XX karyotype (MERLOB et al. 1991). 
Trisomy and other chromosome abnormalities are thought to be less detrimental to the 
development of triploid fetuses than to that of otherwise diploid fetuses.  It has been suggested that, in the 
presence of a triploid and an aneuploid cell line, the two constitutional anomalies may partially cancel 
each other out such that the resultant phenotype is less severe than when either anomaly occurs alone.  
This hypothesis was initially suggested based on the observation of two cases of 69,XXY/45,X 
mixoploidy in which the phenotypes were less severe than either complete triploidy or non-mosaic 
monosomy X (BETTS et al. 1989; QUIGLEY et al. 2005).  An additional case of 2n/3n mixoploidy in 
conjunction with sex chromosome aneuploidy was reported in the case of an 11 month old child with 
severe mental retardation, multiple malformations, and a 48,XXYY/71,XXXYY karyotype (SCHMID and 
VISCHER 1967). 
There have been several published reports of liveborn mixoploid/aneuploid infants with 
autosomal trisomies in which no normal diploid cell line was present.  One particularly exceptional report 
describes a girl with a 47,XX,+15/69,XXX karyotype who lived for more than 3 ½ years (DEAN et al. 
1997).  Normal 46,XX cells were only found in amniotic fluid, amnion, and chorion.  However, these 
accounted for only five of a combined total of 63 cells from these tissues and the authors could not be 
certain if this cell line actually existed or if it was some sort of contamination or artifact.  No 46,XX cells 
were found in umbilical cord, cord blood, peripheral blood, bone marrow, muscle biopsy, or skin 
fibroblasts.  All of these tissues were 47,XX,+15/69,XXX with the triploid cell line predominating in 
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each.  She had multiple dysmorphic features and showed severe psychomotor delay prior to succumbing 
to complications from an upper respiratory infection at the age of 3 years and 8 months.  The authors 
noted only one case of apparently non-mosaic trisomy 15 in a liveborn infant who survived 4 days (DEAN 
et al. 1997). 
A second exceptional case reported by Dahl et al. (1988) describes a liveborn infant with a 
46,XY,+2p/69,XXY karyotype.  This child showed multiple external and internal anomalies and survived 
5 weeks, but with no signs of development or medical improvement.  The authors note that there have 
been no reports of liveborn complete trisomy 2p, though there have been several reports of segmental 
trisomies for 2p or 2q.  All of this latter group were linked to parents who were balanced translocation 
carriers, however the parental karyotypes were normal in this case (DAHL et al. 1988).  Some of the 
features in this case were noted to be consistent with those seen in segmental trisomy 2p. 
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7.0 PARENT-OF-ORIGIN EFFECTS 
 
 
7.1 GENOMIC IMPRINTING 
 
One of the most interesting aspects of triploidy is the effect that the parental origin of the extra haploid set 
of chromosomes has on phenotype.  It is believed that the observed correlation between parental origin of 
the extra haploid set and resultant phenotype is directly related to genomic imprinting (CHANG et al. 
2001).  It has long been recognized that paternally expressed genes are critical for proper development of 
extraembryonic tissues while maternally expressed genes are essential for proper development of the 
embryo proper (MCFADDEN and KALOUSEK 1991).  It has been suggested that this imprinting effect may 
account for an apparent advantage of digynic triploidy as a non-cystic placenta may be correlated with 
longer intrauterine survival (CHANG et al. 2001). 
 Evidence supporting large scale imprinting effects on placental morphology has been found.  It 
has been shown that digynic triploidy with asymmetric IUGR is always associated with severe adrenal 
hypoplasia (MCFADDEN and ROBINSON 2006).  As fetal growth of the adrenal glands is influenced by 
hCG, this finding points to insufficient production of this hormone by the small digynic placenta.  On the 
other hand, diandric triploidy generally shows fairly normal growth and is generally not associated with 
adrenal hypoplasia (MCFADDEN and ROBINSON 2006).  This could thus reflect the increased placental 
volume and/or syncytiotrophoblastic hyperplasia seen in diandric placentas.  These findings all reflect 
studies suggesting that imprinted genes may be more important to placental development and that any 
effects on the fetus are secondary to those on the placenta (MCFADDEN and ROBINSON 2006). 
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7.2 EFFECTS ON EMBRYO MORPHOLOGY 
 
The examination of embryos, triploid or otherwise, can be somewhat problematic for various technical 
and practical reasons (PHILIPP et al. 2004).  Indeed most early abortion specimens are either incomplete 
or damaged during evacuation to the extent that they are of little use for morphological assessment.  The 
malformation pattern seen in triploid embryos appears to be nonspecific (MCFADDEN and ROBINSON 
2006).  These embryos commonly show generalized growth disorganization or other nonspecific 
abnormalities that may be conducive to at least somewhat normal embryogenesis.  Philipp et al. (2004) 
utilized transcervical embryoscopy to perform morphological examinations of missed abortions of less 
than eight weeks gestational age prior to dilation and curettage.  Their survey included 18 triploid 
abortuses, 13 of which were 69,XXY and five 69,XXX.  Structural defects were detected in 17 of these 
embryos and included facial anomalies (n = 15), limb anomalies (n = 13), microcephaly (n = 11), and 
neural tube defects (n = 10).  The authors also noted that 12/18 cases showed signs of partial molar 
degeneration.  It was suggested that the high rate of malformations was representative of severely 
disturbed morphogenesis that are rarely overcome in triploid conceptuses.  The authors were unable to 
offer a hypothesis regarding the apparent overexpression of severe craniofacial and limb defects in 
embryos relative to fetuses.  It is known that the parental origin of the extra haploid set of chromosomes is 
important in determining the placental and embryonic phenotype in up to 2/3 of cases (PHILIPP et al. 
2004). 
 The general consensus is that there does not appear to be a discernable parent-of-origin effect on 
the phenotype of triploid embryos (MCFADDEN and ROBINSON 2006).  The absence of apparent growth 
differences between digynic and diandric embryos suggests that these differences develop later during the 
fetal period.  Evidence also suggests that growth differences may be more related to placental phenotype 
than to direct imprinting effects on the embryo or fetus (MCFADDEN and ROBINSON 2006).  Overall, the 
morphology of triploid embryos appears to be fairly uniform consisting of craniofacial anomalies, 
microcephaly, and delayed limb development (MCFADDEN and KALOUSEK 1991). 
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 7.3 EFFECTS ON FETAL MORPHOLOGY 
 
The majority of the abnormalities seen in either complete triploidy or 2n/3n mixoploidy do not show any 
parent-of-origin effects (MCFADDEN and ROBINSON 2006).  It has been suggested that observed parent-
of-origin effects arise from an altered intrauterine environment which is dependent on placental 
morphology which in turn is dependent on the parental origin of the extra haploid set.  Diandric triploidy, 
also known as type I triploidy, is characterized by relatively normal fetal growth with either relative 
microcephaly or proportionate fetal head size (MCFADDEN and KALOUSEK 1991).  It is thought that this 
may be due to a higher degree of trophoblast development which provides more nourishment to the fetus.  
If IUGR is present, it is usually mild and symmetric (MCFADDEN and ROBINSON 2006).  The adrenal 
glands of diandric triploids are usually normal.  This is thought to be a result of increased placental 
volume and/or hyperplasia of the syncytiotrophoblast which in turn leads to increased levels of hCG.  
Diandric triploidy has also been associated with increased nuchal translucency on ultrasound (DALMIA et 
al. 2005; STEFOS et al. 2002). 
 Digynic, or type II, triploidy is most commonly associated with a strikingly abnormal fetus with 
severe asymmetric IUGR and relative macrocephaly (MCFADDEN and KALOUSEK 1991).  The IUGR is 
thought most likely due to placental insufficiency and most commonly affects the limbs and trunk 
(BARKEN et al. 2008; MCFADDEN and KALOUSEK 1991).  The relative macrocephaly can sometimes be 
to an extreme extent (MINY et al. 1995).  Nuchal translucency is often normal on ultrasound (MCFADDEN 
and ROBINSON 2006).  Severe adrenal hypoplasia is also a common finding along with small kidneys 
(MCFADDEN and ROBINSON 2006; MINY et al. 1995). 
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7.4 EFFECTS ON PLACENTAL MORPHOLOGY 
 
The origin of the diandric and digynic triploid phenotypes remain somewhat unclear and puzzling, though 
it is now thought that it may have to do with a direct imprinting effect on placental morphology and 
function (MCFADDEN and KALOUSEK 1991).  The parental origin of the extra haploid set of 
chromosomes in triploidy appears to play a major role in placental development and morphology.  
Diandric triploid gestations are believed more likely to present as partial hydatidiform moles and are less 
likely to contain fetal components than digynic triploids (ZARAGOZA et al. 2000).  However, one study on 
a large series of triploid conceptuses ranging from 7-16 weeks gestational age found that only 8/53 had 
partial molar placentas (MCFADDEN and PANTZAR 1996).  The authors noted that all eight partial moles 
were among 44 cases of less than nine weeks gestational age and that all four cases of partial mole that 
also had an embryo showed abnormal embryo morphology.  All of the non-molar triploids in this study 
showed mainly non-specific placental changes.  These placentas were mostly non-hydropic with 
occasional collapse of the villous stroma and autolysis of the trophoblastic epithelium. 
There also appears to be a relationship between the gestational age of diandric triploids and the 
presence of a partial molar placenta.  A study by Zaragoza et al. (2000) showed that only 33% of the 
placentas from triploid spontaneous abortions of less than 8.5 weeks gestational age showed partial molar 
changes while this value increased to over 50% for older abortuses.  It is theorized that better trophoblast 
development and only partial cystic degeneration of the placenta may allow for more adequate fetal 
nourishment and thus better growth and development (MCFADDEN and KALOUSEK 1991).  In other 
words, the level of fetal development in diandric triploids may be dependent on the degree of molar 
degeneration of the placenta.  This is opposed to the generally small and hypoplastic condition of digynic 
placentas which may be incapable of providing sufficient nourishment to the developing fetus.. 
 The placental morphology for digynic triploid conceptuses appears to be completely opposite to 
that seen for diandric triploids (ZARAGOZA et al. 2000).  These placentas are often small and non-cystic 
with occasional fibrosis of the stromal cores (MCFADDEN and KALOUSEK 1991).  It has been suggested 
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that the severe IUGR seen in digynic triploidy may result from placental insufficiency.  However, it is not 
possible to distinguish a direct imprinting effect on the fetus from a placental function effect secondary to 
poor trophoblast development and stromal fibrosis (MCFADDEN and KALOUSEK 1991).  The small 
placental size implies a lesser likelihood of intrauterine survival and possibly accounts for the 
preponderance of digynic triploidy seen in the early embryonic period (MCFADDEN and ROBINSON 2006). 
 It has been hypothesized that maternal serum hormonal levels may be an indicator of the 
placental status in triploid gestation (MINY et al. 1995).  Large placentas with partial molar change as 
seen in diandric triploidy are often associated with increased maternal serum alpha fetoprotein (MSAFP) 
and hCG.  Conversely, the small non-cystic placentas indicative of digynic triploidy are often correlated 
with normal levels of MSAFP as well as low hCG or unconjugated estriol (uE).  There appears to be a 
distinct parent-of-origin effect on maternal serum markers during pregnancy. 
 Diandric triploidy usually correlates with elevated maternal serum hCG, free β-hCG, and alpha 
fetoprotein (AFP) (DALMIA et al. 2005; MINY et al. 1995; STEFOS et al. 2002).  Additionally, Dalmia et 
al (2005) noted a slightly decreased level of pregnancy associated plasma protein A (PAPP-A) while 
Miny et al. (1995) found elevated uE in diandric triploid gestations.  Elevated levels of hCG can become 
even more extreme in cases of twin triploid gestation associated with partial mole (FRATES and FEINBERG 
2000).  It has also been suggested that the degree to which levels of hCG are elevated may simply be 
related to placental mass (MCFADDEN et al. 2002a).  Elevated levels of AFP are thought to be related to 
vascular abnormalities in the placenta that allow fetal AFP to leak into the maternal circulation (AVIRAM 
et al. 2008).  The hormonal profile in diandric triploidy may be interpreted as showing an increased risk 
for trisomy 21 (YARON et al. 2004).  Conversely, digynic triploids often present with decreased serum 
hCG, free β-hCG, and AFP (DALMIA et al. 2005; STEFOS et al. 2002).  Levels of hCG as well as those for 
PAPP-A and uE can be markedly decreased (BARKEN et al. 2008; MCFADDEN et al. 2002a).  The serum 
profiles for digynic triploidy are often interpreted as showing an increased risk for trisomy 18 
(MCFADDEN et al. 2002a). 
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7.5 EFFECTS ON GESTATIONAL AGE 
 
Generally, it is believed that the proportion of diandric versus digynic triploidy is dependent on the 
gestational age of the conceptus at the time of ascertainment (ROSENBUSCH 2008).  Studies have shown 
that most diandric triploids have a developmental age greater than 8.5 weeks or greater than 10 weeks 
when an embryo or fetus is present (MCFADDEN and ROBINSON 2006).  Such older abortuses also have an 
increased likelihood of being partial moles (ZARAGOZA et al. 2000).  Diandry accounts for 50-60% of all 
early triploid abortuses and is the predominant parental origin for those abortuses between five and 18 
weeks gestational age (MCFADDEN and ROBINSON 2006; ZARAGOZA et al. 2000).  Diandric triploidy is 
generally present on the border between the embryonic and fetal periods of development (MCFADDEN 
and ROBINSON 2006). 
 On the other hand, those digynic triploid that end in spontaneous abortion tend to do so at an 
earlier age than diandric triploids (ZARAGOZA et al. 2000).  Digynic triploidy predominates in triploid 
gestations of less than 8.5 weeks or those where a fetus is present (MCFADDEN and ROBINSON 2006)..  It 
is generally accepted that digynic triploidy predominates in cases with embryonic development and 
during the fetal period while diandric triploidy is more commonly encountered around the boundary of 
the embryonic and fetal periods  and are less likely to have identifiable embryos or fetuses (MCFADDEN 
and ROBINSON 2006).   It is suggested that digynic triploidy may predominate at the gestational age 
where expectant mothers may be referred for prenatal karyotyping due to an abnormal ultrasound or other 
screening (MINY et al. 1995). 
 A number of studies have attempted to look at the parental origin of triploidy at different 
gestational ages.  McFadden and Robinson (2006) were involved in two separate studies that further 
illustrated that digynic triploidy predominates in the early embryonic period.  These studies totaled 47 
triploid conceptuses of which 32 were digynic and only 15 of diandric origin.  These observations also 
serve to further illustrate the rather complicated relationship between parental origin and gestational age.  
Another study found that 19/23 triploid embryos of greater than 10 weeks gestational age were of digynic 
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origin (BAUMER et al. 2000).  A study by Jacobs et al. (1979) reported that digynic triploids originating 
from a maternal meiosis II error often had a reduced gestational age compared to other types of digynic 
triploidy.  The authors suggested that homozygosity for such a large number of genes may be deleterious 
even in the presence of another haploid set of heterozygous genes.  McFadden and Langlois (2000) used 
DNA polymorphisms to examine the parental origins of triploid conceptuses during the embryonic and 
fetal periods.  They found that 11/14 fetal triploids ranging from 11-34 weeks gestational age were of 
digynic origin.  The proportions of diandric (n = 11) and digynic (n = 13) triploids in conceptuses of less 
than 10 weeks gestation were much closer.  However, there was a significant difference in parental origin 
depending on whether or not the gestation had a recognizable embryo or embryo parts.  Embryos or 
embryo parts were present in 20 cases with 13 of them being digynic whereas 4/5 cases that lacked 
embryo parts were of diandric origin.  The remaining cases were uninformative. 
 The relationship between parental origin of the extra haploid set of chromosomes and gestational 
age of the conceptus appears to be quite complex (ZARAGOZA et al. 2000).  Digynic triploids abort 
relatively early compared to diandric cases and account for a higher proportion of early triploid gestation 
but decline in frequency as gestational age increases.  This trend appears to then reverse later in 
pregnancy as the majority of second and third trimester triploid gestations are often found to be of digynic 
origin.  Overall, most diandric triploids abort at 10-20 weeks of gestation while digynic triploids either 
abort very early or survive until relatively late in gestation (ZARAGOZA et al. 2000).  It is known that the 
majority of triploid gestations with cystic placentas abort in the first trimester (MCFADDEN and 
KALOUSEK 1991).  This suggests that the cytogenetic makeup of the trophoblast may be more important 
than placental function in the sense that digynic triploids often have smaller placentas that would seem to 
be more likely to suffer from insufficiency.  It has been suggested that confined placental mosaicism may 
help to explain this discrepancy (MCFADDEN and KALOUSEK 1991).  There is evidence that the 
trophoblast is 2n/3n in at least some triploid fetuses with the presence of cytogenetically normal 
trophoblast possibly allowing for longer survival.  It is not currently known if the presence of a diploid 
cytotrophoblast is more common in diandric or digynic triploidy (MCFADDEN and KALOUSEK 1991). 
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 This pattern can be illustrated by noting the gestational ages and parental origins of all cases of 
triploidy from a total of six studies.  Among these studies, there were a total of 238 cases in which the 
gestational age and parental origin were known.  Of these cases, 141 were diandric and 97 digynic.  As 
can be seen in Figure 1, digynic triploidy predominates at gestational ages less than 10-11 weeks and 
greater than 20-21 weeks while diandric triploidy predominates from approximately 10-20 weeks.  Since 
there were far fewer digynic cases than diandric cases, the number of digynic cases in each age group 
were multiplied by a factor of approximately 1.45  in order to adjust the values to those expected had 
there been 141 digynic triploids.  The data used to construct this chart can be found in appendix D, Tables 
17-19. 
 
 
0
5
10
15
20
25
30
35
Diandric
Digynic
 
Figure 1. Prevalence of diandric versus digynic triploidy with respect to gestational age 
 
 The reasons for this complex pattern remain somewhat speculative at best (MCFADDEN and 
ROBINSON 2006).  The small digynic placenta implies less likelihood of intrauterine survival and may 
explain their predominance in early abortions.  Conversely, partial molar placentas may be more likely to 
survive into the fetal period.  However, their increased volume and associated elevated hCG levels may 
lead to an earlier clinical presentation and miscarriage.  The precise reasoning for the predominance of 
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digynic triploidy in later gestation is not clear, however the genetic background may play a role 
(MCFADDEN and ROBINSON 2006). 
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8.0 LITERATURE REVIEW 
 
 
8.1 OVERVIEW 
 
An extensive search of the literature turned up total of 63 cases of diploid triploid mixoploidy that were 
published in English.  The ages of these cases ranged from late first trimester terminations of pregnancy 
to adult.  The amount of detail provided regarding phenotypic characteristics was also highly variable 
ranging from very detailed to almost no information.  Many cases including most of those describing 
older children or adults provided no information on placental morphology or histology.  Only 28/63 cases 
provided mechanisms of origin with 19 being of digynic origin and nine being of diandric origin.  A 
detailed table describing the genotypes, parental origin, and phenotypes of all case can be found in 
appendix A, tables 10 and 11.  Table 5 summarizes the genotype and parental origin distribution of these 
cases. 
Table 5. Genotype and parent-of-origin distribution among 2n/3n mixoploid cases 
 46,XX/69,XXX 46,XX/69,XXY 46,XY/69,XXY 46,XY/69,XYY Totals 
Diandric 4 2 3 0 9 
Digynic 9 0 10 0 19 
Unknown 15 6 8 1 30 
Totals 28 8 21 1 58 
- Exclusions 
4 (4) - Gropp et al., 1964 - Karyotype of 3n line not indicated – Possibly restricted to palatal defect 
10b (11) - Fulton et al., 1977 - Karyotype not indicated 
33 (36) - Lin et al., 1998 - No karyotype, 2n/3n by flow cytometry 
35 (38) - Hsieh et al., 1999 - Fetus 2n, Placental karyotype unknown but assume 3n based on PHM 
37 (40) - Zhang et al., 2000 - Fetus 46,XX – Placenta 3n but karyotype not mentioned 
 
 
 The numbers in the first column refer to the cases as they are listed in appendix A, tables 10 and 
11 with the first number being the article in chronological order and the second referring to the overall 
total number of cases, again in chronological order.  There were no cases with 46,XX/69,XYY or 
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46,XY/69,XXX genotypes.  Both of these situations could only result from chimeric fusion of two 
separate embryos or some other unusual mechanism.  The 46,XX/69,XXY column also included two 
cases with 45,X/69,XXY genotypes, one of diandric origin and the other of undetermined origin.  Finally, 
five cases were not included in the distribution table due to incomplete karyotype data and are listed 
separately.  The parental origin of the extra haploid set of chromosomes was not determined in either of 
these latter five cases 
 Additionally, a sample of 67 cases of complete triploidy was reviewed for comparison to 
diploid/triploid mixoploidy.  This likely represents only a fraction of the total number of published cases 
of complete triploidy.  The age range of these cases ranges from first trimester terminations of pregnancy 
to 10 ½ months old, the longest known surviving liveborn infant with complete triploidy.  As with 
diploid/triploid mixoploidy, the phenotypic details of these cases were also highly variable ranging from 
very good to essentially none.  Also like the diploid/triploid mixoploid cases, only a fraction of the 
complete triploid cases provided information regarding the parental origin of the extra haploid set.  A 
total of 26/67 cases provided data on parental origin with 11 being of diandric origin and 15 being of 
digynic origin (Table 6).  The 69,XXX column also includes two cases of 68,XX triploidy of 
undetermined parental origin.  Three cases were not included in the table due to not providing karyotype 
data and are listed separately.  Parental origin was not determined in these three cases.  Detailed data on 
genotype, phenotype, and parental origins can be found in appendix B tables 12 and 13. 
Table 6. Genotype and parent-of-origin distribution among complete triploidy cases 
 69,XXX 69,XXY 69,XYY Total 
Diandric 5 5 1 11 
Digynic 10 5 0 15 
Unknown 24 14 0 38 
Totals 39 24 1 64 
- Exclusions 
37 (44) - Frates & Feinberg, 2000 - No karyotype 
41 (48) - Stefos et al., 2002 - No karyotype 
52 (63) - Madeiros et al., 2008 - No karyotype 
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8.2 ASCERTAINING PARENTAL ORIGIN 
 
A number of different methods have been used to ascertain the parental origin of the extra haploid set of 
chromosomes over the years.  During the 1960’s through 1980’s, investigators usually relied on 
cytogenetic polymorphism analysis or blood group typing of the parents and proband to ascertain parental 
origin.  A few investigators simply relied on observations of phenotypic characteristics and the available 
body of knowledge on triploidy to surmise a theoretical origin in some cases.  Starting in the 1990’s, the 
use of DNA polymorphisms to identify the parental origin of the extra haploid set of chromosome became 
much more prevalent.  Table 7 summarizes the differing modes of ascertainment used to ascertain the 
parental origin of the extra haploid set of chromosomes in various case reports and studies from the 
1960’s through 2000’s and listed in chronological order. 
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Table 7. Historical trends in ascertaining parental origin of the extra haploid set of chromosomes 
Author Type of 3n Type of Report Origin Ascertained 
Book et al., 1962 2n/3n Case report Digynic Theory 
Ellis et al., 1962 2n/3n Case report Digynic Blood group analysis 
Ferrier et al., 1964 2n/3n Case report Digynic Cytogenetic polymorphisms 
Schmid & Vischer, 1967 2n/3n Case report Digynic Cytogenetics/Reasoning 
Sparrevohn et al., 1971 3n Case report Digynic Blood group analysis 
Niebuhr et al., 1972 3n Case report Digynic Blood group analysis 
Dewald et al., 1975 2n/3n Case report Diandric Cytogenetic polymorphisms 
Bocian et al., 1978 3n Case report Digynic Cytogenetic polymorphisms 
Deligdisch et al., 1978 3n Case report Diandric Presence of 2 Y 
chromosomes 
Bieber et al., 1981 3n (2n twin) Case report Digynic Multiple methods 
Graham et al., 1981 2n/3n Case report Diandric Cytogenetic polymorphisms 
Page et al., 1981 3n Case report Diandric Cytogenetic polymorphisms 
Jacobs et al, 1982 3n Study Both Cytogenetic polymorphisms 
Maraschio et al., 1984 3n Case report Diandric Cytogenetic polymorphisms 
Procter et al., 1984 3n Study Diandric Cytogenetic polymorphisms 
Uchida and Freeman, 1985 3n Study Both Cytogenetic polymorphisms 
Sherrard et al., 1986 3n Case report Digynic Blood group typing 
Vejerslev et al., 1986 3n (3 cases) Case reports Diandric Cytogenetic polymorphisms 
Royston & Bannigan, 1987 3n Case report Diandric Cytogenetic polymorphisms 
Rochon & Vekemans, 1990 3n Case report Digynic Cytogenetic polymorphisms 
Galan et al., 1991 3n Case report Digynic Cytogenetic polymorphisms 
Kennerknecht et a., 1993 2n/3n Case report Digynic DNA fingerprinting 
Muller et al., 1993 2n/3n (triplet) Case report Digynic DNA polymorphisms 
Niemann-Seyde & Zoll, 1993 3n Case report Diandric Cytogenetic polymorphisms 
Tuerlings et al., 1993 2n/3n Case report Diandric Logic and probability 
Miny et al., 1995 3n Study Both DNA polymorphisms 
Ikeda et al., 1996 2n/3n Case report Diandric DNA polymorphisms 
Hasegawa et al., 1999 3n Case report Digynic Cytogenetic and DNA 
polymorphisms 
Baumer et al., 2000 3n Study Both DNA polymorphisms 
English et al., 2000 2n/3n Case report Digynic Reasoning 
McFadden and Langlois, 
2000 
3n Study Both DNA polymorphisms 
Zaragoza et al., 2000 3n  Study Both DNA polymorphisms 
Chang et al., 2001 3n Case report Digynic DNA polymorphisms 
Phelan et al., 2001 2n/3n Case report Digynic Reasoning 
Ban et al., 2002 3n Case report Digynic DNA polymorphisms 
van de Laar et al., 2002 2n/3n (3 cases) Case reports Digynic DNA polymorphisms 
Brems et al., 2003 2n/3n (3 cases) Case reports Digynic DNA polymorphisms 
Daniel et al., 2003 2n/3n (4 cases) Case reports Both DNA polymorphisms 
Flori et al., 2003 2n/3n Case report Digynic DNA polymorphisms 
Lim et al., 2003 3n Case report Diandric Reasoning 
Billeaux et al., 2004 3n Case report Diandric DNA polymorphisms 
Dalmia et al., 2005 3n Case report Diandric Phenotype 
Quigley et al., 2005 2n/3n Case report Diandric DNA polymorphisms 
Giurgea et al., 2006 2n/3n Case report Diandric DNA polymorphisms 
McFadden and Robinson 
(2006) 
3n Study Both DNA polymorphisms 
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Table 7 (continued) 
Shafi et al., 2007* 2n/3n Case report Digynic Cytogenetic Markers 
Chen et al., 2008 3n (5 cases) Study/Case reports Digynic DNA polymorphisms 
Rittinger et al., 2008 2n/3n Case report Digynic DNA polymorphisms 
Wegner et al., 2009 2n/3n Case report Diandric DNA polymorphisms 
*This case was actually first reported by Wulfsberg et al. (1991) with these authors using cytogenetic 
polymorphisms to determine the parental origin of the extra haploid set. 
 
 During the 1960’s and early 1970’s blood group analysis was a common means of ascertaining 
parental origin.  Cytogenetic polymorphism analysis was also used during the 1960’s and throughout the 
1970’s and 1980’s.  DNA polymorphism analysis began to appear during the 1990’s and is now the 
preferred method for determining the parental origin of the extra haploid set of chromosomes.  The first 
report of human triploidy in a young boy with a 46,XY/69,XXY karyotype was published in 1960 with 
further studies published two years later (BOOK et al. 1962; BOOK and SANTESSON 1960).  These authors 
did not do any studies to determine the parental origin of the extra haploid set of chromosomes, but 
suggested it arose through a maternal meiosis error or incorporation of the second polar body into a 
blastomere following the first cleavage division. 
 The earliest attempt to ascertain the parental origin of the extra haploid set of chromosomes was 
published in 1963 (ELLIS et al. 1963).  The authors used ABO blood group analysis to determine a 
digynic origin of triploidy in this case.  The proband’s mother was BO while her father was AO.  The 
proband was found to be OO in her blood lymphocytes, but did not have anti-B antigen which should be 
present in type O individuals.  However, B antigen was found in saliva and buccal epithelium leading to 
the conclusion that the proband’s diploid cells were OO while her triploid cells were OOB.  This 
mechanism implies incorporation of the second polar body into a blastomere as a likely mechanism.  
Though the second polar body chromatids are the sister chromatids to those found in the ovum, meiotic 
recombination can explain the presence of different ABO alleles on the two maternally inherited 
homologues in the triploid cell line.  Several other cases have utilized various types of blood typing to 
determine parental origin including Rhesus alleles (Rh) and human lymphocyte antigen (HLA) typing 
(NIEBUHR et al. 1972; SHERARD et al. 1986; SPARREVOHN et al. 1971). 
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 Cytogenetic techniques relied on the various methods of chromosome banding to identify 
polymorphisms that could be used to help determine the parental origin of different haploid sets of 
chromosomes.  These polymorphisms include pericentric inversions, duplications, unusually prominent or 
dull bands, and unusually sized satellites and secondary constrictions on the acrocentric chromosomes.  
The affected parts of chromosomes are generally areas of non-coding constitutive heterochromatin or 
ribosomal RNA genes, thus these variants are of no pathological significance to the individuals who may 
carry them.  Ferrier et al. (1964) used such a method to determine that the extra haploid set of 
chromosomes in the triploid line of a 46,XY/69,XXY mixoploid child was of maternal origin.  The 
proband was found to have a single chromosome 13 with an unusually large satellite in the diploid cell 
line which was duplicated in the triploid cell line.  Though the authors attempted to obtain peripheral 
lymphocytes for karyotyping from both parents, apparently only the paternal lymphocytes produced 
satisfactory slides.  However, neither paternal chromosome 13 showed these large satellites thus it was 
concluded that the unusual chromosome 13 and extra haploid set of chromosomes were derived from the 
mother (FERRIER et al. 1964). 
 Bieber et al. (1981) combined several different methods to determine the parental origin in an 
unusual case of monochorionic diamnionic twins with discordant sex chromosomes.  One twin was a 
healthy boy with a normal 46,XY karyotype while the other was a holoacardiac fetus with a 69,XXX 
karyotype.  The sex chromosome discordance indicate two separate fertilization events, however the 
single chorion is indicative of monozygotic twinning.  Cytogenetic studies were used to determine that 
the extra haploid set in the triploid twin was of maternal origin.  In the father, neither chromosome 13 
showed visible silver staining of the nucleolar organizing region (AgNOR), while both maternal 13’s 
showed staining.  The diploid twin had one chromosome 13 with staining and one without as expected.  
The triploid twin showed two chromosome 13’s with silver staining and one without indicating a digynic 
origin.  Blood group typing also revealed that each twin received a different paternal haplotype 
confirming two separate fertilization events.  Putting the data together, the authors surmised that the 
triploid twin arose through the fertilization of the first polar body.  At least one attempt has been made to 
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determine the parental origin of triploidy using DNA footprinting analysis (KENNERKNECHT et al. 1991).  
These authors were able to determine a digynic origin based on the observation that some bands present 
in the mother were found in the triploid genome of the fetus but not in the diploid fetal genome. 
 The use of molecular DNA markers began to become more prominent in the early 1990’s.  Muller 
et al. (1993) used short tandem repeat polymorphism (STRP) analysis to determine the digynic origin of a 
46,XX/69,XXX mixoploid infant.  This particular case was also of particular interest because the infant 
was one of a set of triplets conceived by way of clomiphene induced ovulation (MULLER et al. 1993).  
The authors attempted to test one STRP marker per chromosome, though seven chromosomes either 
didn’t provide informative results or didn’t have any suitable markers to test.  By comparing maternal and 
paternal alleles with those present in the diploid and triploid cell lines in the infant, the authors were able 
to determine that the extra haploid set was of maternal origin.  For example, the authors used the STRP 
marker MFD 60 for the D1S322 locus on chromosome 1.  The father was 102/118 and the mother was 
96/102.  The infants blood, which was diploid, had the 102/118 alleles while triploid fibroblasts were 
96/102/118 (MULLER et al. 1993).  Though both parents had the 102 allele, it can be concluded that it is 
of maternal origin in both of the infant’s cell lines since it is paired with the 118 allele in diploid 
lymphocytes which is of paternal origin. 
 Microsatellite marker analysis has become the preferred method of ascertainment.  Specifically, 
the use of pericentromeric microsatellite markers allows for more precise determination of the meiotic 
stage during which the error leading to triploidy occurred.  During anaphase I, the homologous pairs of 
chromosomes separate leaving each daughter cell with a haploid set of chromosomes with each 
chromosome consisting of two sister chromatids.  These chromatids then divide during anaphase II to 
produce the haploid gametes.  Thus if an error occurs during meiosis I and the homologous chromosomes 
don’t divide, the resultant daughter cells will essentially be tetraploid with both homologues of each 
chromosome being present and each consisting of two sister chromatids.  After the chromatids divide 
during meiosis I, the resultant gamete will be diploid and have both parental homologues.  In this 
scenario, pericentromeric microsatellite marker analysis of a triploid conceptus that incorporates a diploid 
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gamete resulting from meiosis I error will reveal that the conceptus has inherited both copies of any allele 
for which the parent is heterozygous.  A meiosis II error will result in the sister chromatids failing to 
separate and thus a diploid gamete that will be homozygous at all pericentromeric loci.  More distal loci 
will not always be homozygous in this case due to meiotic crossing over. 
 A number of cases have been ascertained solely based on what is known about triploidy and 
meiosis.  The single case of 69,XYY triploidy reported by Deligdisch et al. (1978) can be inferred to have 
been of diandric origin solely based on the presence of two Y chromosomes.  The fact that the placenta in 
this case was reported to be a partial mole also adds support to the diandric origin.  Diandric triploidy 
arising from dispermy was definitively concluded in a case of a triploid fetus in which the father carried a 
balanced translocation (LIM et al. 2003).  These authors reported on a product of conception carrying a 
69,XXY,t(2;6)(p12;q24)der6,t(2;6)(p12;q24)pat karyotype.  The father was found to carry the balanced 
t(2;6)(p12;q24) translocation.  It can thus be inferred that this conceptus arose through dispermic 
fertilization with one sperm carrying the balanced t(2;6)(p12q24) karyotype by way of alternate 2:2 
segregation while the other sperm carried the unbalanced der(6),t(2;6)(p12;q24) karyotype by way of 
adjacent 1 segregation. 
 Similarly, Tuerlings et al. (1993) used logic and probability to infer diandric origin in a fetus with 
a 47,XX,+18/70,XXX,+18 mixoploid karyotype.  The authors suggest that the most probable mechanism 
was dispermic fertilization of an initially 24,X,+18 oocyte with the second male pronucleus remaining in 
the cytoplasm until after the first cleavage division at which point it was incorporated into a blastomere. 
Incorporation of the second polar body could not have occurred because it would also be aneuploid and 
thus the triploid cell line would have had a different aneuploid karyotype.  If a disomy 18 ovum had 
arisen from a nondisjunction event during meiosis I, then the secondary oocyte would be 48,XX,+18,+18 
while the first polar body would be 44,XX,-18,-18.  The second meiotic division would then produce a 
24,X,+18 ovum and a 24,X,+18 second polar body.  Had this second polar body been incorporated, the 
resultant mixoploid genotype would have been 47,XX,+18/71,XXX,+18,+18.  Such a case of 2n/3n 
mixoploidy with an autosomal trisomy in the diploid line and an autosomal tetrasomy in the triploid line 
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has not been reported.  Had this aberrant oocyte arisen from a meiosis II nondisjunction, then the second 
polar body would have a 22,X,-18 karyotype.  Incorporation of this second polar body would have 
resulted in a 47,XX,+18/69,XXX karyotype.  This latter scenario in which a trisomic cell line coexists 
with an apparently balanced triploid cell line has been reported on a number of occasions (DANIEL et al. 
2003; DEAN et al. 1997; ENGLISH et al. 2000; PHELAN et al. 2001; POST and NIJHUIS 1992).  Daniel et al. 
(2003) actually proposed that the triploid line of their 47,XY,+16/69,XXY embryo was of a simple 
digynic origin, but then suggest that this embryos underwent chimeric fusion with a second 47,XY,+16 
embryo.  Microsatellite analysis did unequivocally prove digynic origin for the triploid cell line, but the 
trisomy 16 cell line was not analyzed and there was no evidence to suggest two separate fertilization 
events were involved.  Post and Nijhuis also proposed a chimeric origin for their 
46,XX/47,XX,+16/69,XXX case of which no further studies were performed to elucidate the true parental 
origin.  This case can also be explained by incorporation of a 22,X,-16 second polar body into a 
47,XX,+16 blastomere to generate the 69,XXX line.  The normal 46,XX line can be explained by trisomy 
rescue in a cell descended from the 47,XX,+16 blastomere. 
 There have been 2 reported cases of 45,X/69,XXY mixoploidy (BETTS et al. 1989; QUIGLEY et 
al. 2005).  These cases are somewhat harder to reconcile.  Quigley et al (2005) used microsatellite marker 
analysis to determine that the extra haploid set in the triploid cell line was of diandric origin and 
suggested delayed incorporation of a second male pronucleus into a blastomere as the origin.  They 
suggested that the 45,X cell line originated from a secondary nondisjunction event resulting in 
chromosome loss in the diploid blastomere.  This mechanism seems plausible, but one would expect to 
find some remaining 46,XX or 46,XY cells depending on the initial sex chromosome complement of the 
diploid blastomere especially when considering the reduced viability of 45,X cells. 
 There have also been two reported cases of apparent diploid/triploid/tetraploid mixoploidy 
(KARTESZI et al. 2006; TOPALOGLU et al. 1998).  When tetraploidy is present in an embryo or fetus, it is 
usually assumed to have arisen from a failure of cytokinesis during the first cleavage division of an 
initially diploid zygote or at a slightly later stage in the case of 2n/4n mixoploidy (SCHLUTH et al. 2004).  
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This is supported by the observation that all reported cases of human tetraploidy have had either XXXX 
or XXYY sex chromosome complements.  The case reported by Karteszi et al. (2006) had a 
46,XX(24%)/69,XXX(60%)/92,XXXX(14%) genotype.  Though no cytogenetic studies were performed, 
it can be inferred that the 69,XXX cell line was derived from the inclusion of an additional X bearing 
gamete into a blastomere after the first cleavage division.  The tetraploidy line could have then arisen 
from a failed cytokinesis in a diploid cell at some stage very early in development.  This case is also 
interesting because the child exhibited a progeroid phenotype resembling that seen in Wiedemann-
Rautenstrauch syndrome during early infancy.  This condition is usually progressive and fatal during 
childhood, however by the time the patient was 2 ½ years old, she had shown a significant improvement 
with most of the progeroid features having largely disappeared (KARTESZI et al. 2006). 
 The second case of 2n/3n/4n mixoploidy is much more fascinating and much more difficult to 
explain.  Topaloglu et al. (1998) reported a child with cryptogenic cirrhosis, membranous 
glomerulonephritis, and other minor dysmorphic features.  The patients lymphocyte karyotype was found 
to be 46,XY(58%)/69,XXY(7%)/92,XXXY(35%).  The presence of a single Y chromosome in each cell 
line rules out a simple failed cytokinesis as the origin for the tetraploid cell line.  Unfortunately, the 
authors did not perform any cytogenetic or molecular studies nor did they attempt to elucidate a possible 
mechanism for this unique case.  Considering the relatively mild phenotype shown by the patient and the 
low proportion of triploid cells, it seems reasonable to assume that the tetraploid cell line is 
digynic/diandric thus resulting in a balanced genome with respect to imprinting.  This situation would 
require a multistep process to occur.  Initially, there may have been a double fertilization of a normal 
23,X zygote by a 23,X sperm and a 23,Y sperm with the zygote subsequently failing to extrude the 
second polar body.  This would have resulted in a tetrapronuclear zygote with two maternal and two 
paternal pronuclei.  Assuming the 23,Y male pronucleus unites with one of the 23,X female pronuclei, 
normal cleavage could have occurred with both extra pronuclei being segregated to the same blastomere.  
At the two-cell stage, one of the additional pronuclei is incorporated into a blastomere nucleus while the 
other continues to remain in the cytoplasm.  Cleavage of this two-cell embryo will result in a four-cell 
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embryo with two 46,XY blastomeres and two 69,XXY blastomeres.  One of the 3n blastomeres will 
contain the final pronucleus which will then merge with the nucleus before the next round of division.  
The end result is an eight-cell embryo containing four 46,XY blastomeres, two 69,XXY blastomeres, and 
two 92,XXXY blastomeres.  The triploid blastomeres may be either diandric or digynic while the 
tetraploid blastomeres will have two maternal and two paternal haploid sets.  The low proportion of 
triploid cells in the patient’s peripheral lymphocytes may also be a result of the same mechanism that 
seemingly excludes triploid cells from the peripheral lymphocytes in other 2n/3n cases. 
 Table 8 summarizes all of the complete triploidy and diploid/triploid mixoploidy cases for which 
the origin of the extra haploid set of chromosomes was determined as well as several interesting 
mixoploid cases for which the parental origin was not determined.  The numbers in the first column are in 
reference to the table listing the complete details of all cases of triploidy and diploid/triploid mixoploidy 
used in this review and which can be found in appendices A and B, tables 10-13.  Additionally, this table 
only lists overall karyotype of each case.  Detailed information on what tissues were karyotyped and the 
proportion of cells in each cell line can be found in appendix A, table 10 and appendix B, table 12..  The 
first number refers to the article in which the case(s) was reported in chronological order while the second 
number refers to the overall case number, again in chronological order.  The complete details of the 
triploid cases and diploid/triploid mixoploid cases are listed in separate tables and are thus numbered 
separately.   
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Table 8.  Details on ascertaining parental origin of the extra haploid set of chromosomes in individual 
cases 
Complete Triploidy 
Digynic Cases 
3 (4) Author: Sparrevohn et al., 1971 
Genotype: 69,XXX 
Age: Born at 37 weeks gestation, died at 93  hours old 
Ascertained: Blood group analysis: Proband received both maternal rhesus alleles – Showed double 
dose affect to anti-M.  Father type N, mother type M 
Mechanism: None proposed 
4 (5) Author: Niebuhr et al., 1972 
Genotype: 69,XXX 
Age: Born at 37 weeks gestation, died at 92  hours old 
Ascertained: Rh constellation showed 3 alleles: Proband showed double dose reaction against anti-
M and single-dose against anti-N – Patient = M/M/N, Mother = M, father = N 
Mechanism: Suggested maternal meiosis failure 
11(13) Author: Bocian et al., 1978 
Genotype: 69,XXY 
Age: TOP  at 24 weeks gestation 
Ascertained: Cytogenetic polymorphisms: 2 fetal #3’s had identical prominent bright markers just 
below the centromere and identical to 1 maternal #3 – 2 fetal #13’s have identical 
prominent bright p-arms identical to 1 maternal #13 – 2 fetal #21’s identical with very 
faint satellites that could only come from mother as both paternal #21’s had medium 
bright satellites 
Mechanism: Meiosis II error – Other maternal #21 had medium-bright satellites 
14(16) Author: Bieber et al., 1981 
Genotype:  69,XXX (holoacardiac twin), 46,XY (normal twin) 
Age:  SB – Unknown gestational age – Had normal LB twin 
Ascertained: MC/DA placenta – QFC and C-banding gave results consistent with 2n maternal 
contribution – Father contributed different leukocyte histocompatibility antigen to 
each twin supporting 2 fertilization events 
Mechanism: Fertilization of 1st polar body 
18(20) Author: Sherrard et al., 1986 
Genotype: 69,XXY 
Age: Born at 37 weeks gestation, died at  312 days old 
Ascertained: HLA typing – No further information given 
Mechanism: None proposed 
21(26) Author: Rochon & Vekemans, 1990 
Genotype: 69,XXY,t(6;14)(p23;q24) – Mother carried balanced t(6;14) 
Age: SA at 8 weeks gestation 
Ascertained: Cytogenetics: Comparison of chromosome heteromorphisms on parental and fetal 
chromosomes 13, 14, and 21 
Mechanism: Maternal meiosis I nondisjunction 
23(28) Author: Galan et al., 1991 
Genotype: 69,XXX 
Age: Born at 37 weeks gestation, died at 7 days old 
Ascertained: Cytogenetic polymorphism: Proband inherited 2 copies of #’s 1, 15, & 21 with 
polymorphisms seen in 1 copy in mother 
Mechanism: Fertilization of 2n ovum by 1n sperm 
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35(42) Author: Hasegawa et al., 1999 
Genotype: 69,XXX 
Age: Born at 31 weeks gestation, died at 46 days old 
Ascertained: Cytogenetics: Q-band polymorphisms, later confirmed by microsatellite analysis 
Mechanism: None proposed 
39(46) Author: Chang et al., 2001 
Genotype: 69,XXX 
Age: Live birth at 33 weeks gestation, died almost immediately 
Ascertained: Molecular studies: STRP analysis 
Mechanism: Maternal meiosis I nondisjunction 
40(47) Author: Ban et al., 2002 
Genotype: 69,XXX 
Age: Stillbirth at 31 weeks gestation 
Ascertained: Molecular studies: STRP analysis 
Mechanism: None proposed 
51a(58) Author: Chen et al., 2008 
Genotype: 69,XXX 
Age: Termination of pregnancy at 16 weeks gestation 
Ascertained: Molecular: QF-PCR and STRP analysis 
Mechanism: Maternal meiosis II error 
51b(59) Author: Chen et al., 2008 
Genotype: 69,XXX 
Age: Termination of pregnancy at 15 weeks gestation 
Ascertained: Molecular: QF-PCR and STRP analysis 
Mechanism: Maternal meiosis II error 
51c(60) Author: Chen et al., 2008 
Genotype: 69,XXX 
Age: TOP 13 weeks 
Ascertained: Molecular: QF-PCR and STRP analysis 
Mechanism: Maternal meiosis II error 
51d(61) Author: Chen et al., 2008 
Genotype: 69,XXY 
Age: TOP 14 weeks 
Ascertained: Molecular: QF-PCR and STRP analysis 
Mechanism: Maternal meiosis II error 
51e(62) Author: Chen et al., 2008 
Genotype: 69,XXY 
Age: TOP 14 weeks 
Ascertained: Molecular: QF-PCR and STRP analysis 
Mechanism: Maternal meiosis II error 
Diandric Cases 
12(14) Author: Deligdisch et al., 1978 
Genotype: 69,XYY 
Age: Born at 22 weeks gestation, died immediately 
Ascertained: Presence of 2 Y chromosomes, partial molar placenta 
Mechanism: None proposed, probably dispermy 
Table 8 (continued)
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Table 8 (continued) 
15(17) Author: Page et al., 1981 
Genotype: 69,XXX 
Age: Born at 35 weeks gestation, died at 17 hours old 
Ascertained: Serological studies: Showed 2 paternally inherited alleles 
Cytogenetic markers: Presence of 2 fetal #22’s with markers identical to those present 
in 1 paternal #22 
Mechanism: Diplospermy II 
17(19) Author: Maraschio et al., 1984 
Genotype: 69,XXX,inv(15)(q15q26) – inv(15) inherited from mother 
Age: Born at term, died at  45 days old 
Ascertained: Cytogenetics: 2 of proband's #15’s showed markers present on 1 paternal #15 
Mechanism: Dispermy 
19a(21) Author: Vejerslev et al., 1986 
Genotype: 69,XXY 
Age: Born at 28 weeks gestation, died within 1 hour 
Ascertained: Cytogenetics: Chromosome heteromorphisms 
Mechanism: Dispermy 
19b(22) Author: Vejerslev et al., 1986 
Genotype: 69,XXY 
Age: Intrauterine fetal demise before 14 weeks gestation 
Ascertained: Cytogenetics: Chromosome Heteromorphisms 
Mechanism: Dispermy 
19c(23) Author: Vejerslev et al., 1986 
Genotype: 69,XXY 
Age: Termination of pregnancy at 18 weeks gestation 
Ascertained: Cytogenetics: Chromosome heteromorphisms 
Mechanism: Dispermy 
20b(25) Author: Royston & Bannigan, 1987 
Genotype: 69,XXY 
Age: Born at 30 weeks gestation, died at 45 minutes old 
Ascertained: Cytogenetic polymorphisms: Presence of 2 unusually large #9’s in proband identical 
to that present in single copy in father 
Mechanism: None proposed 
26(31) Author: Niemann-Seyde and Zoll, 1993 
Genotype: 69,XXX 
Age: Born at 34 weeks gestation, died at 10 ½ weeks old 
Ascertained: Cytogenetics: Chromosome polymorphisms 
Mechanism: None proposed 
43(50) Author: Lim et al., 2003 
Genotype: 69,XXY,t(2;6)(p12;q24)der(6)t(2;6)(p12;q24)pat 
Age: Not indicated: Early spontaneous abortion 
Ascertained: Reasoning 
Mechanism: Dispermy: 1 sperm carried balanced t(2;6) while 2nd sperm carried a der(6) 
chromosome 
45(52) Author: Billieaux et al., 2004 
Genotype: 69,XXX 
Age: Termination of pregnancy at 18 weeks gestation 
Ascertained: Molecular: Microsatellite marker polymorphism analysis 
Mechanism: None proposed 
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Table 8 (continued)  
46(53) Author: Dalmia et al., 2005 
Genotype: 69,XXX 
Age: Termination of pregnancy at 16 weeks gestation 
Ascertained: Phenotype – Large cystic placenta, mild IUGR 
Mechanism: Diplospermy? – Conceived post-ICSI 
 Diploid/Triploid Mixoploidy 
Digynic Cases 
1 (1) Author: Book et al., 1962 
Genotype: 46,XY/69,XXY 
Age: Born at term, Diagnosis established at 3 ½ years old 
Ascertained: Cytogenetic studies 
Mechanism: Suggested maternal meiosis error but provided no real evidence 
2 (2) Author: Ellis et al., 1963 
Genotype: 46,XX/69,XXX 
Age: 6 years old 
Ascertained ABO blood group typing: Father AO, Mother BO, Patient OO in lymphocytes but 
didn’t contain Anti-A antibody – B antigen found in saliva (BOO) 
Mechanism 2nd polar body incorporation into blastomere 
3 (3) Author: Ferrier et al., 1964 
Genotype: 46,XY/69,XXY 
Age: 10 years old 
Ascertained: Cytogenetics: #13 with large satellites in 2n line & 2 #13’s with large satellites in 3n 
line, paternal karyotype lacked large satellited #13 so must have been maternally 
derived 
Molecular studies: Showed both X’s of maternal origin 
Mechanism: Maternal meiotic error 
5 (5) Author: Schmid & Vischer, 1967 
Genotype: 48,XXYY/71,XXXYY 
Age: 11 months old at time of diagnosis 
Ascertained: Cytogenetics, reasoning 
Mechanism: Fertilization by aberrant 25,XYY sperm and incorporation of 2nd PB into blastomere 
25(28) Author: Kennerknecht et al., 1993 
Genotype: 46,XY/69,XXY 
Age: Stillborn at 41 weeks gestation 
Ascertained: DNA fingerprinting: Each band in 2n villi also present in 3n fetus indicating both 
originated from same zygote.  3n fetus has additional maternal bands indicating 
digynic origin. Mother has bands not found in fetus indicative of M-II error. Father 
shows bands not present in villi or fetus 
Mechanism: Maternal M-II error (2nd PB incorporation into a blastomere) to form 2n placenta & 
3n fetus 
26(29) Author: Muller et al., 1993 
Genotype: 46,XX/69,XXX 
Age: 9 months old 
Ascertained: STRP analysis 
Mechanism: 2nd polar body incorporation into blastomere 
36(39) Author: English et al., 2000 
Genotype: 46,XX/47,XX,+6/69,XXX 
Age: Termination of pregnancy at 18 weeks gestation 
Ascertained: STRP analysis 
Mechanism: Digynic: Fertilization of 24,X,+6 ovum and later incorporation of 22,X,-6 2nd polar 
body into blastomere 
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Table 8 (continued) 
39(42) Author: Phelan et al., 2001 
Genotype: 47,XY,+13/69,XXY 
Age: died at 22 hours old 
Ascertained: PCR amplified microsatellite marker analysis 
Mechanism: Suggested 2nd PB incorporation into blastomere with later nondisjunction  
40a(43) Author: van de Laar et al., 2002 
Genotype: 46,XY/69,XXY 
Age: 6 years old 
Ascertained: Microsatellite marker analysis 
Mechanism: Digynic 
40b(44) Author: van de Laar et al., 2002 
Genotype: 46,XY/69,XXY 
Age: 6 years old 
Ascertained: Microsatellite marker analysis 
Mechanism: Digynic 
40c(45) Author: van de Laar et al., 2002 
Genotype: 46,XX/69,XXX 
Age: 21 months old 
Ascertained: Microsatellite marker analysis 
Mechanism: Digynic 
41a(46) Author: Brems et al., 2003 
Genotype: 46,XY/69,XXY 
Age: Not reported 
Ascertained: PCR amplified DNA marker analysis 
Mechanism: 2nd polar body incorporation into blastomere 
41b(47) Author: Brems et al., 2003 
Genotype: 46,XX/69,XXX 
Age: Not reported 
Ascertained: Polymorphic marker analysis 
Mechanism: 2nd polar body incorporation into blastomere 
41c(48) Author: Brems et al., 2003 
Genotype: 46,XX/69,XXX 
Age: Not reported 
Ascertained: Polymorphic marker analysis 
Mechanism: 2nd polar body incorporation into blastomere 
42b(50) Author: Daniel et al., 2003 
Genotype: 46,XY/69,XXY 
Age: 8 years old 
Ascertained: Microsatellite marker analysis 
Mechanism: 2nd polar body incorporation into blastomere 
42c(51) Author: Daniel et al., 2003 
Genotype: 46,XY/47,XY,+16/69,XXY 
Age: Not reported: Presumed termination of pregnancy 
Ascertained: Microsatellite marker analysis 
Mechanism: Chimera: Fertilization of 2n ovum resulting from M-II error followed by fusion with a 
2nd trisomy 16 embryo 
43 (53) Author: Flori et al., 2003 
Genotype: 46,XX/69,XXX 
Age: 5 years old 
Ascertained: Microsatellite marker analysis 
Mechanism: 2nd PB incorporation into blastomere 
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Table 8 (continued)  
51 (61) Author: Shafi et al., 2007 
Genotype: 46,XX/69,XXX 
Age: 25 years old 
Ascertained: Cytogenetic polymorphisms 
Mechanism: 2nd polar body incorporation into blastomere 
52 (62) Author: Rittinger et al., 2008 
Genotype: 46,XX/69,XXX 
Age: 14 years old 
Ascertained: Microsatellite analysis 
Mechanism: Digynic 
Diandric Cases 
9 (9) Author: Dewald et al., 1975 
Genotype: 46,XX/69,XXY 
Age: 13 years old 
Ascertained: Cytogenetics: Proband had 2 #13’s with large satellites & 1 #22 with unusually bright 
region, both inherited from father where they were present in 1 copy 
Mechanism: Delayed dispermy 
13 (14) Author: Graham et al., 1981 
Genotype: 46,XY/69,XXY 
Age: 19 months old 
Ascertained: Cytogenetics: C-band analysis indicated diandric origin more likely than digynic 
origin but results not definitive 
Mechanism: None proposed 
28 (31) Author: Tuerlings et al., 1993 
Genotype: 47,XX,+18/70,XXX,+18 
Age: Termination of pregnancy at 10 weeks gestation 
Ascertained: Logic & probability: Assuming initial 24,X,+18 ovum,  2nd PB would either be 22,X,-
18 or 24,X,+18 so couldn’t get 70,XXX,+18 by 2nd PB incorporation 
Mechanism: Delayed incorporation of 2nd sperm nucleus into 47,XX,+18 blastomere 
31 (34) Author: Ikeda et al., 1996 
Genotype: 46,XX/67,XX,-3,-4,+11,+13,-14,-X (Most likely broken 4n cell) (Placenta) 
Age: Termination of pregnancy at 18 weeks gestation 
Ascertained: Molecular methods showed excess of paternally inherited alleles.  Densitometry gave 
ratio of 1.4 from molar placenta indicative of 2n/3n 
Mechanism: None proposed 
42a(49) Author: Daniel et al., 2003 
Genotype: 46,XX/69,XXX 
Age: Termination of pregnancy, gestational age not reported 
Ascertained: Microsatellite marker analysis 
Mechanism: Delayed dispermy 
42d(52) Author: Daniel et al., 2003 
Genotype: 46,XX/69,XXX 
Age: 3 months old 
Ascertained: Microsatellite marker analysis 
Mechanism: Delayed dispermy 
47 (57) Author: Quigley et al., 2005 
Genotype: 45,X/69,XXY 
Age: 11 weeks old 
Ascertained: Molecular marker analysis 
Mechanism: Authors suggested delayed dispermy with 2n cell undergoing 20 loss of sex 
chromosome 
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48(58) Author: Giurgea et al., 2006 
Genotype: 46,XY/69,XXY (presumed), 3n line apparently restricted to pancreatic lesion 
Age: 6 years old 
Ascertained: Microsatellite marker analysis 
Mechanism: Delayed dispermy 
53(63) Author: Wegner et al., 2009 
Genotype: 46,XX/69,XXY 
Age: Intrauterine fetal demise at 25 weeks gestation 
Ascertained: Microsatellite analysis 
Mechanism: Diandric 
- Interesting Cases with Unknown Parental Origin 
8 (8) Author: Sellyei et al., 1971 
Genotype: 46,XY/69,XYY 
Age: 39 years old 
Note: 3n cells found in very low levels in blood of normal male.  May be remnant of 2n/3n 
mixoploidy or result of tripolar division of rare 4n 92,XXYY cell 
19(22) Author: Dahl et al., 1988 
Genotype: 46,XY,+2p/69,XXY 
Age: Born at 33 weeks gestation (emergency C-section), Died at 5 weeks old 
Note: No known cases of liveborn infant with complete trisomy 2p 
21(24) Author: Callen et al., 1991 
Genotype: Placenta 46,XX/69,XXY 
Age: Normal liveborn infant 
Note: Significant part of placenta derived from vanished 69,XXY twin as evidenced by 
remains of 2nd gestational sac 
22(25) Author: Post & Nijhuis, 1992 
Genotype: 46,XX/47,XX+16/69,XXX 
Age: Termination of pregnancy at 25+2 weeks gestation 
Note Chimera: Placenta largely from vanished 47,XX,+16 twin with 2n line derived from 
trisomy rescue.  Surviving fetus entirely 69,XXX with some 3n cells in placenta 
27(30) Author: Sarno et al., 1993 
Genotype: 46,XX/68,XXX,-11 
Age: Diagnosis established at 14 weeks gestation 
Note: 3n PHM with surviving normal 2n fetus 
32(35) Author: Dean et al., 1997 
Genotype: 46,XX/47,XX,+15,69,XXX 
Age: Diagnosis at  2 ½ years old, died at 3 8/12 years old 
Note 46,XX present in very low numbers and couldn’t be definitively proven.  Suggested 
delayed inclusion of additional 1n set into 1 blastomere and mitotic nondisjunction in 
other resulting in trisomy 15 
34(37) Author: Topaloglu et al., 1998 
Genotype: 46,XY/69,XXY/92,XXXY 
Age: 7 years old 
Note 4n line could not have arisen from simple failed cytokinesis of 2n cell 
49(59) Author: Karteszi et al., 2006 
Genotype: 46,XX/69,XXX/92,XXXX (3n & 4n genotypes presumed) 
Age: 2 ½ years old 
Note: Transient progeroid phenotype present at birth but largely disappeared by age of 2 ½.  
Table 8 (continued)
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8.3 PHENOTYPE DISTRIBUTION 
 
It was difficult to discern any real phenotypic trends with regard to genotype or parent of origin due to the 
wide range of ages and amount of details provided in case reports.  The nine cases of 2n/3n mixoploidy 
determined to be of diandric origin seemed to be particularly lacking in phenotype information.  Two of 
these cases may have been confined placental mosaicism while a third was an elective abortion at 10 
weeks gestation with no phenotypic data provided.  The dearth of phenotypic data on the diandric cases 
combined with the fact that digynic cases outnumbered diandric cases 19-9 makes it impractical to draw 
any conclusions regarding any parent-of-origin specific patterns.  Of the traits known have a parent-of-
origin effect, macrocephaly was more predominant in digynic triploids by a 2-0 count, IUGR was more 
predominant in digynic cases by a 6-2 count, adrenal hypoplasia was more predominant in digynic cases 
by a 2-0 count, and partial mole was more common among diandric cases by a 1-0 count.  There were an 
additional four cases of partial mole among those cases where the parental origin was not conclusively 
determined, but these could probably be assumed to be diandric. 
 Parent-of-origin specific traits appeared to show a more distinct pattern among the complete 
triploid cases.  Intrauterine growth retardation and macrocephaly were each present in 10/15 and 8/15 
digynic triploids respectively, but in only 3/11 and 0/11 diandric triploids respectively.  Strangely, adrenal 
hypoplasia was reported in only 2/15 digynic triploids, but in 5/11 diandric triploids.  Only 5/11 diandric 
triploids were reported to have a partial molar placenta, though 13/41 cases of undetermined parental 
origin were reported to have partial molar placentas.  The differences in prevalence of parent-of-origin 
dependent traits between complete triploids and diploid/triploid mixoploids can likely be attributed to the 
diploid cell line in the latter group diminishing the severity of congenital anomalies.  This theory is 
supported by the observation that these parent-of-origin specific traits are all present in higher numbers in 
complete triploidy despite fairly similar numbers of digynic and diandric triploidy in each group (19/9 
versus 15/11).  Table 9 provides a comparison of the parent-of-origin specific traits between diandric and 
digynic triploidy in both mixoploid and complete triploid cases. 
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Table 9. Comparison of parent-of-origin specific traits in complete triploidy and 2n/3n mixoploidy 
Diandric Triploidy  Digynic Triploidy 
2n/3n (n = 9) 3n (n = 11) Trait 2n/3n (n = 19) 3n (n = 15) 
2 3 IUGR 6 10 
0 0 Macrocephaly 2 8 
0 5 Adrenal Hypoplasia 2 2 
1 5 PHM 0 0 
 
 A number of phenotypic traits generally accepted to not show any parent-of-origin effects showed 
a rather large discrepancy between digynic and diandric cases of diploid/triploid mixoploidy, though 
considering the aforementioned dearth of information on diandric cases and the fact that there were 10 
more digynic cases than diandric, this was probably not significant.  Among the more notable examples 
were low-set or dysplastic ears which were present in 8 digynic and 0 diandric cases.  Micro(retro)gnathia 
was present in 10 digynic cases but only 1 diandric case while syndactyly of the fingers and of the toes 
were more prevalent in digynic triploidy by 13-3 and 11-1 margins respectively.  This phenomenon was 
not apparent among complete triploidy cases, probably because the total number of digynic cases over 
diandric cases was a much closer 15/11 compared to the 19-9 seen in the mixoploid cases.  Not including 
those traits that are known to have a distinct parent-of-origin effect, the largest discrepancy between 
digynic and diandric triploidy was five cases of holoprosencephaly noted among digynic triploids 
compared to only one among diandric triploids.  It should however be noted that all five of these digynic 
triploids with holoprosencephaly came from a single study that was specifically examining chromosomal 
abnormalities associated with this defect (CHEN et al. 2008). 
 Overall, the most common traits seen in diploid/triploid mixoploidy were IUGR (21/62), 
syndactyly of the fingers (27/62), syndactyly of the toes (22/62), and mental or psychomotor retardation 
(29/62).  Among complete triploids, the most prevalent characteristics were IUGR (35/67), low-
set/dysplastic ears  (29/67), and syndactyly of the fingers  (23/67). Additionally, syndactyly of the toes, 
renal abnormalities, and adrenal hypoplasia were each reported in 20 cases.  A table with the complete 
breakdown of phenotypic abnormalities by parental origin and genotype can be found in the appendix C, 
Table 14 for 2n/3n mixoploidy and appendix C, table 15 for complete triploidy.. 
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 When comparing the overall distribution of phenotypic traits between complete triploidy and 
diploid triploid mixoploidy, large discrepancies can be observed between the two groups.  This is in 
agreement with the observation that complete triploidy presents with a greater number and increased 
severity of congenital anomalies than mixoploid individuals.  Additionally, body asymmetry was present 
in 11 mixoploid cases but wasn’t seen at all in the cases of complete triploidy.  As asymmetry is thought 
to be a result of unequal distributions of diploid and triploid cells on either side of the body in mixoploid 
individuals, this is not surprising.  Abnormal curvature of the spine was also seen exclusively in 
mixoploid individuals and can probably be considered secondary to body and/or lower limb asymmetry.  
Finally, pigmentary anomalies were present in 16 mixoploid cases but were not seen in any cases of 
complete triploidy.  As pigmentary anomalies, particularly patches or streaks of hypo or hyperpigmented 
skin, are considered a hallmark of mosaicism; this is also not surprising. 
 The most striking differences between complete triploidy and diploid/triploid mixoploidy was the 
much higher frequency of internal anomalies seen in complete triploidy, a phenomenon which has been 
well documented.  Holoprosencephaly (12 versus 1) and myelomeningocele (7 versus 1) were both much 
more common in complete triploidy.  It should however be noted that five of the cases of 
holoprosencephaly in complete triploidy were reported in a single study examining chromosome 
abnormalities associated with the defect.  Thus this figure cannot be considered to accurately reflect the 
prevalence of holoprosencephaly in complete triploidy, but rather it merely indicates that triploidy is 
potential underlying cause of holoprosencephaly.  Additionally, other general defects of the cerebral 
hemispheres such as abnormal gyral patterns were also more prevalent in complete triploidy by an 11 to 3 
margin.  Though the occurrence of septal defects (8 versus 10) and patent ductus arteriosus or patent 
foramen ovale (4 versus 3) were fairly similar among mixoploids and complete triploidy, there were 10 
instances of more complex heart defects among complete triploids compared to only 3 among 2n/3n 
mixoploids.  Abnormal lobation of the lungs (6 versus 1) and pulmonary hypoplasia (16 versus 2) were 
also much more common in complete triploidy. 
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 Among deformities of the digestive system, hypoplasia or agenesis of the gallbladder and 
hepatomegaly were more common in complete triploidy by 11/1 and 6/1 margins respectively.  Ventral 
wall defects including omphalocele, exomphalos, umbilical hernia, and a single case of ectopia cordis 
were also more prevalent in complete triploidy by an 11/1 margin.  When comparing defects of the 
genito-urinary tract between complete triploidy and diploid triploid mixoploidy, the most striking 
difference was the presence of renal anomalies which were more prevalent in complete triploids by a 20/4 
margin.  Most other abnormalities of the genitalia were fairly evenly distributed between the two groups.  
The one major exception was the prevalence of ovarian anomalies in 7 cases of complete triploidy 
compared to only a single case of 2n/3n mixoploidy.  This could possibly be explained by considering 
that there were 39 cases of XXX complete triploidy compared to 28 cases of XX/XXX mixoploidy. 
 Abnormalities of the endocrine glands were also strikingly more common in complete triploidy.  
Adrenal hypoplasia was observed in 20 complete triploids but only six mixoploids.  Additionally, 
hypoplasia of the thymus and of the thyroid were observed in six and three cases of complete triploidy 
respectively, but were absent from 2n/3n mixoploids.  Finally, there were also significant differences in 
the rates of abnormal placental morphology between complete triploidy and 2n/3n mixoploidy.  Among 
complete triploids, 18 were reported as being partial moles with an abnormal fetus compared to  a single 
case for 2n/3n mixoploidy.  Among 2n/3n mixoploids, four cases were reported as apparent confined 
placental mosaicism characterized by a partial molar placenta with a normal fetus.  A total of 10 complete 
triploid placentas were reported as being small and noncystic compared to only one mixoploid placenta.  
At first, this may seem surprising considering that there were more digynic 2n/3n mixoploids than digynic 
complete triploids.  However, when considering that the mixoploid digynic placentas would likely also 
contain large populations of normal diploid cells, this is not surprising since this latter population will 
allow for more normal placental development.  A complete side-by-side comparison of the phenotypic 
traits seen in diploid/triploid mixoploidy and complete triploidy can be found in appendix C, Table 16. 
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9.0 CONCLUSION 
 
 
Much has been learned about triploidy in humans since the first case of diploid/triploid mixoploidy was 
documented nearly 50 years ago.  The methods used to investigate triploidy have evolved over the 
decades from the comparatively simple cytogenetic and cytological techniques used in the 1960’s to the 
much more advanced molecular techniques in use now.  However, as the technology improved, the 
mystery surrounding triploidy only seemed to deepen and become increasingly complex.  While early 
studies suggested that most triploids were of diandric origin and associated with partial mole, later studies 
suggested digyny was more prevalent and that a smaller proportion of triploids were associated with 
partial mole.  A significant portion of these differences can be attributed to varying degrees of between 
study and ascertainment bias.  Early cytogenetic studies ascertained mostly spontaneous abortions 
regardless of the presence or absence of a fetus.  On the other hand, later molecular studies often sampled 
only cases with a discernable embryo or fetus which biases towards digyny and nonmolar placentas.  
Overall, studies that collected their samples from consecutive series of spontaneous abortions such as 
Jacobs et al. (1982), Warburton et al. (1991), and Redline et al. (1998) can be considered the least biased.  
It has become increasingly apparent that to fully understand triploidy, many factors including parental 
origin, genomic imprinting, placental and fetal phenotypes, and gestational age must be looked at 
together. 
 Though dispermy and retention of the second polar body are regarded as being the two most 
common mechanisms leading to triploidy, a number of additional mechanisms have been proposed and 
documented.  Diandric triploidy has been shown to arise from diplospermy I or II and could also 
potentially arise through abnormal endoreduplication of the male pronucleus.  Several scenarios involving 
abnormal division of the oogonium, primary oocyte, or secondary oocyte can lead to digynic triploidy.  
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Additionally, it is thought that assisted reproduction technology may increase the risk of triploidy in 
certain cases. 
 A number of studies have revealed some of the unique characteristics of triploid cells.  Perhaps as 
a direct result of their increased DNA content, the proliferative capacity of triploid cells is different than 
that of their diploid counterparts.  X chromosome inactivation behaves in an unusual manner in triploid 
individuals with populations of cells having anywhere from zero to two inactive X chromosomes.  The 
meiotic behavior of triploid cells, though as yet poorly understood, appears to be characterized by the 
formation of unusual structures during synapsis and random changes in which two of the three 
homologous chromosomes are paired.  Triploid cells also show some degree of tissue specificity.  The 
primary example of this is their near total absence in the peripheral lymphocytes of diploid/triploid 
mixoploid individuals.  The leading explanation for this phenomenon is a selective growth advantage of 
2n cells over their 3n counterparts. 
 The phenotypic characteristics of complete triploidy are quite broad with every major organ 
system being affected to some degree.  It has been noted that the triploid phenotype often mimics that of 
individual trisomies, particularly trisomy 18.  The few triploid infants who are born alive generally do not 
survive longer than a few hours to days with the longest reported survival being 10 ½ months.  Death is 
usually ascribed to respiratory problems in these rare cases.  Genital abnormalities are a near constant 
feature of triploidy and may be related to the highly variable nature of X inactivation and dosage affects 
of the DAX1 gene in cases of 69,XXY males.  Among diandric triploids, partial hydatidiform mole is a 
very common finding, though it may be likely to go undiagnosed in some cases.  Though less severe than 
complete moles, PHM can lead to severe complications for both mother and fetus.  On rare occasions, a 
triploid partial mole may coexist with a normal diploid fetus through either twinning or confined placental 
mosaicism. 
 The phenotypic spectrum of diploid/triploid mixoploidy is comparable to complete triploidy in 
breadth, but milder in terms of severity.  The longer survival of mixoploid individuals is largely attributed 
to the absence of severe anomalies of the heart and central nervous system that are seen in complete 
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triploidy.  The phenotype of this syndrome often mimics certain genomic imprinting disorders such as 
Prader-Willi syndrome, Beckwith-Wiedemann syndrome, and maternal UPD(14).  There have been a 
number of reported cases of diploid/triploid mixoploidy in which the diploid line contains an additional 
aneuploidy.  It has been noted that in such cases, the phenotype is often less severe than that seen when 
triploidy or trisomy are seen alone.  This phenomenon is best exemplified in a case of a 
47,XX,+15/69,XXX child surviving 3 2/3 years when neither complete triploidy nor complete trisomy 15 
are compatible with survival. 
 One of the more interesting avenues of investigation into triploidy is the parent-of-origin effect on 
phenotype. This phenomenon is thought largely the result of differential imprinting effects that are 
dependent on the parental origin of the additional haploid set of chromosomes.  Diandric triploidy is 
characterized by a relatively well grown fetus with proportionate head size or relative microcephaly along 
with a large cystic placenta.  Conversely, digynic triploidy is characterized by severe asymmetric IUGR, 
relative macrocephaly, and an unusually small, non-cystic placenta.  It remains unclear if the effects on 
fetal morphology are the result of a direct imprinting effect or are secondary to imprinting effects on the 
placenta.  The parent-of-origin effects generally only become apparent during the second trimester of 
pregnancy or during the fetal period. 
Additionally, diandric and digynic triploidy show an unusual distribution with respect to 
gestational age.  Digynic triploids usually either abort early in the first trimester or survive well into the 
fetal period while diandric triploids tend to predominate from 10-20 weeks of gestation.  The underlying 
cause of this phenomenon is currently not well understood, but may be related to imprinting effects on 
placental morphology and function.  As a side effect of this complex pattern, many if not all 
comprehensive studies attempting to ascertain the parental origin of the extra haploid set of chromosomes 
suffer from sampling bias related to the gestational ages of their specimens.  Most of these studies look at 
triploid conceptuses over a very broad range of gestational ages and rarely if ever provide specific 
gestational ages for each case.  The increasing prevalence of routine prenatal screening also adds a degree 
of bias since most triploids that are detected in this manner will be aborted. 
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A review of the literature revealed that there have been more reported cases of digynic triploidy 
than diandric triploid in both the complete and mixoploid groups.  When considering the triploid cell line 
of 2n/3n mixoploids there were 28 XXX cases compared to 29 XXY cases.  However, among complete 
triploids, there were 39 69,XXX cases compared to 24 69,XXY cases.  Many different methods have been 
used to ascertain the parental origin of the extra haploid set of chromosomes over the years.  Most early 
reports relied on blood group analysis and cytogenetic polymorphisms while later reports almost 
exclusively rely on molecular DNA polymorphism analysis.  A few reports of 2n/3n mixoploidy were 
able to ascertain the parental origin simply by observing the karyotypes of the different cell lines.  IUGR, 
macrocephaly, and adrenal hypoplasia were more common in digynic 2n/3n mixoploids while PHM was 
more common in diandric mixoploids and complete triploids.  Though IUGR and macrocephaly were 
more common in digynic complete triploids, adrenal hypoplasia was more common in diandric complete 
triploids.  Most other traits did not show large differences between diandric and digynic triploidy and 
those that did can largely be attributed to sample size and the completeness of phenotype reports.  
Overall, syndactyly and low-set ears were among the most common traits in both complete triploidy and 
2n/3n mixoploidy.  There were generally fewer anomalies overall among 2n/3n mixoploids and 
significantly fewer central nervous system, cardiopulmonary, and renal anomalies among mixoploids 
compared to complete triploidy. 
 This comprehensive review of the literature provides an in depth look at what is currently known 
about human triploidy and diploid/triploid mixoploidy.  The findings of this review could be used to help 
design future studies into the origins and characteristics of human triploidy that are free of the bias that 
has plagued earlier studies.  From a public health standpoint, such studies could provide insight into the 
management and perhaps prevention of triploid gestation.  In order to unravel the mysteries surrounding 
triploidy, a couple more detailed studies will have to be done.  It may be necessary to combine the results 
of many studies examining the parental origin of triploids in an effort to obtain a better view of the 
gestational age effect.  It is also imperative to provide a gestational age for each case rather than a broad 
range for the whole study.  Additional studies will need to be carried out to examine how imprinted genes 
96 
 
97 
 
affect early embryonic development and the development of the trophoblast.  It may also be prudent to 
combine these imprinting studies with dosage-effect studies.  Only by conducting these studies and 
paying close attention to detail will the answers to the many questions surrounding human triploidy be 
found. 
 
 
 
 
 
APPENDIX A 
 
 
 
COMPLETE DATA FOR ALL CASES OF 2N/3N MIXOPLOIDY 
 
 
 The following tables contain the complete case information for all cases of diploid/triploid 
mixoploidy cited within this paper and used for the literature review.  The cases are numbered in 
chronological order, with the exception of one case, and alphabetical order in the case of multiple 
publications from the same year.  There are a total of 63 cases from 53 published reports.  Case 51(61) 
had been published previously, but only the later publication is indicated in the table.  Table 10 contains 
detailed information of the karyotype and tissue distribution of diploid and triploid cell lines.  The 
parental origin of the extra haploid set of chromosomes and its mode of ascertainment are also noted 
when available.  The age listed refers to the age of the proband at the time the 2n/3m mixoploidy was 
ascertained or at the time of the patient’s final assessment or death prior to the publication of the case 
report. 
 Table 11 lists the morphological data of all cited cases of diploid/triploid mixoploidy.  The first 
three columns are the same as in Table 10.  The phenotypic characteristics of the placenta as well as the 
proband are listed when available.  The phenotypic characteristics of the proband may be divided into 
external and internal findings when appropriate.  The final column lists any additional notes that may be 
of relevance to that particular case. 
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Table 10. Complete genetic and molecular data for all cases of 2n/3n mixoploidy 
Authors Case # Age Genotype Origin 
(BOOK and 
SANTESSON 1960) 
1 (1) 3 1/2 
y/o 
- Skin fibroblasts: 46,XY(16%)/69,XXY(84%) 
- Fascia lata: 46,XY(51%)/69,XXY(49%) 
 - Bone marrow & Leukocytes: 46,XY 
 - Many 2n cells grossly unbalanced 
- Suggest meiotic 
error during 
oogenesis but don't 
provide any 
supporting evidence 
(ELLIS et al. 1963) 2 (2) 6 y/o - Skin fibroblasts: 46,XX/69,XXX in about 
equal proportions at 2 sites from opposite sides 
of body 
- Leukocytes: Entirely 46,XX 
- Digynic based on 
ABO blood group 
analysis 
(FERRIER et al. 1964) 3 (3) 10 
y/o 
- Leukocytes: 46,XY(50) 
- Right fascia lata: 46,XY(15)/69,XXY(4) 
- Fibroblasts (Right forearm): 
46,XY(156)/69,XXY(11) 
- Fibroblasts (Left forearm #1): 
46,XY(85)/69,XXY(9) 
- Fibroblasts (Left forearm #2): 
46,XY(176)/69,XXY(13) 
- Large satellited chromosome 13 in 2n line, 
duplicated in 3n line 
- Digynic based on 
finding of paternal 
#13's with no large 
satellites 
- Molecular studies 
also showed both X's 
maternally derived 
(GROPP et al. 1964) 4 (4) 3 1/2 
m/o 
- Palatal mucosa in area of defect: 72 
chromosomes with extra F group 
- Lymphocytes: 46,XY 
- ? 
- Possibly restricted 
to malformation 
(SCHMID and 
VISCHER 1967) 
5 (5) 11 
m/o 
- Lymphocytes: 48,XXYY(63) 
- Fibroblasts: 48,XXYY(243)/71,XXXYY(88) 
- Labeling studies: 2n cells consistently showed 
1 late replicating X 
- Fertilization by 
abnormal sperm 
followed by 2nd 
polar body 
incorporation into 
blastomere 
(VAN DEN BERGHE 
and VERRESEN 1970) 
6 (6) d 8 
h/o. 
- Blood: 46,XX(17)/69,XXX(24) 
- Also 4 hypodiploid (45) and 14 6n cells 
- ? 
(JENKINS et al. 1971) 7 (7) 10 
1/2 
y/o 
- Peripheral lymphocytes: 46,XX 
- Skin fibroblasts: 46,XX/69,XXX 
- X-chromatin studies showed single polar 
body 
- ? 
(SELLYEI et al. 1971) 8 (8) 39 
y/o 
- 322 lymphocyte mitotic plates revealed some 
69,XYY among 1st 30 cells analyzed 
- Also showed 2 4n and 1 polytrisomic (57 
chromosomes) cell 
- Puzzling, 
Remnants of 2n/3n 
mosaicism? 
(DEWALD et al. 1975) 9 (9) 13 
y/o. 
- Blood (initial): 46,XX 
- Blood (repeat): 
46,XX(93)/69,XXY(5)/92,XXXX(2) 
- Skin (initial): 46,XX(40%)/69,XXY60%) 
after 5 passages  
- Skin (repeat): showed 
46,XX(34%)/69,XXX(66%) 
- Dispermy: Delayed 
incorporation of 2nd 
male pronucleus into 
blastomere 
(FULTON et al. 1977) 10a 
(10) 
11 
y/o. 
- Blood: 46,XX 
- Fibroblasts: 46,XX/69,XXX 
- 2n/3n ratio: 1:1 at 5 years and 4:1 at 11 years 
- ? 
10b 
(11) 
13 
y/o. 
- Karyotype not indicated - ? 
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Authors Case # Age Genotype Origin 
(FRYNS et al. 1980) 11 (12) 21 
y/o 
- Lymphocytes: 46,XX 
- Skin fibroblasts (right forearm): 
46,XX(75)/69,XXX(36) 
- Skin fibroblasts (left forearm): 
46,XX(88%)/69,XXX(12%) 
- Buccal smear showed Barr bodies in 20% of 
cells 
- ? 
(GINSBERG et al. 
1981) 
12 (13) d 3 
h/o 
- Lymphocytes: 69,XXY(102)/46,XY(1) - ? 
(GRAHAM JR. et al. 
1981) 
13 (14) 19 
m/o 
- Lymphocyte (1 d/o & 3 m/o): 46,XY 
- Skin (R arm, 1 d/o): 
46,XY(94%)/69,XXY(6%) 
- Skin (L arm, 1 d/o): 
46,XY(79%)/69,XXY(21%) 
- Skin (R leg) - 1 d/o: 
46,XY(67%)/69,XXY(33%) 
                        - 9 m/o: 
46,XY(78%)/69,XXY(22%) 
- Skin (L leg) - 1 d/o: 
46,XY(66%)/69,XXY(34%)  
                        - 9 m/o: 
46,XY(87%)/69,XXY(13%) 
- Suggested diandric 
but couldn’t be 
proved 
(THARAPEL et al. 
1983) 
14a 
(15) 
d 40 
h/o 
- Lymphocytes: 46,XY 
- Skin fibroblasts: 46,XY(61%)/69,XXY(39%) 
- Lung fibroblasts: 46,XY(46%)/69,XXY(54%) 
- Reevaluation of lymphocytes showed 1 of 50 
cells was 68,XXY,-17 suggesting low level 
mosaicism 
- ? 
14b 
(16) 
8 1/2 
y/o 
- Lymphocytes: Entirely 46,XX at 4 days and 1 
yr. 
- 2 skin biopsies at 1 yr – site 1: 
46,XX(40%)/69,XXX(60%) 
                                         - site 2: 
46,XX(34%)/69,XXX(66%) 
- Buccal smear showed 44% of cells had 1Barr 
body and no cells with 2 
- ? 
(DONNAI et al. 1986) 15a 
(17) 
12 
y/o 
- Blood: 46,XX 
- Fibroblasts:46,XX(16%/ 69,XXX(84%) 
- ? 
15b 
(18) 
1 y/o - Blood: 46,XX 
- Fibroblasts: 46,XX(59%/69,XXX(41%) 
- ? 
(PETTENATI et al. 
1986) 
16 (19) d 2 
d/o 
- Bone marrow: 46,XX(41%)/69,XXX(59%) 
- Peripheral lymphocytes: 
46,XX(96%)/69,XXX(4%) 
- ? 
(TANTRAVAHI et al. 
1986) 
17 (20) 3 y/o - Initial blood lymphocytes: 46,XX(15) 
- Additional lymphocytes: 
46,XX(292)/69,XXY(8) 
- Skin fibroblasts: 46,XX(887)/69,XXY(3) 
- Buccal smear for X-chromatin studies: 5/100 
cells positive 
- ? 
(BENDON et al. 1988) 18 (21) TOP 
20 
wks 
- Liver and skin: 46,XY(50%)/69,XXY(50%) 
- Placenta: Entirely 69,XXY 
- ? 
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Authors Case # Age Genotype Origin 
(DAHL et al. 1988) 19 (22) d 5 
w/o 
- Lymphocytes (63 cells): 
69,XXY(20%)/46,XY,+2p(80%) 
- Skin fibroblasts (3 cells): 46,XY,+2p 
- Parents and patient negative for fra(2)(q13) 
- ? 
(BETTS et al. 1989) 20 (23) TOP, 
20 
wks. 
- Fibroblasts: 45,X(35)/69,XXY(115) 
- Gonad: 45,X(4)/69,XXY(7) 
- ? 
(CALLEN et al. 1991) 21 (24) N/A - Cord blood, amnion, child: entirely 46,XX 
- 3 separate macroscopically normal areas of 
placenta: 46,XX/69,XXY 
- Chorion and grossly abnormal placenta: 
Entirely 69,XXY 
- Chimera: Major 
contribution of 
placenta from 
resorbed 69,XXY 
twin 
(POST and NIJHUIS 
1992) 
22 (25) TOP 
25+2 
wks 
- LT-CVS: 46,XX(4)/47,XX,+16(12) - 
Cordocentesis entirely 69,XXX 
- Total of 4 placental samples: 
46,XX(24)/47,XX,+16(103)/69,XXX(19) 
- All 3 cell types found in placenta with 
proportions varying by site 
- Skin fibroblasts entirely 3n 
- Chimera: Trisomy 
16 placenta from 
vanishing twin + 
surviving 3n fetus - 
2n cells from 
trisomy rescue 
(DAUBENEY et al. 
1993) 
23 (26) 3 y/o - Lymphocytes: 46,XX with 22p+ 
- Skin fibroblasts: 
46,XX/69,XXX/69,XXX,+22p+ 
- Father also possessed 22p+, probably normal 
polymorphism 
- ? 
(JARVELA et al. 1993) 24 (27) 20 
m/o 
- Cord blood at 30 wk gestation: 46,XX 
- Postnatal blood: 46,XX 
- Skin fibroblasts: 69,XXX(28)/46,XX(2) 
- ? 
(KENNERKNECHT et 
al. 1993) 
25 (28) SB 
41 
wks 
- CVS direct prep: 46,XY 
- Peri-umbilical blood: 69,XXY 
- Digynic: Likely 
maternal M-II non-
disjunction 
(MULLER et al. 1993) 26 (29) 9 m/o - Lymphocytes: 46,XX 
- Fibroblasts: 69,XXX(46)/46,XX(4) 
- Digynic 
(SARNO JR. et al. 
1993) 
27 (30) Dx 
14 
wks 
GA 
- AF: 46,XX 
- Villous core mesenchyme: 68,XXX,-11 
- Term placenta and amnion: 46,XX 
- Chorionic plate: 46,XX(50%)/68,XXX,-
11(50%) 
-  Chorionic villi: 100% 3n 
- Neonatal blood: 46,XX 
- Suggest 
postzygotic loss of 
1n set from 
originally 3n 
conceptus 
(TUERLINGS et al. 
1993) 
28 (31) TOP, 
10 
wks. 
- Skin: 47,XX,+18 
 CVS at 9 1/2 wks. and after TOP: 
70,XXX,+18  
- LT-CVS of mesenchymal core cells: 
47,XX,+18(3)/70,XXX,+18(3) 
- Dispermy: Delayed 
incorporation of 2nd 
male pronucleus 
(CARAKUSHANSKY et 
al. 1994) 
29 (32) 4 1/2 
y/o 
- Blood lymphocytes: 
46,XX(57%)/69,XXX(43%) 
- ? 
(WOODS et al. 1994) 30 (33) d 15 
y/o 
- Lymphocytes: Repeatedly normal 46,XX (?, 
probably typo in paper) 
- Skin fibroblasts: 69,XXY(29)/45,XY,-15(1) 
- Maternal lymphocytes = 
46,XX(42)/45,X(3)/47,XXX(4)/48,XXXX(1) 
- ? 
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Authors Case # Age Genotype Origin 
(IKEDA et al. 1996) 31 (34) TOP 
18 
wks 
- Normal appearing placenta: 46,XX  
- Hydropic placenta: 46,XX(273)/67,XX,-3,-
4,+11,+13,-14,-X(1) (May have been broken 4n 
cell) 
- Molecular analysis confirmed 2n/3n in 
placenta 
- Permission not granted for fetal karyotyping 
- Diandric based on 
molecular analysis 
showing excess of 
paternal alleles 
(DEAN et al. 1997) 32 (35) d 3 
2/3 
y/o 
- AF (35 wks): 
46,XX(2)/47,XX,+15(7)/69,XXX(4) - 13 cells 
- AF (subculture): 47,XX,+15(14)/69,XXX(22) 
- 36 cells 
- Cord blood (birth): 
47,XX,+15(5)/69,XXX(80) - 85 cells 
- Cord (birth): 47,XX/+15(5)/69,XXX(20) - 25 
cells 
- Amnion (birth): 
46,XX(2)/47,XX,+15(3)/69,XXX,(20) - 25 
cells 
- Chorion (birth): 
46,XX(1)/47,XX,+15(4)/69,XXX(20) - 25 cells 
- Blood (1.5 y/o): 47,XX,+15(2)/69,XXX(358) 
- 360 cells 
- Muscle (1.5 y/o): 
47,XX,+15(10)/69,XXX(90) - 100 cells 
- Skin (1.5 y/o): 47,XX,+15(9)/69,XXX(91) - 
100 cells 
- Bone Marrow (1.5 y/o): 69,XXX(163) - 163 
cells 
- Suggest delayed 
inclusion of 
additional 1n set into 
blastomere followed 
by mitotic 
nondisjunction in 
second blastomere 
creating trisomy 15 
cell line 
(LIN et al. 1998) 33 (36) IUFD 
22 
wks. 
- Flow cytometry of heart sections: 32% 3n 
- Chromosome analysis not done due to 
macerated condition of fetus 
- ? 
(TOPALOGLU et al. 
1998) 
34 (37) 7 y/o - Peripheral blood lymphocytes: 
46,XY(58%)/69,XXY(7%)/92,XXXY(35%) 
- ? 
(HSIEH et al. 1999) 35 (38) 18 
m/o 
- Amniocentesis: 46,XX 
- Placenta: N/A (Assume 3n based on Dx of 
PHM) 
- ? 
(ENGLISH et al. 2000) 36 (39) TOP 
18 
wks. 
- CVS & placenta: 46,XX/47,XX,+6/69,XXX 
- Skin & muscle: 69,XXX 
- 3n cell line had 2 maternal genomes 
- Maternal M-II 
nondisjunction 
produces 24,X,+6 
ovum fertilized by 
normal sperm with 
later mitotic trisomy 
rescue.  3n line 
originates from 
incorporation of 
22,X,-6 polar body 
into blastomere 
(ZHANG et al. 2000) 37 (40) IUFD 
20 
wks 
- Amniocentesis at 15 weeks: 46,XX 
- Normal placental villi 2n 
- Cystic placental villi 3n 
- Loss of 1n set from 
3n conceptus 
- Fertilization of 4n 
oocyte creating 5n 
zygote which splits 
into 2n & 3n 
components 
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(LAMBERT et al. 
2001) 
38 (41) 8 y/o - Blood: 46,XY(99.5%)/69,XXY(0.5%) (200 
cells) 
- Fibroblasts (right arm): 
46,XY(59%)/69,XXY(41%) (70 cells) 
- Fibroblasts (left arm): 46,XY (15 cells) 
- ? 
(PHELAN et al. 2001) 39 (42) d 22 
h/o 
- Amniocytes: 47,XY,+13(12)/69,XXY(4) - 16 
cells 
- Cord blood: 47,XY,+13(16)/69,XXY(4) - 20 
cells 
- Fibroblasts: 47,XY,+13(7)/69,XXY(18) - 25 
cells 
- Amnion: 69,XXY(32) - 32 cells 
- Chorionic villi: 47,XY,+13(15) - 15 cells 
- Fusion of 
blastomere with 2nd 
polar body with later 
chromosome 13 
nondisjunction 
(VAN DE LAAR et al. 
2003) 
40a 
(43) 
6 y/o - Lymphocytes: 46,XY 
- Fibroblasts: 69,XXY(22)/46,XY(10) 
- Digynic 
40b 
(44) 
6 y/o - Lymphocytes: 46,XY 
- Fibroblasts: 69,XXY(33%)/46,XY(67%) 
- Digynic 
40c 
(45) 
21 
m/o 
- Lymphocytes: 46,XX 
- Fibroblasts: 69,XXX(45)/46,XX(5) 
- Digynic 
(BREMS et al. 2003) 41a 
(46) 
N/A - Lymphocytes: 46,XY 
- Skin fibroblasts: 46,XY/69,XXY 
- Digynic: 2nd polar 
body incorporation 
into blastomere 
41b 
(47) 
N/A - Lymphocytes: 46,XX 
- Skin fibroblasts: 46,XX/69,XXX 
- Digynic: 2nd polar 
body incorporation 
into blastomere 
41c 
(48) 
N/A - Lymphocytes: 46,XX 
- Skin fibroblasts: 46,XX/69,XXX 
- Digynic: 2nd polar 
body incorporation 
into blastomere 
(DANIEL et al. 2003) 42a 
(49) 
N/A - ST-CVS: 46,XX(23) 
- LT-CVS: 69,XXX(50) 
- Diandric: delayed 
incorporation of 2nd 
sperm into 
blastomere 
42b 
(50) 
8 y/o - Blood: 46,XY(20) 
- Skin: 69,XXY(45)/46,XY(5) 
- Digynic: delayed 
incorporation of 2nd 
polar body into 
blastomere 
42c 
(51) 
N/A - AF: 69,XXY(28)/47,XY,+16(4) - Chimera: Digyny 
from maternal M-II 
error resulting in 2n 
ovum and 
fertilization by 
normal sperm + 
Fusion with 2nd 
trisomy 16 embryo 
42d 
(52) 
3 m/o - AF: 46,XX(50) 
- LT-CVS: 69,XXX(14)/46,XX(2) 
- ST-CVS = 46,XX(25) 
- Postnatal blood = 46,XX 
- Diandric: delayed 
incorporation of 2nd 
sperm into 
blastomere 
(FLORI et al. 2003) 43 (53) 5 y/o - Amniocytes, fetal and postnatal lymphocytes: 
46,XX 
- Skin fibroblasts (1 y/o): 
69,XXX(30)/46,XX(70) 
                             (5 y/o): 
69,XXX(298)/46,XX(2) 
- Digynic: 
Incorporation of 2nd 
polar body into 
blastomere 
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(DEVRIENDT et al. 
2004) 
44 (54) 8 y/o - Lymphocytes: 46,XY  
- Scrotal skin biopsy during surgery: 69,XXY 
(n = 4) 
- Buccal smear: Interphase FISH revealed 
46,XY86%)/69,XXY(14%) 
- ? 
(VATISH et al. 2004) 45 (55) b 26 
wks 
d ? 
h/o 
- Lymphocytes: 69,XXY/46,XX 
- Skin fibroblasts: 69,XXY(30%)/46,XX(70%) 
- ? 
(WRIGHT and WALES 
2004) 
46 (56) N/A - AF: 46,XX 
- Blood lymphocytes: 46,XX 
- Skin fibroblasts and gonadal tissue: 
46,XX/69,XXY 
- Chimera: Authors 
couldn't think of 
mechanism leading 
to XX/XXY from 
single zygote 
(QUIGLEY et al. 
2005) 
47 (57) 11 
w/o 
- Lymphocytes: 45,X - FISH studies showed no 
evidence of SRY 
- 197/200 cells showed pattern consistent with 
1 X chromosome while 3/200 consistent with 2 
X chromosomes 
- Fibroblasts: 69,XXY 
- Repeat fibroblasts showed 3/60 cells 45,X 
- Diandric: Delayed 
dispermy with 2n 
cell undergoing 
secondary loss of 
sex chromosome 
(GIURGEA et al. 
2006) 
48 (58) 6 y/o - Almost entirely 46,XY except for pancreatic 
lesions which were 3n 
- Diandric: 
Postzygotic 
diploidization of 
triploid or delayed 
incorporation of 2nd 
sperm into 1 of 2 
blastomeres 
(KARTESZI et al. 
2006) 
49 (59) 2 1/2 
y/o 
- Peripheral lymphocytes: 46,XX 
- Skin biopsy: 2n(26%)/3n(60%)/4n(14%) 
- ? 
(OKTEM et al. 2007) 50 (60) 8 y/o - Lymphocytes: 46,XX 
- Skin: 46,XX/69,XXY or 46,XX/69,XX,+mar 
(mar later identified as Y) 
- 20% of ovarian tissue contained Y 
chromosome 
- ? 
(SHAFI et al. 2007) 51 (61) 25 
y/o 
- Lymphocytes: 46,XX 
- Skin fibroblasts: 46,XX(65%)/69,XXX(35%) 
-Digynic: 
Incorporation of 2nd 
polar body into 
blastomere 
(RITTINGER et al. 
2008) 
52 (62) 14 
y/o 
- Lymphocytes: 46,XX 
- Cultured fibroblasts: 69,XXX(15)/46,XX(3) 
- Interphase FISH fibroblasts: 
69,XXX(200)/46,XX(13)/92,XXXX(6) 
- 4n cells likely culture artifact 
- Digynic 
(WEGNER et al. 2009) 53 (63) IUFD 
25 
wks 
- Native amniocytes: 
46,XX(70%)/69,XXY(30%) 
- 2n/3n confirmed by FISH on 2nd 
amniocentesis 
- Fetal WBC showed 1 (uncultured) & 3 
(cultured) 3n cells 
- Fetal urine cells: 8.8 3n cells (n = 80) 
- Diandric based on 
microsatellite 
analysis 
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Table 11. Complete phenotype data and additional notes for all cases of 2n/3n mixoploidy 
Author Case # Age Phenotype Notes 
(BOOK and 
SANTESSON 1960) 
1 (1) 3 ½  
y/o 
- Placenta: N/A 
- Child: BW 2100 g, psychomotor delay, 
occasional feeding difficulty, localized 
lipomatosis, thin lower legs, small for age, 
micrognathia, bony and cutaneous syndactyly of 
hands/feet, some abnormal ataxic movements, 
porencephaly 
 - First reported 
case of 2n/3n 
mixoploidy 
(ELLIS et al. 1963) 2 (2) 6 y/o - Placenta: N/A 
- Child: Mild MR, right sided hemiatrophy, 
zygodactyly 
- Mother had slight 
congenital 
asymmetry but 
normal karyotype 
(FERRIER et al. 1964) 3 (3) 10 
y/o 
- Placenta: N/A 
- Child: BW 1850 g, body asymmetry, dolicho-
oxycephaly, feeding difficulties, psychomotor 
delay, enuria, partial 3-4 syndactyly of hands, 
complete 3-4 syndactyly of left foot, abnormal 
pigmentation on right side, small penis/scrotum, 
cryptorchidism, decreased bone age, thin long 
bones, hypoplastic right pelvis, very low urinary 
gonadotrophin secretion 
  
(GROPP et al. 1964) 4 (4) 3 1/2 
m/o 
- Placenta: N/A 
- Child: Harelip, cleft palate 
  
(SCHMID and VISCHER 
1967) 
5 (5) 11 
m/o 
- Placenta: N/A 
- Child: Severe developmental and mental delay, 
thin limbs, prominent forehead, peculiar facies,  
low-set abnormal ears, coloboma, cutaneous 
abnormalities, muscular atrophy, 3-4 syndactyly 
of fingers, 2-3 syndactyly of toes 
 
(VAN DEN BERGHE and 
VERRESEN 1970) 
6 (6) d 8 
h/o. 
- Placenta :N/A 
- External: Asymmetric head, low-set 
malformed ears, joint contractures, cutaneous 
syndactyly of hands and feet, normal appearing 
genitalia with testes in scrotum 
- Internal = N/A 
 
(JENKINS et al. 1971) 7 (7) 10 
1/2 
y/o 
- Placenta: N/A 
- Child: Asymmetric growth (right side larger), 
psychomotor delay, MR, heart murmur, 
downturned corners of mouth, thoracic scoliosis, 
clinodactyly with single crease of left 5th finger, 
EEG showed slowed activity bilaterally 
  
(SELLYEI et al. 1971) 8 (8) 39 
y/o 
- Proband: Apparently normal - Screening due to 
genetic disorder in 
son 
(DEWALD et al. 1975) 9 (9) 13 
y/o. 
- Placenta : N/A 
- Child: Ambiguous genitalia, urogenital 
anomalies, feminine appearance, severe mental 
and developmental delay, bilateral clubfoot, 
small gonad in left scrotum 
-  Internal: small vagina, no prostate, small right 
gonad in pelvis  
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Author Case # Age Phenotype Notes 
(FULTON et al. 1977) 10a 
(10) 
11 
y/o. 
- Placenta: N/A 
- Child: Motor and developmental retardation, 
left hemiatrophy, facial and body asymmetry, 
pigmentary abnormalities of legs, left sided 
grand  mal seizures, kyphoscoliosis, 2-3-4 
syndactyly of left toes and fingers, generalized 
weakness 
- Sister with grand 
mal seizures 
10b 
(11) 
13 
y/o. 
- Placenta: N/A 
- Child: Severe MR, truncal obesity, dorsal 
scoliosis, bilateral blepharoptosis 
 
(FRYNS et al. 1980) 11 (12) 21 
y/o 
- Placenta: N/A 
- Proband: Severe psychomotor retardation, 
"oldish appearance" with facial lipodystrophy, 
peculiar facies, mandibular prognathism, , facial 
asymmetry, truncal obesity, left 
hemihypotrophy, , lumbar lordosis, finger 
syndactyly, unusual feet with 2-3 syndactyly, 
VSD murmur, generalized dysrythmy on EEG 
  
(GINSBERG et al. 1981) 12 (13) d 3 
h/o 
- Placenta: N/A 
- Child: Generalized edema, unusual facies, low-
set ears, ocular anomalies, ambiguous genitalia, 
rocker bottom feet,, dysplastic kidneys, adrenal 
hypoplasia, Leydig cell hyperplasia, partial 
cerebellar agenesis 
- Maternal oral 
contraceptive use 
until 20 weeks 
gestation 
(GRAHAM JR. et al. 
1981) 
13 (14) 19 
m/o 
- Placenta: N/A 
- Child: BW 2480 g, transverse palmar crease, 
short 1st and 5th metacarpals, 5th finger 
clinodactyly, partial 2-3-4 syndactyly of fingers, 
asymmetric growth, hemihypoplasia, decreased 
muscle strength, mild developmental delay, 
facial and body asymmetry (right side structures 
smaller) 
- Maternal 
proteinuria and 
hypertension during 
3rd trimester 
(THARAPEL et al. 
1983) 
14a 
(15) 
d 40 
h/o 
- Placenta: Reported normal 
- Child: IUGR, cyanotic at birth, neurologically 
depressed, brachycephaly, blepharophimosis, 
low-set ears, micrognathia, peculiar facies, short 
neck, bell-shaped thorax with wide set nipples, 
weak heart tones, small genitalia with bilateral 
hydrocele, hypotonia, wrinkled skin with little 
subcutaneous tissue, flexion deformities of 
knees and elbows, clinodactyly of fingers, left 
transverse palmar crease, bilateral clubfoot, 
syndactyly of toes 
  
14b 
(16) 
8 1/2 
y/o 
- Placenta: Normal 
- Child: decreased fetal movement, hypotonia, 
unusual facies, micrognathia, deficient muscle 
mass in limbs, clinodactyly of fingers, abnormal 
dermatoglyphics, hypoplastic 4th and 5th toes, 
psychomotor delay, body asymmetry, seizure 
disorder developed around 3 yrs,  pigmentary 
anomalies becoming more pronounced with age 
- Paternal great aunt 
with sever MR & 
severe spastic CP 
- Mother took 
antibiotics early in 
pregnancy 
(DONNAI et al. 1986) 15a 
(17) 
12 
y/o 
- Placenta: N/A 
- Child :Severe MR, face and body asymmetry, 
truncal obesity, unusual hands and feet, sandal 
gap 
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Author Case # Age Phenotype Notes 
15b 
(18) 
1 y/o - Placenta: N/A 
- Child: Body asymmetry, diffuse retinal 
pigmentary disturbance, obesity, unusual feet, 
sandal gap 
  
(PETTENATI et al. 
1986) 
16 (19) d 2 
d/o 
- Placenta: N/A 
- Child: BW 1969 g @ 43 wks, IUGR, 
hypoglycemia, depressed nasal bridge, 
telecanthus, low set posteriorly rotated ears, 
facial asymmetry, bulbous nasal tip, 
micrognathia, right cutaneous 3-4 finger 
syndactyly, 5th finger clino/camptodactyly, 
hypoplastic right thumb, hypoplastic right 
hallux, short toes, sandal gap, hypoplastic toes 
4-5 and 2-3 toe syndactyly, metatarsus adductus, 
talipes equinovarus 
- Necropsy: Adrenal hypoplasia, partial agenesis 
of corpus callosum, heart defect, incompletely 
pulmonary lobation, multiple hemorrhages in 
lungs and cerebellum 
  
(TANTRAVAHI et al. 
1986) 
17 (20) 3 y/o - Placenta: N/A 
- Child: Ambiguous genitalia, hermaphroditism, 
skin pigmentary dysplasia, right foot larger than 
left 
  
(BENDON et al. 1988) 18 (21) TOP 
20 
wks 
- Placenta: Thick with small echolucencies, 
characteristic changes of PHM 
- Fetus: Hydrocephaly, lumbosacral 
myelomeningocele, IUGR 
- Autopsy: Bulbous nose, microstomia, 3-4 
syndactyly, small adrenals, thickened tricuspid 
valve, macrocephaly, hydrocephaly, micropenis, 
hypospadias, gonads consisting of central small 
testicular region and peripheral rim of immature 
ovarian tissue, abnormally large 
utricle/mullerian structure in place of prostate 
  
(DAHL et al. 1988) 19 (22) d 5 
w/o 
- Placenta: N/A 
- External: IUGR, respiratory insufficiency, high 
forehead, micrognathia, peculiar facies, 
asymmetric funnel chest, slender pelvis, thin 
extremities, 3-4 syndactyly of hands, sandal gap, 
flexion deformities of multiple joints, convex 
thoracic scoliosis 
- Internal: Horseshoe kidney, dextroposition of 
lower descending & sigmoid colon, mesocolon 
not attached to cecum and ascending colon 
  
(BETTS et al. 1989) 20 (23) TOP 
20 
wks 
- Placenta: N/A 
- External: Incompletely masculinized genitalia, 
slight hypertelorism, prominent forehead, 
receding jaw, malformed ears, single palmar 
crease, sandal gap 
- Internal: Grossly male gonads, adrenal 
hypoplasia 
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(CALLEN et al. 1991) 21 (24) N/A - Placenta: 670 g, bulky, strikingly abnormal, 
numerous vesicular villi scattered throughout 
parenchyma and intermixed with 
macroscopically normal villous tissue, grossly 
enlarged hydropic villi covered with thin layer 
of trophoblast showing focal hyperplasia and 
containing central cisterns without normal fetal 
vessels, flat sac at one edge consisting of 2 
adherent amnions and degenerate chorion with 
no apparent fetal remnants 
- Child: Normal 2.3 kg female born at 35 weeks 
gestation 
  
(POST and NIJHUIS 
1992) 
22 (25) TOP 
25+2 
wks 
- Placenta: 122 g with normal appearance 
- Fetus (external): IUGR, hypertelorism, 
coloboma, camptodactyly, other minor 
dysmorphic features 
- Fetus( internal): Transposition of great vessels, 
VSD, intestinal malrotation, agenesis of 
gallbladder 
  
(DAUBENEY et al. 
1993) 
23 (26) 3 y/o - Placenta: N/A 
- Child: Plagiocephaly, hypotelorism, depressed 
nasal bridge, 4-5 clinodactyly of fingers, 
pigmentary anomalies on chest, developmental 
delay, hypotonia, precocious puberty at 3 
months, seizures, ventriculomegaly 
  
(JARVELA et al. 1993) 24 (27) 20 
m/o 
- Placenta: 420 g, no abnormalities 
- External: BW 1410 g, narrow skull, 
hypertelorism, micrognathia, high narrow 
palate, low-set ears, complete 3-4 finger 
syndactyly, partial 2-3 toe syndactyly, facial 
asymmetry, streaky pigmentary anomalies on 
legs and wrists 
- Internal: Agenesis of septum pellucidum and 
posterior corpus callosum, very delayed 
neurological development, hypotonia, areflexia, 
feeding difficulties for 1st 5 months, 
hypothyroidism, precocious puberty Dx at 5 
months, Infantile seizures with hypsarrythmia 
on EEG, 
  
(KENNERKNECHT et al. 
1993) 
25 (28) SB 41 
wks 
- Placenta: N/A 
- Fetus: BW 760 g, severe IUGR, dysmorphic 
brain 
  
(MULLER et al. 1993) 26 (29) 9 m/o - Placenta = N/A 
- Child: Cerebral anomalies, precocious puberty 
at 6 months, intractable myoclonic seizures, 
sensorineural hearing loss, intestinal malrotation 
One of set of 
triplets (others 
normal) conceived 
with fertility drugs 
(SARNO JR. et al. 
1993) 
27 (30) Dx 14 
wks 
GA 
- Placenta: Unusually thickened with diffuse 
multi-cystic appearance 
- Child: Apparently normal female, BW 1935 g 
  
(TUERLINGS et al. 
1993) 
28 (31) TOP 
10 
wks. 
-Placenta: N/A 
- Fetus: N/A 
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(CARAKUSHANSKY et 
al. 1994) 
29 (32) 4 1/2 
y/o 
- Placenta: N/A 
- Child: BW 2900 g, craniosynostosis, 
microcephaly, poor suck reflex, severe 
psychomotor delay, peculiar facies, 
microstomia, micrognathia, facial and body 
asymmetry, single transverse palmar crease on 
left, 5th finger clinodactyly, soft tissue 3-4 
syndactyly of toes, proximally positioned 
halluces, pigmentary dysplasia on lower body, 
marked hypotonia, microophthalmia, coloboma, 
ovaries not seen on ultrasound 
  
(WOODS et al. 1994) 30 (33) d 15 
y/o 
- Placenta: N/A 
- Child: Severe MR, short stature, asymmetry, 
failure to thrive, apparent macrocephaly, 
peculiar facies, bossed forehead, micrognathia, 
abnormal ears, 3-4 syndactyly of left hand, 2-3 
syndactyly of left foot, undescended right testis, 
severe developmental delay, moderate 
hypotonia, generalized osteoporosis, cotton reel 
shaped vertebrae, grand mal epilepsy, flexion 
contractures of large joints, lumbar scoliosis 
  
(IKEDA et al. 1996) 31 (34) TOP 
18 
wks 
- Placenta: PHM, areas of hydropic & normal 
villi, capillary formation in hydropic villi 
- Fetus: Grossly normal, 248 g, appropriate for 
dates 
  
(DEAN et al. 1997) 32 (35) 2 1/2 
y/o 
- Placenta: N/A 
- Child: IUGR, fetal akinesia persisting 
throughout life, macrocephaly , small palpebral 
fissures, 3-4 syndactyly of fingers, 2-3 
syndactyly of toes, severe developmental and 
intellectual delay 
Died at 3 y 8 mo. 
(LIN et al. 1998) 33 (36) IUFD 
22 
wks. 
- Placenta: 74g, apparently normal 
- Fetus: IUGR, omphalocele, radial agenesis, 4-
5 syndactyly right hand, 2-3 syndactyly left 
hand 
  
(TOPALOGLU et al. 
1998) 
34 (37) 7 y/o - Placenta: N/A 
- Child: Hepatomegaly, hypertension, flat 
occiput, short palpebral fissures, low-set ears, 
transverse palmar crease, short thumbs, heart 
murmur, moderate ascites, pedal edema, 
cryptogenic cirrhosis, membranous 
glomerulonephritis 
- Parents 1st degree 
cousins 
(HSIEH et al. 1999) 35 (38) 18 
m/o 
- Placenta: Huge, hydropic and multicystic at 18 
weeks; evidence of molar areas invading normal 
areas at birth 
- Infant: BW 1551 g, IUGR, respiratory distress 
at birth, complete recovery within 2 weeks & 
healthy at 18 months 
  
(ENGLISH et al. 2000) 36 (39) TOP 
18 
wks. 
- Placenta: very small, 23 g (expected 130 g at 
18 weeks) 
- Fetus: Severe IUGR, abnormal ears, poor limb 
muscle development, oligohydramnios, 3-4 
syndactyly of right hand & left foot, bilateral 
talipes equinovarus, adrenal hypoplasia 
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(ZHANG et al. 2000) 37 (40) IUFD 
20 
wks 
- Placenta: 500 g with cystic molar villi 
scattered throughout and intermixed with 
normal villi 
- Fetus: 500 g, delivered at 23 wks, severe 
maceration precluded further examination 
  
(LAMBERT et al. 2001) 38 (41) 8 y/o - Placenta: N/A 
- Child external: MR, developmental. delay, 
seizures, obesity, lordosis,  single palmar crease, 
5th finger campto/clinodactyly,  2-3 toe 
syndactyly, calcaneovalgus, asymmetry 
Child Internal: Epileptic activity on EEG, 
vermis hypoplasia 
  
(PHELAN et al. 2001) 39 (42) d 22 
h/o 
- Placenta: Very small 154.3 g, small diameters, 
hypoplastic decidua but no parenchymal cysts 
- Infant: Severe IUGR, abnormal ears, cleft 
palate, syndactyly of fingers and toes 
  
(VAN DE LAAR et al. 
2003) 
40a 
(43) 
6 y/o - Placenta: N/A 
- Prenatal: IUGR, oligohydramnios, decreased 
movement 
- Child: Unusual facies, body asymmetry, 
marked hypotonia, joint contractures, 2-3 
syndactyly of toes, small phallus, bifid scrotum, 
severe developmental delay 
  
40b 
(44) 
6 y/o - Placenta: N/A 
-  Prenatal: IUGR 
- Child: Growth retardation, failure to thrive, 
hypotonia, dysmorphic features, syndactyly, 
small underdeveloped genitalia, severe 
psychomotor delay 
  
40c 
(45) 
21 
m/o 
- Placenta: N/A 
- Child: Peculiar facies, small ASD, rocker 
bottom feet, 3-4 syndactyly of left hand, long 
digits, anteriorly placed anus, bilateral cochlear 
hearing loss, thyroid agenesis, developmental 
delay 
  
(BREMS et al. 2003) 41a 
(46) 
N/A - Placenta: N/A 
- Child: N/A 
  
41b 
(47) 
N/A - Placenta: N/A 
- Child: N/A 
  
41c 
(48) 
N/A - Placenta: N/A 
- Child: N/A 
  
(DANIEL et al. 2003) 42a 
(49) 
N/A - Placenta: N/A 
- Fetus: Dandy-Walker hydrocephalus, severe 
oligohydramnios, cardiac anomalies (single 
ventricle), small right VSD 
- Hydrocephalus 
detected at 19 wks, 
no further details 
on pregnancy 
outcome 
42b 
(50) 
8 y/o - Placenta: N/A 
- Child: Globally delayed, microcephaly, 
microstomia, micrognathia, short stature, 
osteoporosis, truncal obesity, controlled 
diabetes, 3-4 syndactyly of hands and feet 
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42c 
(51) 
N/A - Placenta: Non-cystic 
- Fetus: Severe IUGR, wasted, 
holoprosencephaly, complete arhinia, large 
midline cleft palate, syndactyly of fingers and 
toes, hypoplastic genitalia, adrenal hypoplasia, 
sex reversal with normal uterus, ovaries, and 
fallopian tubes 
- Pregnancy 
terminated but date 
not given 
42d 
(52) 
3 m/o - Placenta: N/A 
- "Child: Normal female 
  
(FLORI et al. 2003) 43 (53) 5 y/o - Placenta: N/A 
- Child external: IUGR, polyhydramnios, 
unusual facies, micrognathia, low-set posteriorly 
rotated ears, truncal obesity, club hands and feet, 
3-4 syndactyly of left hand, pigmentary 
dysplasia along Blaschko's lines on legs, severe 
psychomotor delay 
- Child internal: Fronto-parietal atrophy, focal 
pachygyria, hypsarythmia 
  
(DEVRIENDT et al. 
2004) 
44 (54) 8 y/o - Placenta: N/A 
- Child: BW 2.5 kg at 37 wks, IUGR, 
hypospadias, ring-shaped skin creases on all 4 
limbs, abundant connective tissue, right 
preauricular pit, asymmetric leg circumference, 
hyperpigmented areas of skin, mild 
developmental delay, tapering fingers, weight > 
97th percentile @ 8 y/o 
- Conceived 
through ICSI 
(VATISH et al. 2004) 45 (55) b 26 
wks 
d ? 
h/o 
- Placenta: 406 g, circumscribed area with small 
vesicles, hypoplastic terminal villi, hydropic 
villi with abnormal contours and trophoblastic 
pseudoinclusions but no trophoblast 
proliferation, overall features of PMD and PHM 
- Child: Increased leg muscle bulk, bulbous toes 
Mother: Severe 
early onset 
preeclampsia at 26 
wks 
- Emergency C-
section due to fetal 
distress 
(WRIGHT and WALES 
2004) 
46 (56) N/A - Placenta: 2.0 kg, large, pale 
- Child: BW 2.84 kg, ambiguous genitalia, true 
hermaphroditism, micrognathia, macroglossia, 
microcephaly, sloping forehead, wide simian 
crease, bilateral ovotestes 
- Age of child not 
indicated 
(QUIGLEY et al. 2005) 47 (57) 11 
w/o 
- Placenta: N/A 
- Child: Ambiguous genitalia, 3-4 syndactyly of 
left hand, CHD, pigmentary mosaicism, showed 
normal development at 11 weeks old 
Mom 36 y/o 
(GIURGEA et al. 2006) 48 (58) 6 y/o - Placenta: N/A 
- Child: Hypoglycemia, unusual facies, 
abnormal pancreas, liver hamartoma 
  
111 
 
Author Case # Age Phenotype Notes 
(KARTESZI et al. 2006) 49 (59) 2 1/2 
y/o 
- Placenta: N/A 
- Child External: Deep set eyes, prominent 
forehead, beaked nose, thin wrinkled skin, 
prominent veins,  left sided inguinal hernia, 
partial 3-4 finger syndactyly, arachnodactyly, 
narrow feet, cutis laxa on trunk, muscle 
hypotonia, truncal ataxia, strabismus, gluteal 
lipodystrophy, developmental delay 
- Child internal: Subependymal cyst, ASD 
 
 - Neonatal 
phenotype matched 
Dx criteria for 
Wiedemann-
Rautenstrauch 
syndrome but 
progeroid features 
markedly 
diminished by 2 1/2 
yrs of age 
(OKTEM et al. 2007) 50 (60) 8 y/o - Placenta: N/A 
- Child: Pigmentary dysplasia following 
Blaschko's lines, early developmental delay, 2-3 
soft tissue syndactyly of toes, 5th finger 
clinodactyly, growth retardation, otherwise 
phenotypically normal with normal internal and 
external genitalia 
  
(SHAFI et al. 2007) 51 (61) 25 
y/o 
- Placenta: N/A 
- Patient: Psychomotor delay, MR, facial 
asymmetry, truncal obesity, syndactyly, 
transverse palmar crease, pigmentary dysplasia, 
neonatal polycythemia 
- Adult onset: Back pain, kyphosis, skin lesions, 
weakness of distal hand muscles 
MZ twin with 
similar phenotype 
but no evidence of 
3n cell line 
(RITTINGER et al. 
2008) 
52 (62) 14 
y/o 
- Placenta: N/A 
- Child: BW 2400 g, prominent forehead, broad 
nasal tip, small chin, clino/camptodactyly of 
fingers, soft tissue 2-3 syndactyly of right foot 
and 3-4 of left, bulbous tip of 2nd toes, 
calcaneovalgus, psychomotor delay, seizures, 
truncal obesity, lumbarization of S1, elongation 
of metacarpals 2-3, ankylosis of proximal 
interphalangeal joint of 5th fingers, patchy or 
streaky hyperpigmentation, precocious puberty, 
scoliosis, growth retardation 
  
(WEGNER et al. 2009) 53 (63) IUFD 
25 
wks 
- Placenta: Hypertrophic 
- Fetus: Polyhydramnios, tricuspid regurgitation, 
pericardial effusion, mild pyelectasia 
- Autopsy: Microgenia, macroglossia, 
hypertelorism, 3-4 finger syndactyly, 
hypoplastic right lung, short right arm, mild 
dilation of ureters, unambiguously female 
external genitalia despite 69,XXY line (internal 
organs not examined due to autolysis) 
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APPENDIX B 
 
 
 
COMPLETE DATA FOR ALL CASES OF COMPLETE TRIPLOIDY 
 
 Table 12 provides complete karyotype details for all cases of complete triploidy cited in this 
paper as well as those used in the literature review.  The cases are listed and numbered in the same 
manner as for the diploid/triploid mixoploid cases.  There were a total of 67 cases collected from 56 
different published articles.  Case 51a(58) had been published separately in a previous article, but only the 
more recent article is listed in the table.  Information regarding the parental origin of the extra haploid set 
of chromosomes and the mode by which they were ascertained is also included when available.  Table 13 
provides the complete phenotype data for all cases of complete triploidy as well as any relevant notes.  
These tables are set up in the same way as Tables 10 and 11. 
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Table 12. Complete genetic and molecular data for all cases of complete triploidy 
Authors Case # Age Genotype Origin 
(BUTLER et al. 
1969) 
1 (1) d 23 
h/o 
- Peripheral blood and skin: 69,XXX 
- Fibroblast sex chromatin analysis: 67 (32.5%) 
with single Barr body, 134 (65%) X-chromatin 
negative, 5 (2-5%) with 2 Barr bodies though 2 may 
have been 6n cells based on size 
- ? 
(PATTERSON et 
al. 1971) 
2a (2) SB 29 
wks 
- Placental vesicles: 69,XXX 
- Thymus, skin, spleen: 69,XXX 
- ? 
2b (3) SA 25 
wks 
- Skin fibroblasts: 69,XXX - ? 
(SPARREVOHN 
et al. 1971) 
3 (4) d 93 
h/o 
- Lymphocytes:  69,XXX 
- Autoradiography: 2 late-replicating X's in 12/22 
cells & 1 in 1/22 cells 
- Digynic: Blood 
group analysis 
showed both maternal 
rhesus alleles 
(NIEBUHR et al. 
1972) 
4 (5) d 93 
h/o 
- Lymphocytes: 69,XXX - Suggestive of 
maternal meiosis 
failure 
(SIMPSON et al. 
1972) 
5 (6) d 3 d/o - Lymphocytes: Entirely 69,XXY - ? 
(HENRIKSSON et 
al. 1974) 
6 (7) d 9 h/o - Leukocytes: 69,XXY - ? 
(LEISTI et al. 
1974) 
7 (8) d 7 d/o - Karyotype from multiple tissues: 69,XXY 
- No evidence of X-chromatin in 1500 buccal cells 
- ? 
(GOSDEN et al. 
1976) 
8 (9) b 26 
wks 
d < 1 
hr 
- Cardiac blood, skin fibroblasts, muscle: 69,XXX - ? 
(DUDAKOV et 
al. 1977) 
9a (10) SA 4th 
month 
- Skin, amnion, placenta: 69,XXX - ? 
9b 
(11) 
b 37 
wks 
d 4 d/o 
- Peripheral lymphocytes: 69,XXX - ? 
(FULTON et al. 
1977) 
10 
(12) 
d 50 
min 
- Karyotype: 69,XXY - ? 
(BOCIAN et al. 
1978) 
11 
(13) 
TOP 
24 wks 
- Q-band karyotype: 69,XXY in all 25 cells scanned - Digynic based on 
presence of 2 fetal 
homologues with 
polymorphism 
present in 1 copy in 
mother 
(DELIGDISCH et 
al. 1978) 
12 
(14) 
LB 22 
wks 
d  < 1 
min 
- Cord blood, fetal fibroblasts, Wharton's jelly: 
69,XYY 
- Diandric based on 
presence of 2 Y 
chromosomes 
(LUCIANI et al. 
1978) 
13 
(15) 
TOP 
17 wks 
- Fetal blood and fibroblasts: 69,XXX - ? 
(BIEBER et al. 
1981) 
14 
(16) 
SB - Gut fibroblasts: 69,XXX - Digynic: 1st polar 
body fertilization 
(PAGE et al. 
1981) 
15 
(17) 
d 17 
h/o 
- Karyotype: Entirely 69,XXX - Diandric: 
Diplospermy II 
(BROEKHUIZEN 
et al. 1983) 
16 
(18) 
TOP 
24 wks 
- Karyotype: 69,XXY - ? 
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(MARASCHIO et 
al. 1984) 
17 
(19) 
d 45 
d/o 
- Lymphocytes & fibroblasts: Entirely 69,XXX 
- Karyotype: 69,XXX,inv(15)(q15q26) - inv(15) of 
maternal origin 
- Diandric: Probably 
dispermy 
(SHERARD et al. 
1986) 
18 
(20) 
d 312 
d/o 
- Bone marrow, lymphocytes, fibroblasts: 69,XXY 
- Repeat lymphocytes at 9 months old showed no 
evidence of mosaicism 
- Digynic: HLA 
typing 
(VEJERSLEV et 
al. 1986) 
19a 
(21) 
b 28 
wks 
d < 1 
hr 
- Karyotype: 69,XXY - Diandric: dispermy 
19b 
(22) 
IUFD 
< 14 
wks 
- Karyotype: 69,XXY - Diandric: dispermy 
19c 
(23) 
TOP 
18 wks 
- Karyotype: 69,XXY - Diandric: dispermy 
(ROYSTON and 
BANNIGAN 
1987) 
20a 
(24) 
d 3 h/o - Peripheral leukocytes: 69,XXX - ? 
20b 
(25) 
d 45 
min 
- Peripheral leukocytes & skin fibroblasts: 69,XXY 
- Paternal heteromorphism with 1 #9 noticeably 
larger than other 
- Diandric: infant had 
2 unusual #9's similar 
to that seen in father 
(ROCHON and 
VEKEMANS 
1990) 
21 
(26) 
SA 8 
wks 
- Products of conception: 69,XXY,t(6;14)(p23;q24) 
- Mother balanced carrier 46,XX,t(6;14)(p23;q24) 
- Digynic: M-I non-
disjunction based on 
comparison of 
parental & fetal 
chromosome 
heteromorphisms on 
#'s 13, 14, & 21 
(SCHWAIBOLD 
et al. 1990) 
22 
(27) 
d 20 
h/o 
- Karyotype: 69,XXX in 30 metaphases 
- RBA staining showed 2 late-replicating X 
chromosomes 
- Could not be 
determined due to 
insufficient FISH 
signal 
(GALAN et al. 
1991) 
23 
(28) 
d 7 d/o - Lymphocytes: 69,XXX - Digynic: 
Fertilization of 2n 
ovum by 1n sperm 
(MERLOB et al. 
1991) 
24 
(29) 
d 6 d/o - Bone marrow, skin fibroblasts: 68,XX  - ? 
(PETIT et al. 
1992) 
25 
(30) 
TOP 
20 wks 
- Q-banding of chorionic villi, skin fibroblasts & 
peripheral blood: 69,XXY 
- No evidence of Barr bodies in 200 cells 
- ? 
(NIEMANN-
SEYDE and 
ZOLL 1993) 
26 
(31) 
d 10 
1/2 
w/o 
- Peripheral blood & skin fibroblasts: 69,XXX - Diandric: 
Cytogenetic 
polymorphisms 
(SEPULVEDA et 
al. 1994) 
27 
(32) 
TOP 
12 wks 
- CVS, fetal skin, placenta: 69,XXY - ? 
(PIETRANTONI 
et al. 1995) 
28 
(33) 
TOP 
18+3 
wks 
- Fetal blood and placenta: 69,XXY - ? 
(SMETS et al. 
1995) 
29 
(34) 
d 38 
h/o 
- Peripheral blood and skin fibroblasts: 69,XXY - ? 
(SOREM and 
SHAH 1995) 
30 
(35) 
TOP 
26 wks 
- Cordocentesis: 69,XXY - ? 
(DE RAVEL et al. 
1996) 
31a 
(36) 
SB 31 
wks 
- Fetal blood: 69,XXX - ? 
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31b 
(37) 
TOP 
26 wks 
- Cordocentesis: 69,XXX - ? 
31c 
(38) 
TOP 
32 wks 
- Fetal blood: 69,XXY - ? 
(JOHNSON et al. 
1997) 
32 
(39) 
TOP 
17 wks 
- Fetus: 69,XXX - ? 
(LUDWIG et al. 
1998) 
33 
(40) 
TOP 
15 wks 
- CVS and amniocentesis: Entirely 69,XXX - ? 
(RAMSEY et al. 
1998) 
34 
(41) 
TOP 
14 wks 
- Fetus: 69,XXX - ? 
(HASEGAWA et 
al. 1999) 
35 
(42) 
b 31 
wks 
d 46 
d/o 
- Amniocentesis: 69,XXX 
- Postnatal cord blood, skin fibroblasts, peripheral 
lymphocytes: 69,XXX 
- Digynic based on 
Q-band 
heteromorphisms and 
confirmed by 
microsatellite marker 
analysis 
(KAFFE et al. 
1989) 
36 
(43) 
TOP 
22 wks 
- Amniocentesis and fetal tissue: 68,XX - ? 
(FRATES and 
FEINBERG 2000) 
37 
(44) 
TOP 
14+5 
wks 
- Both fetuses 3n - ? 
(MCFADDEN et 
al. 2000) 
38 
(45) 
d. < 1 
hr 
- Amnion & chorion: 69,XXY 
- FISH studies found no definitive evidence of 
mosaicism 
- ? 
(CHANG et al. 
2001) 
39 
(46) 
LB 33 
wks 
d < 1 
min 
- Fetal karyotype: 69,XXX - Digynic: Maternal 
M-II non-disjunction 
based on STRP 
marker analysis 
(BAN et al. 
2002) 
40 
(47) 
SB 31 
wks 
- CVS (due to severe oligohydramnios): 69,XXX - Digynic: STRP 
analysis 
(STEFOS et al. 
2002) 
41 
(48) 
TOP 
18 wks 
- Triploid - ? 
(GASSNER et al. 
2003) 
42 
(49) 
SF 
20+3 
wks 
- Karyotype: 69,XXX - Probably digynic 
based on phenotype 
(LIM et al. 
2003) 
43 
(50) 
N/A - Karyotype: 
69,XXY,t(2;6)(p12;q24)der(6)t(2;6)(p12;q24)pat 
- Diandric: Dispermy, 
1st sperm carried 
balanced t(2;6) and 
2nd carried der(6) 
(BIANCA et al. 
2004) 
44 
(51) 
TOP 
22 wks 
- Amniocentesis: 69,XXX - ? 
(BILLIEUX et al. 
2004) 
45 
(52) 
TOP 
18 wks 
- Amniocentesis and fetal biopsy: 69,XXX - Diandric: 
Microsatellite marker 
analysis 
(DALMIA et al. 
2005) 
46 
(53) 
TOP 
16 wks 
- Amniocytes: 69,XXX 
- Post-TOP skin and placenta confirm 3n 
- Diandric based on 
pattern of 
malformations 
(ILIOPOULOS et 
al. 2005) 
47 
(54) 
b 39 
wks 
d 164 
d/o 
- Peripheral blood: 69,XXX(50) - ? 
(KOS et al. 
2005) 
48 
(55) 
TOP 
26 wks 
- Cordocentesis: 69,XXY,inv(9)(p11q13) in all 
lymphocytes 
- ? 
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(BARSOOM et 
al. 2006) 
49 
(56) 
TOP 
20 wks 
- Amniocentesis: 69,XXX - ? 
(MENDILCIOGLU 
et al. 2006) 
50 
(57) 
SF 19 
wks 
- Amniocentesis: 69,XXX (growth discordant 
fetus); 46,XX (normal fetus) 
- ? 
(CHEN et al. 
2008) 
51a 
(58) 
TOP 
16 wks 
- TA-CVS:  69,XXX - Digynic: Maternal 
M-II by QF-PCR and 
STRP analysis 
51b 
(59) 
TOP 
15 wks 
- Karyotype: 69,XXX - Digynic: Maternal 
M-II error 
51c 
(60) 
TOP 
13 wks 
- Karyotype: 69,XXX - Digynic: Maternal 
M-II error 
51d 
(61) 
TOP 
14 wks 
- Karyotype: 69,XXY - Digynic: Maternal 
M-II error 
51e 
(62) 
TOP 
13 wks 
- Karyotype: 69,XXY - Digynic: Maternal 
M-II error 
(MEDEIROS et 
al. 2008) 
52 
(63) 
TOP 
22 wks 
- 3n by flow cytometry - ? 
(TAKABACHI et 
al. 2008) 
53 
(64) 
d 221 
d/o 
- Lymphocytes: 69,XXX - ? 
(BEKDACHE et 
al. 2009) 
54 
(65) 
SB 33 
wks 
- Amniocentesis: 69,XXY - ? 
(FALKERT et al. 
2009) 
55 
(66) 
TOP 
16+2 
wks 
- CVS: 69,XXX - ? 
(SOLOMON et al. 
2009) 
56 
(67) 
SA 8 
wks 
- Fetal chromosomes: 69,XXX - ? 
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Table 13. Complete phenotype data and additional notes for all cases of complete triploidy 
Author Case # Age Phenotype Notes 
(BUTLER et al. 
1969) 
1 (1) d 23 
h/o 
- Placenta: Large 945 g (normal 450 g), scattered small 
calcification foci 
- Child: BW 1825 g (< 10th centile), flat face, 
hypertelorism, coloboma, long upper lip, underdeveloped 
low-set ears, short neck, single palmar crease, Absent 
distal flexion creases on fingers 2-4, proximally placed 
thumbs, unusual dermatoglyphics, short halluces, sandal 
gap, long 2nd and 3rd toes, hypoglycemia, areflexia, heart 
murmur, congestive heart failure 
- Necropsy: Dilated right heart with osteum secundum 
defect, VSD, bicuspid aortic & pulmonary valves, 
hydronephrotic right kidney, dysplastic left kidney, 
hypoplastic ovaries, adrenal hypoplasia, small brain, 
hepatosplenomegaly, poorly developed eyes 
 - Possibly first 
reported case of 
liveborn 
complete 
triploidy 
(PATTERSON et 
al. 1971) 
2a (2) SB 29 
wks 
- Placenta: Large, 817 g, diffuse hydatidiform degeneration 
- Child: Hydramnios, severe hare-lip, bilateral 3-4 
syndactyly, long 5th fingers, flexion deformity of toes 2-4, 
exomphalos containing most of small intestine, ASD, large 
left kidney, cystic right kidney 
  
2b (3) SA 25 
wks 
- Placenta: 281 g, diffuse hydatidiform degeneration 
- Fetus: 789 g, high arched palate, 3-4 syndactyly of left 
hand, long 5th fingers, splayed toes, umbilical hernia 
containing large portion of intestine, protrusion of part of 
liver into chest through diaphragmatic defect 
  
(SPARREVOHN 
et al. 1971) 
3 (4) d 93 
h/o 
- Placenta: N/A 
- Child: BW 1600 g at 37 wks, very immature, 
macrocephaly, small malformed low-set ears, 
micrognathia, blepharophimosis, long thick upper lip, 
arachnodactyly, irregular finger insertion, webbing 
between fingers, knee contractures, foot/ankle deformities, 
esophageal atresia 
- Necropsy: agenesis of corpus callosum, esophageal 
atresia, tracheo-esophageal fistula, alobar left lung, 
agenesis of gallbladder/cystic ducts, adrenal hypoplasia 
  
(NIEBUHR et 
al. 1972) 
4 (5) d 93 
h/o 
- Placenta: N/A 
- Child: Large head, asymmetric dysmorphic face, trachea-
esophageal fistula, hand and foot malformations, 3-4 
syndactyly of left hand, agenesis of corpus callosum, 
agenesis of gallbladder, persistent urachus 
  
(SIMPSON et al. 
1972) 
5 (6) d 3 
d/o 
- Placenta: N/A 
- Child: BW 2500 g, myelomeningocele, icterus, 
prominent occiput, soft fontanelles, low-set ears, broad 
nasal bridge, bulbous nose, epicanthal folds, upslanted 
palpebral fissures, macroglossia, arachnodactyly, bilateral 
transverse palmar crease, 5th finger camptodactyly, small 
penis 
- Autopsy: Small brain, occipital polygyria, dilated lateral 
ventricles, coloboma, slightly enlarged heart, fenestrated 
septum primum, fusion of pulmonary valve commissure, 
small scrotum, small testes with immature tubules and few 
interstitial cells 
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(HENRIKSSON 
et al. 1974) 
6 (7) d 9 
h/o 
- Placenta: Large, 1400 g 
- Child: Extreme hypotonia, neonatal areflexia, 3-4 finger 
syndactyly, 2-3-4 toe syndactyly, omphalocele, large LV, 
PFO, atelectatic lung disease with erythropoietic cells in 
capillaries, atrophic thymus, small bile ducts, hypoplastic 
gallbladder, adrenal hypoplasia, Leydig cell hyperplasia 
  
(LEISTI et al. 
1974) 
7 (8) d 7 
d/o 
- Placenta: Large, edematous, 1350 g 
- Child: BW 2800 g at 41 wks, Hypotonia, weak reflexes, 
numerous target-like erythrocytes in peripheral blood, 
peculiar facies, hypertelorism, beaked nose with shallow 
bridge, ocular asymmetry, small vertically ovoid corneas, 
high arched palate, micrognathia, large posterior 
fontanelle, edema of hands and feet, soft tissue 2-3-4 
syndactyly of hands, Retroflexed thumbs, flexion 
contractures of proximal interphalangeal joints of 5th 
finger, single transverse palmar crease, unusual 
dermatoglyphics, Partial 2-3-4-5 soft tissue syndactyly of 
toes, ambiguous external genitalia, severe micropenis, bifid 
scrotum with no palpable gonads, perineal urethral opening 
- Autopsy: Atelectatic lungs, small intraabdominal gonads 
attached to rudimentary epididymus, rudimentary uterus, 
gonads consisted of testicular tissue with Leydig cell 
hyperplasia, histologically normal fallopian tubes, some 
renal dysplasia, severe adrenal hypoplasia, 
microophthalmia, optic atrophy, coloboma 
  
(GOSDEN et al. 
1976) 
8 (9) b 26 
wks 
d < 1 
hr 
- Placenta: 750 g, diffuse hydatidiform change 
- Fetus: BW 860 g, prominent forehead, depressed nasal 
bridge, low-set malformed ears, long upper lip, flared 
ribcage, wide set aplastic nipples, flexion deformities of 
fingers, 3-4 finger syndactyly, hyperconvex nails, single 
transverse palmar crease, overdeveloped thigh muscles, 
talipes equinovarus, 3-4 toe syndactyly, sandal gap 
- Autopsy: Cardiomegaly, small hemorrhagic lungs, cystic 
right kidney, adrenal hypoplasia, ovarian hypoplasia, large 
abnormal brain with dilated ventricles, Dandy-Walker 
malformation 
  
(DUDAKOV et 
al. 1977) 
9a (10) SA 
4th 
month 
- Placenta: 114 g, macroscopically normal areas along with 
areas with cystic villi, microscopic features of transitional 
mole 
- Fetus: 27 g, low-set ears, 3-4 finger syndactyly, 2-3 toe 
syndactyly, VSD 
  
9b(11) b 37 
wks 
d 4 
d/o 
- Placenta: N/A 
- Fetus: IUGR, oligohydramnios, BW 1020 g, large 
posteriorly rotated ears, hypertelorism, broad nasal bridge, 
peculiar facies, hypoplastic mandible, cleft soft palate, 
overlapping fingers, radial deviation of fingers 3-5, pes 
varus, rocker bottom feet, 2-3 toe syndactyly, small chest, 
respiratory distress, cardiomegaly, small lungs, jaundice, 
bleeding 
- Autopsy: Agenesis of gallbladder and bile ducts, VSD, 
small lungs, hypoplastic and cystic kidneys, very small but 
histologically normal adrenals, bicornuate uterus, 
subarachnoid hemorrhage over left cerebellum 
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(FULTON et al. 
1977) 
10 (12) d 50 
min 
- Placenta: N/A 
- Child: Cebocephaly, holotelencephaly, severe ocular 
anomalies, retinal dysplasia, single midline nostril, low-set 
ears, meningomyelocele, bilateral single transverse palmar 
crease, 3-4 syndactyly of left toes, thymus hypoplasia, 
agenesis of gallbladder, ambiguous genitalia, 
extramedullary hepatic hematopoiesis, adrenal hyperplasia, 
undescended testes, Leydig cell hyperplasia 
  
(BOCIAN et al. 
1978) 
11 (13) TOP 
24 
wks 
- Placenta: Fragmented, 10 cm diameter, 1000 g 
- Fetus: Relative macrocephaly, IUGR, abnormally shaped 
skull, large fontanelles, hypoplastic occipital and parietal 
bones, malar hypoplasia, prominent glabella, bulbous 
beaked nose, large VSD, 3-4 syndactyly of all limbs, single 
transverse palmar crease, positional deformities of legs, 
soft tissue constrictions about thighs, vertebral anomalies, 
radioulnar synostosis  
  
(DELIGDISCH 
et al. 1978) 
12 (14) LB 22 
wks 
d  < 1 
min 
- Placenta: Large (450 g), PHM degeneration, mostly 
vesicular with trophoblastic hyperplasia, some fleshy 
normal areas 
- Fetus: BW 200 g at 22 wks, cyclopia, complete 2-3 
(finger) & 2-3-4 (toe) syndactyly 
- Necropsy: 2 medially fused eyeballs, supraorbital 
proboscis, absent philtrum, microstomia, frontal 
porencephaly, agenesis of corpus callosum/septum 
pellucidum/optic chiasma, holoprosencephaly, 
thyroid/adrenal agenesis, intraabdominal testes, 
hypoplastic Leydig cells, absent scrotum, micropenis, 
polycystic kidneys 
- Maternal 
grandparents 1st 
cousins 
(LUCIANI et al. 
1978) 
13 (15) TOP 
17 
wks 
- Placenta: Pseudomolar cystic degeneration 
- Fetus: No apparent external anomalies 
  
(BIEBER et al. 
1981) 
14 (16) SB - Placenta: Extensive vascular anastomoses between small 
area supplying acardiac twin and larger area supplying 
normal twin 
- Fetus: Holoacardia, grossly malformed 
- Normal 
46,XY MC/DA 
co-twin 
(PAGE et al. 
1981) 
15 (17) d 17 
h/o 
- Placenta: 120 g, extensive squamous metaplasia around 
cord insertion, keratinization of amnion with underlying 
dense fibrosis 
- Infant: IUGR, BW 920 g, triangular face, flattened nose, 
low-set ears, mild jaundice, syndactyly of fingers & toes, 
slight hepatomegaly, agenesis of gallbladder 
  
(BROEKHUIZEN 
et al. 1983) 
16 (18) TOP 
24 
wks 
- Placenta: 683 g, hydrops and cystic changes consistent 
with PHM 
- Fetus: 361 g, Polyhydramnios, hydranencephaly, 
polycystic kidneys, myelomeningocele 
 
(MARASCHIO 
et al. 1984) 
17 (19) d 45 
d/o 
- Placenta: Normal 
- Child: BW 1600 g, hypotonia, hyporeactive, rounded 
head, hypertelorism, high forehead, low nasal bridge, large 
low-set posteriorly rotated ears, micrognathia, short neck, 
slender thorax, malposed 2nd finger, single transverse 
palmar crease, tetradactyly of left foot, long 2nd and 3rd 
toes, severe jaundice, hepatomegaly, atrophic areas of skin, 
slight atrophy of corpus callosum, severe adrenal 
hypoplasia, hypoplastic ovaries 
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(SHERARD et 
al. 1986) 
18 (20) d 312 
d/o 
- Placenta: small; thin, hypoplastic villi with scalloped 
outlines and central edema, minimal trophoblastic 
hyperplasia consistent with PHM 
- Child: BW 1417 g at 37 wks, IUGR, hypotonia, 
prominent occiput, triangular face, hypertelorism, large 
thin ears, thin abdominal muscles, undescended testes, 
hydrocele, beaked nose, cleft lip/palate, micrognathia, 
flexed wrists, ulnar deviation of hands, 2-3 syndactyly of 
left hand, clino/camptodactyly, bowed right tibia, rocker 
bottom feet, VSD, hypsarrhythmia, feeding difficulties, 
psychomotor delay 
  
(VEJERSLEV et 
al. 1986) 
19a 
(21) 
b 28 
wks 
d < 1 
hr 
- Placenta: 760 g, central vesicles, edema, fibrous 
degeneration, did not meet criteria for PHM 
- Fetus: BW 1050 g, webbed neck, single transverse 
palmar crease, dysplastic 5th fingers, hypospadias, tracheo-
esophageal fistula, adrenal hypoplasia, hydronephrosis, 
hydroureters 
  
19b 
(22) 
IUFD 
< 14 
wks 
- Placenta: 145 g, PHM 
- Fetus: 8 g when delivered at 20 wks, moderate 
maceration but no apparent  gross abnormalities 
  
19c 
(23) 
TOP 
18 
wks 
- Placenta: PHM 
- Fetus: 16 cm CRL, no apparent gross abnormalities 
  
(ROYSTON and 
BANNIGAN 
1987) 
20a 
(24) 
d 3 
h/o 
- Placenta: small (948 g sans cord and membranes), grossly 
and microscopically normal 
- Fetus: BW 1286 g at 31 wks, epicanthal folds, 
hypertelorism, micrognathia, flattened nose, macroglossia, 
generalized edema, cutaneous 2-3-4 syndactyly of hands 
and feet, cystic adenomatoid malformation of lung, adrenal 
hypoplasia, extramedullary hematopoiesis, small 
thyroid/thymus, reduced number of primary follicles in 
ovaries 
  
20b 
(25) 
d 45 
min 
- Placenta: 880 g, grossly normal 
- Fetus: Epicanthal folds, microophthalmia, opacified 
corneas, flattened nasal bridge, cleft palate, macrocephaly, 
small fontanelles, small low-set ears, exomphalos 
micropenis, bifid scrotum, single transverse palmar crease, 
cutaneous 2-3-4 syndactyly of hands and feet, 
hydrocephalus, partial agenesis of corpus callosum, 
malformed basal ganglia, complete absence of cerebellar 
Purkinje cells, right ventricular hypotrophy, infandibular 
pulmonary stenosis, VSD, immature lungs (appeared ~20 
wks), adrenal hypoplasia, extramedullary hematopoiesis, 
small thymus/thyroid, intraabdominal testes with Leydig 
cell hyperplasia, aniridia,  coloboma, retinal dysplasia 
  
(ROCHON and 
VEKEMANS 
1990) 
21 (26) SA 8 
wks 
- Placenta: Non-hydropic 
- Embryo: N/A 
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(SCHWAIBOLD 
et al. 1990) 
22 (27) d 20 
h/o 
- Placenta: Hypoplastic, 214 g, immature terminal villi, 
single flat continuous trophoblast 
- Child: BW 1050 g, triangular face, microstomia, 
hypertelorism, low-set malformed ears, microretrognathia, 
3-4 finger syndactyly, proximally positioned thumbs, short 
toes, symmetrical bilobar hypoplastic lungs, ASD, VSD, 
splenomegaly, agenesis of gallbladder, adrenal/renal 
hypoplasia, ovarian hilum cell hyperplasia 
  
(GALAN et al. 
1991) 
23 (28) d 7 
d/o 
- Placenta: N/A 
- Child: IUGR, macrocephaly, microstomia, micrognathia, 
beaked nose, low set ears, ocular asymmetry, finger 
syndactyly, club feet, incipient genitalia, hydrocephaly, 
cerebral atrophy, partial agenesis of corpus callosum 
  
(MERLOB et al. 
1991) 
24 (29) d 6 
d/o 
- Placenta: N/A 
- Child: BW 2000 g at 39 wks (small), microcephaly, large 
posterior fontanelle, small underdeveloped ears, proptosis, 
hypotelorism, coloboma, depressed nasal bridge, 
prominent columnella, microstomia, short philtrum, cleft 
palate, low set nipples, ulnar deviation of thumbs, 
transverse palmar crease, fusiform digits, large feet, 2-3 
syndactyly of toes, large halluces, 5th toe clinodactyly, 
prominent clitoris absent fourchette, persistent fetal 
circulation 
  
(PETIT et al. 
1992) 
25 (30) TOP 
20 
wks 
- Placenta: Grossly enlarged, focal hydropic changes, 
persistent immature stromal cells, hypoplastic trophoblast 
- Fetus: Hydrocephaly, hepatomegaly, relative 
macrocephaly, small flat facies, malar hypoplasia, 
microophthalmia, microstomia, micrognathia, low-set 
poorly lobulated ears, short neck with low hairline and 
abundant skin, narrow thorax, clinodactyly, 3-4 finger 
syndactyly, ambiguous external genitalia (hypospadias, 
urogenital blind slit) 
Autopsy: Triventricular hydrocephaly, agenesis of corpus 
callosum, agenesis of formix, ASD, hepatomegaly, adrenal 
hypoplasia, rudimentary small gonads in internal inguinal 
position, testes had reduced number of seminiferous 
tubules and were surrounded by rim of immature ovarian 
tissue 
  
(NIEMANN-
SEYDE and 
ZOLL 1993) 
26 (31) d 10 
½ w/o 
- Placenta: Placental insufficiency 
- Child: BW 800 g at 34 wks, IUGR, respiratory distress, 
dolichocephaly, microcephaly, blepharedema, 
hypertelorism, short upturned nose, short philtrum, 
microstomia, microretrognathia, low-set dysmorphic ears, 
short neck, macro/camptodactyly of hands and feet, 
maldeveloped external genitalia, CHD 
- Autopsy: Pulmonary hypoplasia with absent lobation, 
multicystic horseshoe kidney, small bladder, adrenal 
hypoplasia, ovarian hypoplasia, thyroid cyst, aplasia of 
gallbladder, hepatic degeneration, cerebral cyst in septum 
pellucidum 
  
(SEPULVEDA et 
al. 1994) 
27 (32) TOP 
12 
wks 
- Placenta: Enlarged, thickened, parenchymal cysts, villous 
hydrops, no trophoblastic hyperplasia 
- Fetus: Ectopia cordis, ventral wall defect, increased 
nuchal translucency 
Authors note 
similarity to 
pentalogy of 
Cantrell 
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Author Case # Age Phenotype Notes 
(PIETRANTONI 
et al. 1995) 
28 (33) TOP 
18+3 
wks 
- Placenta: hydropic, irregular, gelatinous, hydropic villous 
changes but not consistent with PHM, small 
chorioangioma 
- Fetus: IUGR, omphalocele, probable NTD, 
polyhydramnios 
  
(SMETS et al. 
1995) 
29 (34) d 38 
h/o 
- Placenta: Large (1800 g), macroscopically consistent 
with PHM 
- Child: Polyhydramnios, BW 1434 g at 30+2 wks, 
cyanosis, edema, severe hypotonia, large posterior 
fontanelle, low-set malformed ears, microophthalmia, 
corneal opacities, coloboma, microstomia, cleft palate, left 
intraabdominal mass, ambiguous genitalia, micropenis, 
cryptorchidism, multicystic kidneys, macrocytosis 
  
(SOREM and 
SHAH 1995) 
30 (35) TOP 
26 
wks 
- Placenta: Large, PHM 
- Fetus: BW 557 g, polyhydramnios, omphalocele, cleft 
lip/palate, severe IUGR, ambiguous genitalia, single 
transverse palmar crease, low-set ears 
  
(DE RAVEL et 
al. 1996) 
31a 
(36) 
SB 31 
wks 
- Placenta: Normal 
- Fetus: BW 477 g, oligohydramnios, asymmetric IUGR, 
relative macrocephaly, micrognathia, low-set malformed 
ears, 2-3-4 syndactyly of all limbs, malformed external 
genitalia, poorly formed labia minora, absent clitoris 
- Autopsy: Hypoplastic lungs with absent lobation, aplasia 
of gallbladder, agenesis of right kidney, ureter, and 
adrenal, poor development of cerebral gyri 
  
31b 
(37) 
TOP 
26 
wks 
- Placenta: Small 
- Fetus: Severe IUGR, hypertelorism, bulbous nose, 
malformed ears, micrognathia, 3-4 finger and 2-3 toe 
syndactyly 
- Autopsy: Cleft palate, pulmonary hypoplasia, distended 
ileum ending in blind pouch, hypoplastic and collapsed 
colon 
  
31c 
(38) 
TOP 
32 
wks 
- Placenta: Edematous with large immature villi 
- Fetus: IUGR, aplasia cutis of posterior scalp, 3-4 
syndactyly of all limbs, talipes equinovarus 
- Autopsy: Astomia, mandibular aplasia, low-set 
posteriorly angulated ears, pulmonary hypoplasia, gastric 
hypoplasia, gallbladder hypoplasia, renal hypoplasia, 
adrenal hypoplasia, ambiguous external genitalia, 
cryptorchidism, scant seminiferous tubules, prominent 
Sertoli cells, abundant Leydig cells, arhinencephaly, 
hypoplasia of corpus callosum 
  
(JOHNSON et 
al. 1997) 
32 (39) TOP 
17 
wks 
- Placenta: Normal 
- Fetus: Vertebral anomalies, renal dysplasia, single flexion 
crease on index fingers 
  
(LUDWIG et al. 
1998) 
33 (40) TOP 
15 
wks 
- Placenta: Swiss cheese-like appearance on ultrasound, 
PHM 
- Fetus: Nuchal edema, IUGR 
- Complicated 
by maternal 
OHSS 
(RAMSEY et al. 
1998) 
34 (41) TOP 
14 
wks 
- Placenta: Thickened, PHM, focal areas of hydropic 
trophoblastic villi 
- Fetus: Gastroschisis, abdominal wall defect 
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Author Case # Age Phenotype Notes 
(HASEGAWA et 
al. 1999) 
35 (42) b 31 
wks 
d 46 
d/o 
- Placenta: Small (152 g), non-cystic 
- Child: IUGR, BW 650 g at 31 wks), oligohydramnios, 
hypotonia, respiratory distress, relative macrocephaly, 
blepharophimosis, microophthalmia, hypertelorism, low-
set malformed ears, short neck, micrognathia, asymmetric 
funnel chest, cutaneous 3-4 (finger) and 2-3 (toe) 
syndactyly, slight ventriculomegaly, bilateral absence of 
5th ribs 
- Autopsy: Thymic hypoplasia, ovarian dysgenesis 
  
(KAFFE et al. 
1989) 
36 (43) TOP 
22 
wks 
- Placenta: 40 g, normal fetal vasculature, focal 
microscopic calcification 
- Fetus: 210 g, IUGR, relative macrocephaly, 
hydrocephaly, dysmorphic facies, hypoplastic mandible, 
broad nasal bridge, short philtrum, low-set ears, eye 
anomalies, handlebar clavicles, cervical rib, medial 
deviation of ribs, flexion deformities of fingers, proximal 
placement of thumbs, talipes equinovarus, bicuspid aortic 
valve, aortic stenosis, anomalous origin of left subclavian 
artery, cystic horseshoe kidney, hypoplastic lungs without 
lobation, ovarian hypoplasia, extramedullary 
hematopoiesis, adrenal hypoplasia 
  
(FRATES and 
FEINBERG 
2000) 
37 (44) TOP 
14+5 
wks 
- Placenta: Large, multiple cysts, thin membrane separating 
individual amnions 
- Presenting twin: Severe hydrops, excessive skin 
thickening, ascites, holoprosencephaly, endocardial 
cushion defect 
- Non-presenting twin: similar but less severe 
- Twin 3n 
gestation 
(MCFADDEN et 
al. 2000) 
38 (45) d. < 1 
hr 
- Placenta: Large, 3 vessel cord, normal villous 
architecture, no signs of PHM 
- Child: Born at 32 wks, IUGR 
- Autopsy: Protuberant eyes, flattened nasal bridge, small 
alae nasi, occipital encephalocele, lumbar 
meningomyelocele, microcephaly, abnormal gyri, low set 
ears, mild nuchal webbing, 2-3 syndactyly of hands & feet, 
left talipes equinovarus, omphalocele, perimembranous 
VSD, multivalvular dysplasia, hypoplastic aortic isthmus, 
right renal agenesis, small phallus, very small labioscrotal 
folds, perineal urethral opening, internal genitalia 
consisting of mullerian derivatives and uterus-like 
structure, dysgenetic gonads consisting of immature 
testicular tissue 
  
(CHANG et al. 
2001) 
39 (46) LB 33 
wks 
d < 1 
min 
- Placenta: small, non-cystic 
- Fetus: IUGR, BW 1100 g, oligohydramnios, cleft lip, 
relative macrocephaly, each lung missing lobe 
  
(BAN et al. 
2002) 
40 (47) SB 31 
wks 
- Placenta: N/A 
- Child: BW 1200 g, oligohydramnios, hypoplastic LV, 
asymmetric IUGR, pulmonary hypoplasia, renal 
hypoplasia, adrenal hypoplasia, limb abnormalities 
  
(STEFOS et al. 
2002) 
41 (48) TOP 
18 
wks 
- Placenta: PHM 
- Fetus: Hydrocephaly, severe IUGR 
- Maternal 
HELLP 
syndrome 
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(GASSNER et 
al. 2003) 
42 (49) SF 
20+3 
wks 
- Placenta: Abnormally small 
- Fetus: Asymmetric IUGR, relative macrocephaly, cleft 
lip/palate/ CHD 
-Selective 
feticide, normal 
46,XY DC co-
twin 
(LIM et al. 
2003) 
43 (50) ? - 
Early 
SA 
- POC: Initially described as blighted ovum but later 
reclassified as 3n PHM 
  
(BIANCA et al. 
2004) 
44 (51) TOP 
22 
wks 
- Placenta: Smaller than normal 
- Fetus: Symmetrical IUGR, diaphragmatic hernia, peculiar 
facies, cutaneous 2-3 toe syndactyly, pulmonary 
hypoplasia, herniation of stomach and large portion of 
intestines into thorax  
  
(BILLIEUX et 
al. 2004) 
45 (52) TOP 
18 
wks 
- Placenta: Large (480 g), features consistent with PHM 
- Fetus: 159 g, abnormalities of limbs, CNS, heart, and 
kidneys 
- Maternal 
peripartum 
cardiomyopath
y 
(DALMIA et al. 
2005) 
46 (53) TOP 
16 
wks 
- Placenta: large, cystic 
- Fetus: Echogenic bowel and kidneys, dilated renal pelvis, 
open sacral spina bifida, micrognathia, low set ears, 
talipes, 3-4 syndactyly of left foot, ambiguous external 
genitalia, intestinal malrotation, cystic kidneys, 
adrenal/thymus hypoplasia, small spleen/liver 
- Conceived 
through ICSI 
(ILIOPOULOS et 
al. 2005) 
47 (54) b 39 
wks 
d 164 
d/o 
- Placenta: N/A 
- Child: BW 1850 g, IUGR, relative macrocephaly, 
oligohydramnios, asymmetric skull, small palpebral 
fissures, small fontanelles, low-set ears, flat nasal bridge, 
small tongue, right hand hexadactyly, overlapping 3rd and 
4th fingers, single transverse palmar crease, overlapping 2nd 
and 3rd toes, tonic-clonic convulsions, partial aplasia of 
occipital lobe, partial aplasia of corpus callosum, 
hypotonia, respiratory problems 
  
(KOS et al. 
2005) 
48 (55) TOP 
26 
wks 
- Placenta: 70% approximately normal, 30% consisted of 
large and edematous villi 
- Fetus: Spina bifida, microcephaly, left JGCT of testis, 
female external genitalia, agenesis of corpus callosum, 
pulmonary hypoplasia, stenosis of pulmonary ostium, right 
Sertoli cell adenoma, hypoplastic uterus 
- JCGT = 
juvenile 
granulosa cell 
tumor of testis 
(BARSOOM et 
al. 2006) 
49 (56) TOP 
20 
wks 
- Placenta: Subchorionic hemorrhage, some hydropic 
change 
- Fetus: 229 g, grossly normal, some webbing of fingers & 
toes 
- Possible 
undetected 
mixoploid? 
(MENDILCIOGL
U et al. 2006) 
50 (57) SF 19 
wks 
- Placenta: Smaller than normal 
- Fetus : IUGR, hydrocephaly 
- Selective feticide precluded further examination 
following delivery of co-twin at 38 wks 
- Healthy co-
twin delivered 
@ 38 wks 
(CHEN et al. 
2008) 
51a 
(58) 
TOP 
16 
wks 
- Placenta: Small, non-cystic 
- Fetus: IUGR, anhydramnios, alobar holoprosencephaly, 
relative macrocephaly, cyclopia, thin small trunk 
 Initially 
reported 
separately, 
(CHEN et al. 
2002) 
51b 
(59) 
TOP 
15 
wks 
- Placenta: N/A 
- Fetus: Alobar holoprosencephaly, asymmetric IUGR, 
midfacial cleft 
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51c 
(60) 
TOP 
13 
wks 
- Placenta: Single umbilical artery 
- Fetus: Alobar holoprosencephaly, proboscis, 
oligohydramnios, asymmetric IUGR, relative 
macrocephaly 
  
51d 
(61) 
TOP 
14 
wks 
- Placenta: N/A 
- Fetus: Alobar holoprosencephaly, oligohydramnios, 
asymmetric IUGR, absence of urinary bladder, relative 
macrocephaly 
  
51e 
(62) 
TOP 
13 
wks 
- Placenta: N/A 
- Fetus: Alobar holoprosencephaly, oligohydramnios, 
asymmetric IUGR 
  
(MEDEIROS et 
al. 2008) 
52 (63) TOP 
22 
wks 
- Placenta: Grossly normal, weight 295 g ( > 95th 
percentile for gestational age), features typical of PHM, 
admixture of normal and markedly enlarged villi with mild 
trophoblastic hyperplasia, microscopic foci of severely 
atypical trophoblastic cells consistent with intraplecental 
choriocarcinoma 
- Fetus: Spina bifida 
  
(TAKABACHI et 
al. 2008) 
53 (64) d 221 
d/o 
- Placenta: Very small, 71 g, no cystic villi, short cord 
- Child: BW 556 g, severe IUGR, relative macrocephaly, 
marked hypotonia, frontal bossing, apparent hypertelorism, 
blepharophimosis, microstomia, micrognathia, low-set 
ears, bell-shaped thorax, syn/clino/camptodactyly, 
malposition of fingers, thoracic hypoplasia, decreased lung 
permeability, skeletal anomalies, PDA, ASD, VSD, 
pulmonary hypertension, hyperbillirubinemia, postnatal 
growth deficiency, significant psychomotor delay 
  
(BEKDACHE et 
al. 2009) 
54 (65) SB 33 
wks 
- Placenta: Large, Multicystic, 895 g at delivery ( > 95th 
percentile), chorionic cysts, scalloping, villous and 
extravillous trophoblastic inclusions, no features of molar 
change 
- Fetus: Alobar holoprosencephaly, proboscis, severe 
hypotelorism, severe hydrocephalus, BW 1185 g  
 – Described as 
female but no 
further info, 
post mortem 
declined 
(FALKERT et 
al. 2009) 
55 (66) TOP 
16+2 
wks 
- Placenta: Thickened with multiple cysts, pathology 
consistent with PHM 
- Fetus: Symmetric IUGR, small omphalocele 
- Maternal 
HELLP 
syndrome 
(SOLOMON et 
al. 2009) 
56 (67) SA 8 
wks 
- Placenta: N/A 
- Embryo: Probable alobar holoprosencephaly, severe 
hypotelorism, proboscis, no evidence of nasal pits or 
mouth, webbed but distinct fingers, no toe rays, 
measurements consistent with 30-34 days gestational age, 
level of maceration precluded further examination 
  
 
 
 
 
 
APPENDIX C 
 
 
 
PHENOTYPE DATA FOR ALL CASES OF COMPLETE TRIPLOIDY AND 2N/3N 
MIXOPLOIDY 
 
 Tables 14-16 provide a breakdown of the different congenital anomalies seen in cases of 
diploid/triploid mixoploidy and complete triploidy respectively.  The different congenital abnormalities 
are largely grouped by organ system or region.  The list of abnormalities listed is by no means exhaustive, 
but rather includes those that are somewhat to very common either in triploidy as a whole or in a 
particular subgroups of triploids.  Table 14 lists the phenotypic characteristics of diploid/triploid 
mixoploidy according to parental origin, genotype, and total.  In this case, genotype only refers to the sex 
chromosome constitution of the diploid and triploid lines and any cases in which additional aneuploidies 
were present were included under the group corresponding to their sex chromosome constitution.  The 
cases of 45,X/69,XXX were included under XX/XXX sex chromosome constitution.  Similarly, the cases 
of 68,XX triploidy were included in the column for 69,XXX in Table 15 which provides the breakdown 
of phenotypic characteristics for complete triploidy.  Table 16 provides a side-by-side comparison of 
these traits between diploid/triploid mixoploidy and complete triploidy without regard to parent-of-origin 
or genotype. 
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Table 14. Phenotypic traits of 2n/3n mixoploid cases according to parent-of-origin and genotype 
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Class Totals 9 10 19 4 2 3 9 15 5 8 6 34 62
Prenatal  
Polyhydramnios 1 0 1 0 0 0 0 0 0 0 0 0 1
Oligohydramnios 1 1 2 1 0 0 1 0 1 1 0 2 5
IUGR 1 5 6 0 1 1 2 5 1 5 2 13 21
Premature birth ( < 37 weeks) 1 1 2 0 0 0 0 3 0 2 1 6 8
Craniofacial  
Cranium - Asymmetric/Dysplastic 0 3 3 0 0 0 0 3 0 2 0 5 8 
Ears - Low set/Dysplastic 4 4 8 0 0 0 0 3 0 4 2 9 17 
Epicanthal folds ? 1 1 2 0 0 0 0 0 0 0 0 0 2 
Facies - Peculiar/Other 0 2 2 0 0 1 1 5 0 1 0 6 9 
Fontanelles - Abnormal size 1 0 1 0 0 0 0 0 0 1 0 1 2 
Forehead - Bossed/Prominent 3 3 6 0 0 0 0 3 0 3 1 7 13 
Hypertelorism/Telecanthus 3 1 4 0 1 0 1 3 0 1 1 5 10 
Hypotelorism 0 0 0 0 0 0 0 1 0 0 0 1 1 
Macrocephaly 1 1 2 0 0 0 0 0 0 1 0 1 3 
Macroglossia 1 1 2 0 1 0 1 0 1 0 0 1 4 
Microcephaly 0 0 0 0 0 0 0 2 1 1 0 4 4 
Micro(retro)gnathia 4 6 10 0 1 0 1 3 1 3 1 8 19 
Microstomia 0 4 4 0 0 0 0 2 0 2 0 4 8 
Nose - Unusual shape 4 3 7 0 0 1 1 6 0 4 0 10 18 
Ocular anomalies 0 2 2 0 1 0 0 5 0 2 1 8 10 
Palate/Lip - Cleft 0 3 3 0 0 0 0 0 0 1 1 2 5 
Palate - High Arched 0 1 1 0 0 0 0 1 0 1 0 2 3 
Palpebral Fissures - Abnormal 1 1 2 0 0 0 0 4 0 1 1 6 8 
Upper Limbs 
Thin/Hypoplastic 1 3 4 0 0 0 0 2 0 1 0 3 7 
Fingers - Arachnodactyly 1 0 1 0 0 0 0 1 0 1 0 2 3 
Fingers - Clino/Camptodactyly 2 2 4 0 0 1 1 7 1 2 0 10 15 
Fingers - Syndactyly 6 7 13 0 2 1 3 6 0 4 1 11 27 
Hands/Digits - Aberrant placement 0 1 1 0 1 0 0 0 0 1 0 1 2 
Joint Deformities 1 3 4 0 0 0 0 0 0 4 0 4 8 
Palmar crease - Single transverse 4 1 5 0 1 1 2 2 1 3 2 9 16 
Lower Limbs 
Thin/Hypoplastic 1 4 5 0 0 0 0 2 0 1 0 3 8 
Feet - Rocker bottom/Talipes 4 1 5 0 1 0 1 3 0 3 0 6 12 
Joint Deformities 0 2 2 0 0 0 0 0 0 4 0 4 6 
Toes - Sandal Gap 0 0 0 0 0 0 0 3 0 1 1 5 5 
Toes - Syndactyly 3 8 11 0 0 1 1 6 1 3 0 10 22 
Trunk/Other General Malformations  
Abdominal wall defects 0 0 0 0 0 0 0 0 0 0 1 1 1 
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Asymmetry - Body 1 2 3 0 0 0 0 7 0 1 0 8 11 
2 1 3 0 0 1 1 7 0 Asymmetry - Face 0 0 7 11 
Asymmetry - Limbs 2 0 2 0 0 0 0 2 1 2 0 5 7 
Dermatoglyphics - Abnormal 0 0 0 0 0 0 1 0 1 0 2 2 
1 0 1 0 0 0 0 1 1 0 0 Hematopoietic abnormalities 2 3 
Hypotonia/Dyskinesia 2 4 6 0 1 1 2 6 0 3 0 9 17 
Kyphosis/Lordosis/Scoliosis 2 1 3 0 0 0 0 5 0 3 1 9 12 
Nipples - Abnormal/Supernumerary 1 2 3 0 0 0 0 0 0 1 0 1 4 
Pigmentary anomalies 3 2 5 0 1 0 1 7 2 1 0 10 16 
Truncal obesity 3 2 5 0 1 0 1 4 0 1 1 6 12 
Developmental/Neurological Abnormalities
Feeding difficulty/Dysphagia 1 3 4 0 0 0 0 2 0 0 0 2 6 
Hearing Loss 2 0 2 0 0 0 0 1 0 0 0 1 3 
Mental/Psychomotor Retardation 6 6 12 0 1 1 2 10 1 3 1 15 29 
Neonatal Areflexia/Dysreflexia 0 0 0 0 0 1 1 3 0 0 0 3 4 
Neonatal Respiratory Distress 0 1 1 0 0 0 0 1 0 4 0 5 6 
Postnatal growth deficiency 1 4 5 0 0 1 1 1 1 0 0 2 8 
Seizures/Abnormal EEG 3 3 6 0 0 0 0 5 0 2 0 7 13 
Central Nervous System Abnormalities  
Cerebellum - Abnormalities 0 0 0 0 0 0 0 0 0 2 0 2 2 
Cerebrum - General/Gyral Anomalies 1 2 3 0 0 0 0 0 0 0 0 0 3 
Corpus Callosum - Agenesis 0 0 0 0 0 0 0 2 0 0 0 2 2 
Holoprosen/telencephaly 0 1 1 0 0 0 0 0 0 0 0 0 1 
Hydrocephaly/Ventriculomegaly 2 1 3 1 0 0 1 1 0 2 0 3 7 
Myelomeningocele/Spina bifida 0 0 0 0 0 0 0 0 0 1 0 1 1 
Cardiovascular & Pulmonary Abnormalities
Atrial/Ventricular septal defect 1 1 2 1 1 0 2 3 0 1 0 4 8 
PDA/PFO 0 0 0 0 1 0 1 3 0 0 0 3 4 
Complex heart disease 0 0 0 1 0 0 1 2 0 0 0 2 3 
Valvular defects 0 0 0 0 0 0 0 1 0 1 0 2 2 
Lungs - Abnormal lobation 0 0 0 0 0 0 0 1 0 0 0 1 1 
Lungs - Hypoplastic/Atelectatic 0 0 0 0 1 0 1 0 0 1 0 1 2 
Gastrointestinal Abnormalities 
Esophagus - Atresia/TE fistula 0 0 0 0 0 0 0 0 0 0 0 0 0 
Gallbladder - A/Dysgenesis 0 0 0 0 0 0 0 1 0 0 0 1 1 
Hepatomegaly 0 0 0 0 0 0 0 0 0 0 1 1 1 
Intestinal Malrotation 1 0 1 0 0 0 0 1 0 0 0 1 2 
Splenomegaly 0 0 0 0 0 0 0 0 0 0 0 0 0 
Genito-Urinary Abnormalities 
Cryptorchidism 0 1 1 0 0 0 0 0 2 3 0 5 6 
Genitalia - Ambiguous 0 0 0 0 1 0 1 0 2 2 1 5 6 
Genitalia - Hypoplastic/Small 1 4 5 0 1 0 1 0 2 3 1 6 12 
Genitalia - Normal female - XX/XXY 0 0 0 0 1 0 1 0 1 0 0 1 2 
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Leydig Cell Hyperplasia 0 0 0 0 0 0 0 0 0 1 0 1 1 
Ovarian abnormalities 0 0 0 0 0 0 0 1 0 0 0 1 1 
Ovotestes 0 0 0 0 0 0 0 0 2 1 0 3 3 
Precocious puberty 2 0 2 0 0 0 0 2 0 0 0 2 4 
Renal abnormalities 0 1 1 0 1 0 1 0 0 2 0 2 4 
Endocrine/Metabolic Disorders 
Adrenal hypoplasia 1 1 2 0 0 0 0 1 0 2 1 4 6 
Thymus - A/Dysgenesis 0 0 0 0 0 0 0 0 0 0 0 0 0 
Thyroid - A/Dysgenesis 0 0 0 0 0 0 0 0 0 0 0 0 0 
Hypobilirubinemia/Jaundice 0 0 0 0 0 0 0 0 0 0 0 0 0 
Placental Abnormalities 
PHM with Abnormal Fetus 0 0 0 0 0 0 0 0 0 1 0 1 1 
PHM with Normal Fetus 0 0 0 1 0 0 1 1 0 0 2 3 4 
Other/Non-molar 0 1 1 0 0 0 0 0 0 0 0 0 1 
Small/Hypoplastic 0 1 1 0 0 0 0 0 0 0 0 0 1 
Apparent CPM 0 0 0 0 1 0 1 0 1 0 0 0 1 
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Table 15. Phenotypic traits of complete triploidy cases according to parent-of-origin and genotype 
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Class Totals 10 5 15 5 5 1 11 24 14 3 41 67 
Prenatal  
Polyhydramnios 0 0 0 0 0 0 0 1 3 0 4 4 
Oligohydramnios 5 2 7 0 0 0 0 3 0 0 3 10 
IUGR 6 4 10 3 0 0 3 16 4 2 22 35 
Premature birth ( < 37 weeks) 3 0 3 2 0 0 2 7 5 0 12 17 
Craniofacial 
Cranium - Asymmetric/Dysplastic 0 2 2 2 0 0 2 1 1 0 2 6 
Ears - Low set/Dysplastic 3 1 4 3 1 0 4 12 9 0 21 29 
Epicanthal folds ? 0 0 0 0 0 0 0 1 2 0 3 3 
Facies - Peculiar/Other 0 2 2 1 0 0 1 5 4 0 9 12 
Fontanelles - Abnormal size 0 1 1 0 0 0 0 1 3 1 5 6 
Forehead - Bossed/Prominent 0 0 0 1 0 0 1 2 0 0 2 3 
Hypertelorism/Telecanthus 1 1 2 1 0 0 1 6 1 0 7 10 
Hypotelorism 0 0 0 0 0 0 0 1 0 0 1 1 
Macrocephaly 6 2 8 0 0 0 0 6 2 8 4 16 
Macroglossia 0 0 0 0 0 0 0 1 1 0 2 2 
Microcephaly 0 1 1 1 0 0 1 1 2 0 3 5 
Micro(retro)gnathia 3 1 4 2 1 0 3 8 2 0 10 17 
Microstomia 1 0 1 2 0 1 3 3 3 0 6 10 
Nose - Unusual shape 2 2 4 2 0 0 2 7 4 0 11 17 
Ocular anomalies 2 0 2 0 0 0 0 3 6 0 9 11 
Palate/Lip - Cleft 0 1 1 0 0 0 0 5 4 0 9 10 
Palate - High Arched 0 0 0 0 0 0 0 1 1 0 2 2 
Palpebral Fissures - Abnormal 2 0 2 0 0 0 0 3 3 0 6 8 
Upper Limbs 
Thin/Hypoplastic 0 0 0 0 0 0 0 1 0 0 1 1 
Fingers - Arachnodactyly 1 0 1 0 0 0 0 1 1 0 2 3 
Fingers - Clino/Camptodactyly 0 1 1 1 0 0 1 1 2 0 3 5 
Fingers - Syndactyly 3 2 5 1 0 1 2 11 5 0 16 23 
Hands/Digits - Aberrant placement 1 1 2 1 0 0 1 6 0 0 6 9 
Joint Deformities 0 0 0 1 0 0 1 2 1 0 3 4 
Palmar crease - Single transverse 0 1 1 1 1 0 2 3 5 1 9 12 
Lower Limbs  
Thin/Hypoplastic 0 0 0 0 0 0 0 1 0 0 1 1 
Feet - Rocker bottom/Talipes 2 1 3 0 1 0 1 4 2 0 6 10 
Joint Deformities 1 1 2 0 0 0 0 2 0 0 2 4 
Toes - Sandal Gap 0 0 0 0 0 0 0 3 1 0 4 4 
Toes - Syndactyly 1 1 2 1 1 1 3 9 6 0 15 20 
Trunk/Other General Malformations 
Abdominal/ventral wall defects 0 0 0 0 0 0 0 4 7 0 11 11 
Asymmetry - Body 0 0 0 0 0 0 0 0 0 0 0 0 
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Asymmetry - Face 1 0 1 0 0 0 0 0 0 0 0 1 
Asymmetry - Limbs 0 0 0 0 0 0 0 0 0 0 0 0 
Dermatoglyphics - Abnormal 0 0 0 0 0 0 0 1 0 0 1 1 
Hematopoietic abnormalities 0 0 0 0 0 0 0 3 3 0 6 6 
Hypotonia/Dyskinesia 2 1 3 1 0 0 1 3 3 0 6 10 
Kyphosis/Lordosis/Scoliosis 0 0 0 0 0 0 0 0 0 0 0 0 
Nipples - Abnormal/Supernumerary 0 1 1 0 0 0 0 2 0 0 2 3 
Pigmentary anomalies 0 0 0 0 0 0 0 0 0 0 0 0 
Truncal obesity 0 0 0 0 0 0 0 0 0 0 0 0 
Developmental/Neurological 
Feeding difficulty/Dysphagia 0 1 1 0 0 0 0 0 0 0 0 1 
Hearing Loss 0 0 0 0 0 0 0 0 0 0 0 0 
Mental/Psychomotor Retardation 0 1 1 0 0 0 0 1 0 0 1 2 
Neonatal Areflexia/Dysreflexia 1 0 1 1 0 0 1 1 3 0 4 6 
Neonatal Respiratory Distress 2 1 3 2 0 0 2 5 2 0 7 12 
Postnatal growth deficiency 0 0 0 0 0 0 0 1 0 0 1 1 
Seizures/Abnormal EEG 0 1 1 0 0 0 0 1 0 0 1 2 
Central Nervous System  
Cerebellum - Abnormalities 0 0 0 0 0 0 0 0 2 0 2 2 
Cerebrum - General/Gyral Anomalies 1 0 1 2 0 0 2 3 5 0 8 11 
Corpus Callosum - Agenesis 1 0 1 0 0 0 0 2 4 0 6 7 
Holoprosen/telencephaly 3 2 5 0 0 1 1 1 3 2 6 12 
Hydrocephaly/Ventriculomegaly 2 0 2 0 0 0 0 3 5 1 9 11 
Myelomeningocele/Spina bifida 0 0 0 0 1 0 1 0 5 1 6 7 
Cardiovascular/Pulmonary Anomalies 
Atrial/Ventricular septal defect 0 2 2 0 0 0 0 6 2 0 8 10 
PDA/PFO 0 0 0 0 0 0 0 1 2 0 3 3 
Complex heart disease 1 0 1 2 0 0 2 2 3 2 7 10 
Valvular defects 0 0 0 0 0 0 0 1 1 0 2 2 
Lungs - Abnormal lobation 1 0 1 1 0 0 1 4 0 0 4 6 
Lungs - Hypoplastic/Atelectatic 3 0 3 1 0 0 1 7 5 0 12 16 
Gastrointestinal Abnormalities  
Esophagus - Atresia/TE fistula 1 0 1 0 1 0 1 1 0 0 1 3 
Gallbladder - A/Dysgenesis 1 0 1 2 0 1 3 4 3 0 7 11 
Hepatomegaly 0 0 0 2 1 0 3 1 2 0 3 6 
Intestinal Malrotation 0 0 0 0 1 0 1 0 0 0 0 1 
Splenomegaly 0 0 0 0 0 0 0 2 0 0 2 2 
Genito-Urinary Abnormalities 
Cryptorchidism 0 1 1 0 0 1 1 0 8 0 8 10 
Genitalia - Ambiguous 0 0 0 0 1 0 1 0 9 0 9 10 
Genitalia - Hypoplastic/Small 1 0 1 1 1 1 3 1 5 0 6 10 
Leydig Cell Hyperplasia 0 0 0 0 0 0 0 0 4 0 4 4 
Ovarian abnormalities 1 0 1 1 0 0 1 5 0 0 5 7 
Ovotestes 0 0 0 0 0 0 0 0 1 0 1 1 
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Renal abnormalities 2 0 2 2 2 0 4 8 6 0 14 20 
Endocrine/Metabolic Disorders 
Adrenal hypoplasia 2 0 2 2 2 1 5 7 6 0 13 20 
Thymus - A/Dysgenesis 1 0 1 0 1 0 1 1 3 0 4 6 
Thyroid - A/Dysgenesis 0 0 0 0 0 1 1 1 1 0 2 3 
Hypobilirubinemia/Jaundice 0 0 0 2 0 0 2 2 1 3 3 5 
Placental Abnormalities  
PHM with Abnormal Fetus 0 0 0 1 3 1 5 7 4 2 13 18 
PHM with Normal Fetus 0 0 0 0 0 0 0 0 0 0 0 0 
Other/Non-molar 0 0 0 0 1 0 1 2 5 0 7 8 
Small/Hypoplastic 3 1 4 0 0 0 0 6 0 0 6 10 
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Table 16.  Phenotype comparison between 2n/3n mixoploidy and complete triploidy 
  2n/3n 3n 
Totals 62 67
Prenatal  
Polyhydramnios 1 4
Oligohydramnios 5 10
IUGR 21 35
Premature birth ( < 37 weeks) 8 17
Craniofacial 
Cranium - Asymmetric/Dysplastic 8 6
Ears - Low set/Dysplastic 17 29
Epicanthal folds ? 2 3
Facies - Peculiar/Other 9 12
Fontanelles - Abnormal size 2 6
Forehead - Bossed/Prominent 13 3
Hypertelorism/Telecanthus 10 10
Hypotelorism 1 1
Macrocephaly 3 16
Macroglossia 4 2
Microcephaly 4 5
Micro(retro)gnathia 19 17
Microstomia 8 10
Nose - Unusual shape 18 17
Ocular anomalies 10 11
Palate/Lip - Cleft 5 10
Palate - High Arched 3 2
Palpebral Fissures - Abnormal 8 8
Upper Limbs 
Thin/Hypoplastic 7 1
Fingers - Arachnodactyly 3 3
Fingers - Clino/Camptodactyly 15 5
Fingers - Syndactyly 27 23
Hands/Digits - Aberrant placement 2 9
Joint Deformities 8 4
Palmar crease - Single transverse 16 12
Lower Limbs 
Thin/Hypoplastic 8 1
Feet - Rocker bottom/Talipes 12 10
Joint Deformities 6 4
Toes - Sandal Gap 5 4
Toes - Syndactyly 22 20
Trunk/Other General Malformations 
Abdominal wall defects 1 11
Asymmetry - Body 11 0
Asymmetry - Face 11 1
Asymmetry - Limbs 7 0
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  2n/3n 3n 
Dermatoglyphics - Abnormal 2 1
Hematopoietic abnormalities 3 6
Hypotonia/Dyskinesia 17 10
Kyphosis/Lordosis/Scoliosis 12 0
Nipples - Abnormal/Supernumerary 4 3
Pigmentary anomalies 16 0
Truncal obesity 12 0
Developmental/Neurological 
Feeding difficulty/Dysphagia 6 1
Hearing Loss 3 0
Mental/Psychomotor Retardation 29 2
Neonatal Areflexia/Dysreflexia 4 6
Neonatal Respiratory Distress 6 12
Postnatal growth deficiency 8 1
Seizures/Abnormal EEG 13 2
Central Nervous System 
Cerebellum - Abnormalities 2 2
Cerebrum - General/Gyral Anomalies 3 11
Corpus Callosum - Agenesis 2 7
Holoprosen/telencephaly 1 12
Hydrocephaly/Ventriculomegaly 7 11
Myelomeningocele/Spina bifida 1 7
Cardiovascular & Pulmonary Abnormalities 
Atrial/Ventricular septal defect 8 10
PDA/PFO 4 3
Complex heart disease 3 10
Valvular defects 2 2
Lungs - Abnormal lobation 1 6
Lungs - Hypoplastic/Atelectatic 2 16
Gastrointestinal Abnormalities 
Esophagus - Atresia/TE fistula 0 3
Gallbladder - A/Dysgenesis 1 11
Hepatomegaly 1 6
Intestinal Malrotation 2 1
Splenomegaly 0 2
Genito-Urinary Abnormalities  
Cryptorchidism 6 10
Genitalia - Ambiguous 6 10
Genitalia - Hypoplastic/Small 12 10
Genitalia - Normal female - XX/XXY 2  
Leydig Cell Hyperplasia 1 4
Ovarian abnormalities 1 7
Ovotestes 3 1
Precocious puberty 4  
Renal abnormalities 4 20
Endocrine/Metabolic Disorders  
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  2n/3n 3n 
Adrenal hypoplasia 6 20
Thymus - A/Dysgenesis 0 6
Thyroid - A/Dysgenesis 0 3
Hypobilirubinemia/Jaundice 0 5
Placental Abnormalities  
PHM with Abnormal Fetus 1 18
PHM with Normal Fetus 4 0
Other/Non-molar 1 8
Small/Hypoplastic 1 10
Apparent CPM 1  0
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APPENDIX D 
 
 
 
DATA USED IN THE CONTSTRUCTION OF FIGURE 1 
 
 
 Table 17 shows the raw data used in the construction of Figure 1.  For each study where the 
gestational ages of individual cases were listed, the gestational ages (given in weeks) are divided between 
diandric and digynic cases.  The numbers in bold next to the words “diandric” and “digynic” represent the 
mean gestational ages of that group of cases in that particular study.  The two earliest studies initially 
reported their data in menstrual age and this was converted to gestational age by subtracting two weeks.  
Additionally, most studies listed the gestational age in the format (weeks)+(days).  For the purpose of 
constructing this figure, gestational ages listed as (weeks)+(4-6 days) were rounded up to the next whole 
week and those listed as (weeks)+(0-3 days) were rounded down to the whole week.  Table 18 shows the 
total number of diandric and digynic triploids listed by gestational age in one week intervals from six 
weeks or less to 22 weeks or more.    Because the distribution for individual weeks was uneven, and 
particularly due to a large discrepancy in the number of diandric versus digynic cases at 18 weeks 
gestation, it was necessary to use two week intervals to produce a neater graph.  Additionally, since there 
were 34 more cases of diandric triploidy than digynic triploidy, the totals for digynic triploidy on each 
two week interval were multiplied by a factor of approximately 1.45 in order to adjust the population so it 
appeared the data included equal numbers of diandric and digynic triploids.  These adjusted values are 
shown in Table 19.  The numbers in table 19 represent the final form of the data used to construct Figure 
1. 
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Table 17.  Gestational ages of individual cases 
Jacobs et al.,  1982 - Gestational ages (Menstrual age - 2 weeks) 
Diandric 15.54 Digynic 8.50 
7 17 18 22 7 9 10 7 
17 18 18 11 7 22 6 9 
13 19 9 22 7 10 13 7 
5 18 13 16 8 9 7 5 
17 29 10 26 7 8 7 8 
16 15 22 13 7 7     
16 14 11 12         
17 15 15 25         
10 15 17 12         
11 13 10 20         
20 18 17 14         
12 16 27 14         
18 9 13 16         
16 10 16 11         
15               
Proctor et al., 1994 - Gestational ages (Menstrual age - 2 weeks) 
Diandric 11.17 Digynic   
10 19 7 6         
13 12             
Miny et al., 1995 
Diandric 16.20 Digynic 19.82 
18 10 17 18 16 8 33 19 
18       17 19 28 21 
        19 16 22   
Baumer et al., 2000 - Gestational ages 
Diandric 22.80 Digynic 20.50 
28 37 22 19 19 29 34 17 
8       25 21 17 17 
        17 22 24 22 
        14 19 18 17 
        30 20 20 8 
Zaragoza et al., 2000 - Gestational ages 
Diandric 12.02 Digynic 9.89 
14 10 6 18 6 7 12 11 
13 18 18 5 10 15 8 13 
12 8 12 12 10 10 5 8 
14 13 10 13 11 11 12 12 
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6 13 9 7 8 10 9 7 
7 12 12 12 9 5 7 13 
11 10 13 16 19 7 12   
14 11 16 13         
16 10 11 10         
15 13 5 14         
15 14 13 15         
11 11 7 12         
13 10 15 13         
19 11 10 13         
13 12 13 9         
McFadden & Robinson, 2006 - Gestational ages 
Diandric 13.38 Digynic 9.88 
18 9 8 10 8 10 8 9 
17 15 15 15 12 10 14 5 
        10 6 17 10 
        10 8 10 11 
 
Table 18.  Breakdown of diandric and digynic triploids by gestational age 
 Diandric Digynic 
≤ 6 weeks 6 7 
7 weeks 5 14 
8 weeks 3 11 
9 weeks 5 6 
10 weeks 14 12 
11 weeks 10 4 
12 weeks 12 5 
13 weeks 19 4 
14 weeks 8 2 
15 weeks 12 1 
16 weeks 10 2 
17 weeks 8 7 
18 weeks 13 1 
19 weeks 4 6 
20 weeks 2 1 
21 weeks 1 2 
≥ 22 weeks 9 12 
Totals 141 97 
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Table 19. Final form of the data used to construct Figure 1 
Gestational age (weeks) Diandric Digynic Digynic (Adjusted)* 
≤ 7 11 21 30.52577 
8-9 8 17 24.71134 
10-11 24 16 23.25773 
12-13 31 9 13.08247 
14-15 20 3 4.360825 
16-17 18 9 13.08247 
18-19 17 7 10.17526 
20-21 3 3 4.360825 
≥ 22 9 12 17.4433 
Totals 141 97 141 
* Adjustment value for digynic triploids: 1.453608 
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